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1. INTRODUCTION 
The introduction of new and more sensitive analytical equipment for the detection of 
chemicals in complex sample matrices on the one hand and a growing knowledge about 
their ecotoxicological effects on the other hand has drawn the attention to new 
compounds, which have heretofore been largely outside the scope of monitoring and 
regulation. These so-called ‘chemicals of emerging concern’ (CECs) or ‘emerging 
contaminants’, were previously undetected or had not been considered as a risk [1-3]. The 
term emerging contaminants is however somewhat ambiguous since these contaminants 
are not necessarily new substances [4]. CECs encompass a diverse group of compounds, 
including algal and cyanobacterial toxins, brominated and organophosphate flame 
retardants, plasticizers, hormones and other endocrine disrupting compounds (EDCs), 
pharmaceuticals and personal care products (PPCPs), drugs of abuse and their 
metabolites, disinfection by-products, organometallics, nanomaterials, polar pesticides 
and their degradation/transformation products, perfluorinated compounds (PFCs), and 
surfactants and their metabolites [5]. Both the high environmental distribution of CECs 
and their potential ecotoxicological effects at very low concentrations have found 
increasing interest among researchers, regulating authorities and the public [2,4].  
In addition, the introduction of the European Reach Legislation has drawn the attention 
towards the emerging more polar anthropogenic pollutants. According to Hogenboom et 
al. [6], REACH will drive producers to develop newly designed chemicals that will be 
less persistent, bioaccumulative or toxic. Generally, these newly designed chemicals 
could be characterized as hydrophilic compounds, which may result in higher mobilities 
in the aquatic environment [6]. This shift in focus from persistent organic pollutants and 
heavy metals towards more polar CECs, has already become apparent in the scientific 
literature of the last decade on environmental chemistry [5,7].  
Concentrations of CECs in aquatic systems are very low, typically in the ng L-1 
concentration level up to the low µg L-1 range. Relatively low concentrations of CECs 
may be expected to occur in biotic matrices as well. Therefore, very sensitive analytical 
procedures are needed to obtain sufficiently low detection limits enabling measurement of 
environmental concentrations. In addition, biotic samples are complex matrices 
containing high amounts of possible interfering compounds demanding extensive 
extraction and clean-up procedures to obtain extracts amenable to analysis. As a result, 
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the reliable quantification of CECs in both aqueous and biological samples has appeared 
as a huge challenge to environmental analytical chemists. The possible solutions to 
encounter these challenges are reviewed within this work. In this context, state-of-the-art 
instrumentation for sample preconcentration, analyte separation and detection was 
discussed. PPCPs, pesticides, estrogenic compounds, alkyphenolethoxylates (APEOs), 
bisphenol A (BPA) and phthalates are contaminants of particular concern, as many of 
them exhibit endocrine-disrupting properties [8]. Therefore, the analytical chemistry of 
these groups of CECs was surveyed within this review. In addition, PFCs were also 
considered, since these bioaccumulative chemicals are known to be abundant in the 
aquatic environment, where they could exert possible adverse effects on human and 
wildlife [9]. 
 
2. EMERGING MICROPOLLUTANTS 
2.1 Pharmaceuticals 
Pharmaceuticals are the active ingredients of medicinal products extensively used in 
human and veterinary medicine [10]. The group of pharmaceuticals include 
approximately 3,000 different natural or synthetic chemicals with a large variation in 
chemical structure, function, mode of action and behaviour [11-13]. This wide group may 
be classified into different therapeutic classes. The most common classes are the 
antibiotics, nonsteroidal anti-inflammatory drugs (NSAIDs), β-blockers, lipid regulators, 
antiepileptic drugs, β2-sympathomimetics, cancer therapeutics and psychiatric drugs. 
Unintentionally, the universal use of pharmaceuticals turned out to a relative new 
environmental concern: their introduction into the aquatic environment [14]. Typically, 
human pharmaceuticals are excreted, either in their native form or as metabolites, 
followed by release into the aquatic environment through the wastewater treatment 
network [13,15]. In addition, improper disposal and manufacturing processes could 
contribute to the overall pharmaceutical load in aquatic systems as well [16,17]. 
Furthermore, also veterinary pharmaceuticals are introduced in huge amounts into the 
aquatic environment, either directly via excretion of grazing animals and fish farms, or 
indirectly via land application of manure [18]. Because of their continuous release into 
the aquatic environment, pharmaceuticals are considered as “pseudopersistent 
compounds” [16]. Consequently, growing public and scientific concern has arisen 
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regarding the occurrence and potential effects of pharmaceuticals in the aquatic 
environment [19]. The chemical structures of the pharmaceuticals considered in this 
doctoral thesis are presented in Figure I.1. 
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Figure I.1. Chemical structures of the targeted pharmaceuticals within this doctoral thesis.  
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2.2 Personal care products 
Personal care products (PCPs) are generally considered together with the pharmaceuticals 
as the group of pharmaceuticals and personal care products (PPCPs). However, unlike 
pharmaceuticals, PCPs are substances intended for external use on the human body [20]. 
PCPs constitute a diverse group of compounds which are used in soaps, lotions, 
toothpaste, fragrances, sunscreens, a.o. The main classes of PCPs include ultraviolet (UV) 
filtering compounds, insect repellents, fragrances, disinfectants and preservatives. The 
chemical structures of some well-known PCPs are shown in Figure I.2.  
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Figure I.2. Chemical structures of some environmentally important PCPs. 
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PCPs are generally not subjected to metabolic alterations, resulting in the release of large 
quantities of unaltered compounds into the environment [20]. Consequently, in 
accordance with the pharmaceuticals, concern about PCPs is related to their presence in 
the aquatic environment and their potential to elicit adverse environmental effects [21]. 
2.3 Polar pesticides 
Pesticides are substances or mixtures of substances aimed at preventing, destroying, 
repelling or mitigating pests. They comprise a large number of compounds that belong to 
many chemical structurally diverse groups, which may be divided based on functional 
groups in their molecular structure (e.g. inorganic, organonitrogen, organohalogen or 
organosulfur compounds), or based on their specific biological activity towards target 
species (e.g. insecticides, fungicides, herbicides, acaricides, etc.). Within these different 
classes, herbicides are the most frequently applied pesticides followed by insecticides, 
fungicides and others [22-24]. Pesticides are generally utilized for agricultural practices, 
but also for forestry, horticulture, or amenities (including highways, airports, railways, 
industrial sites, parks, public spaces, and sport grounds) [25,26]. Their worldwide use 
resulted in an increasing concern in two areas. Firstly, there is a general concern about the 
possible presence of residues of pesticides and their metabolites in foods, which have, in 
any stage of their growth or production cycle, been treated with pesticides [22]. Secondly, 
land application of pesticides and subsequent drift, run-off, drainage, and leaching has 
lead to the contamination of the aquatic environment, with resulting potential toxic and 
harmful effects to non-target aquatic organisms [27,28]. A large group of pesticides are 
also considered as EDCs [29]. 
2.4 Endocrine disrupting compounds 
According to the US Environmental Protection Agency (EPA), an environmental EDC is 
defined as an exogenous agent that interferes with the synthesis, secretion, transport, 
binding, action, or elimination of natural hormones in the body that are responsible for 
the maintenance of homeostasis, reproduction, development, and/or behaviour [30]. 
Typical representative endocrine disruptors are natural and synthetic hormones, such as 
estrone (E1), 17β-estradiol (βE2), 17α-estradiol (αE2), estriol (E3), mestranol (MeEE2) 
and the synthetic contraceptive 17α-ethynylestradiol (EE2) [31]. The group of EDCs 
includes also phyto-estrogens, plant-derived estrogenic substances, which are believed to 
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induce sexual disruption in aquatic life, albeit with reduced potency as compared to the 
natural and synthetic hormones mentioned above [32]. Furthermore, a large group of 
man-made CECs act like EDCs as well: APEOs, metabolites and derivates used as 
surfactants (e.g. 4-nonylphenol); BPA which is particularly utilized in the manufacture of 
polycarbonate plastics and epoxy resins [31]; PPCPs (section 2.1 and 2.2), pesticides 
(section 2.3), phthalates (section 2.5), a.o. The chemical structures of several 
environmentally important EDCs are demonstrated in Figure I.3.  
 
Estrone (E1) 
 
Estradiol (E2)
 
Ethinylestradiol (EE2)
Nonylphenol 
 
Bisphenol A
 
Phthalates (general structure)
 
Figure I.3. Chemical structures of environmentally important EDCs. 
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application, phthalates are ubiquitous in the environment and have been widely detected 
in food, air, water, soil and sediments [35]. Within the group of phthalates, di(2-
ethylhexyl)phthalate (DEHP) and n-dibutylphthalate (DBP) have been reported to be the 
most ubiquitous phthalates in environmental samples [38]. Since phthalates are often 
mentioned as suspected endocrine disruptors, increased scientific attention has been 
granted to these CECs [35,39].  
2.6 Perfluorinated compounds 
Perfluorinated compounds (PFCs) comprise a diverse group of chemicals characterized 
by a fluorinated hydrophobic carbon chain substituted with various hydrophilic functional 
groups. The hydrophobic carbon chain may vary in chain length, is fully or partially 
fluorinated, and may be linear or branched [40,41]. Within the group of PFCs, the 
perfluoroalkyl carboxylates (PFCAs) and perfluoroalkyl sulfonates (PFSAs) are the most 
intensively studied, with perfluorooctanesulfonate (PFOS) and perfluorooctanoate 
(PFOA) as the pollutants of greatest concern [40]. Because of their chemical and thermal 
stability and their specific surfactant properties, PFCs are used in a great number of 
industrial and consumer applications and products: as additives in fire-fighting foam and 
food packaging, as fat and water repellents for textile, paper and leather treatment, as 
performance chemicals, and as polymerization aid for the production of fluorinated 
polymers such as polytetrafluoroethylene (PTFE) and polyvinylidene fluoride (PVDF) 
[40,42]. In addition, PFCs are known to be stable to heat, acids and bases, and to reducing 
and oxidizing agents. Consequently, PFCs have been reported to be extremely persistent 
environmental contaminants with bioaccumulative and toxic properties [43-45]. 
Therefore, the concern about the environmental fate and prevalence of PFCs has been 
recognized as an emerging issue in environmental chemistry. Moreover, PFOS is recently 
included in the Annex B list of the Stockholm Convention on Persistent Organic 
Pollutants (POPs), which is a global treaty to protect human health and the environment 
from chemicals that remain intact in the environment for long periods, become widely 
distributed geographically, accumulate in the fatty tissue of humans and wildlife, and 
have adverse effects to human health or to the environment, [325,326]. The chemical 
structures of the PFCs considered in this doctoral work are shown in Figure I.4.  
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Compound Abbreviation Structural formula Structure 
Perfluoroalkyl sulfonates PFASs  S
FF
C
C
F
F
F
n
O-
O
O
Perfluorobutane sulfonate  PFBS C4F9SO-3 n = 3 
Perfluorohexane sulfonate PFHxS C6F13SO-3 n = 5 
Perfluorooctane sulfonate PFOS C8F17SO-3 n = 7 
Perfluorodecane sulfonate PFDS C10F21SO-3 n = 9 
Perfluoroalkyl carboxylic acids PFCAs  C
O
OH
FF
C
C
F
F
F
n  
Perfluoropentanoic acid PFPA C5HF9O2 n = 3 
Perfluorohexanoic acid PFHxA C6HF11O2 n = 4 
Perfluoroheptanoic acid PFHpA C7HF13O2 n = 5 
Perfluorooctanoic acid PFOA C8HF15O2 n = 6 
Perfluorononanoic acid PFNA C9HF17O2 n = 7 
Perfluorodecanoic acid PFDA C10HF19O2 n = 8 
Perfluoroundecanoic acid PFUnA C11HF21O2 n = 9 
Perfluorododecanoic acid PFDoA C12HF23O2 n = 10 
Perfluorotetradecanoic acid PFTeA C14HF25O2 n = 12 
Perfluorooctane sulfonamide PFOSA C8H2F17SO2N 
S
FF
C
C
F
F
F
7
NH2
O
O
 
Figure I.4. Chemical structures of the targeted PFCs within this doctoral thesis. 
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3. ENVIRONMENTAL CHEMISTRY 
In recent years, advances in instrumentation have resulted in a significant progress in the 
detection of CECs in environmental matrices. Within this review, it was not our objective 
to give a complete compilation of papers dealing with analysis of CECs. Instead, it was 
our purpose to discuss the current performance in quantifying CECs in the aquatic 
environment and highlight some recent advances. 
3.1 Pharmaceuticals 
3.1.1 Water analysis 
Overall, hundreds of papers have been published on pharmaceutical analysis of non-
treated and treated waters [46]. Still, it has taken until 2007 for the US EPA to publish the 
EPA Method 1694 [47], a standardized methodology for the analysis of more than 70 
pharmaceuticals in environmental matrices. Recently, this standard protocol was 
improved by Ferrer et al. [46]. Within both methodologies, the target pharmaceuticals are 
divided in several subgroups of compounds, each with their specific optimized analytical 
procedure. As a result of their typical physicochemical properties and chemical structures, 
this division into smaller subgroups is required. Consequently, the development of 
multiclass methods, which is the general trend in recent years, demands a compromise in 
the selection of experimental conditions such as sample preparation, separation and 
detection [5,48]. Nevertheless, a typical procedure for the analysis of a broad group of 
pharmaceuticals in aqueous matrices has been reported in literature and is shown in 
Figure I.5 [49]. This procedure included filtration and acidification for acidic 
pharmaceuticals, extraction, if necessary an additional clean-up step, derivatization in 
case of detection with gas chromatography (GC) and finally detection with GC or liquid 
chromatography (LC) in combination with mass spectrometry (MS). 
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Figure I.5. Typical procedure for the analysis of pharmaceuticals in aqueous matrices, as reported by 
Fatta et al. [49]. 
 
Until 2007, all studies reporting on procedures for pharmaceutical analysis have been 
thoroughly reviewed by Fatta et al. [49] and Kot-Wasik et al. [50]. Within recent years, 
there has been a tremendous progress in analytical techniques for trace analysis in 
environmental samples [51]. Therefore, the most recent studies on pharmaceutical 
analysis, from sample preparation to analyte separation and detection, are discussed 
below.  
At first, filtration of water samples was suggested prior to the concentration procedure, to 
remove particulate matter and to avoid clogging of the sorbent used for solid-phase 
extraction (SPE) [51-53]. However, filtration removes together with suspended solids 
also the fraction of target compounds sorbed to particulates [54]. Therefore, it was 
recommended to wash the glass fiber filters with methanol after filtration [55]. 
Centrifugation of wastewater samples was performed as well in case of observable 
suspended particulate matter [56]. Before sample extraction, the pH of the samples was 
Aqueous sample
Filtration
(and acidification
for acidic pharmaceuticals)
LC-MS
LC-MS²
GC-MS
GC-MS²
Extraction
SPE, SPME, LPME, lyophilization
(Clean-up)
Solvent exchange, SPE cartridges
Derivatization
(on-line or off-line)
Methylation
Silylation
Pentafluorobenzylation
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adjusted or reagents may be added to optimize the extraction efficiency. Studies 
suggested to adjust the pH to acidic, basic or neutral conditions, depending on the analyte 
[47,55,57,58]. In addition, chelating agents (e.g. di- or tetrasodium 
ethylenediaminetetraacetate: Na2EDTA or Na4EDTA), quenching agents (e.g. ascorbic 
acid) and other preservatives could be added to samples prior to extraction [47,59-61]. 
Further sample preparation and clean-up is necessary for three main reasons: to remove 
interferences which would otherwise affect the determination of analytes, to concentrate 
analytes to detectable concentrations, and to perform solvent switching to the desired 
solvent conditions used for detection. Up to date, SPE is still the most frequently applied 
sample preparation technique. Using SPE, improved retention of pharmaceuticals was 
obtained by the development of new polymeric sorbents, mostly hydrophilic-hydrophobic 
balanced material. The copolymer of divinylbenzene and vinylpyrrolidone, better known 
as Oasis HLB, is currently the most commonly used SPE-sorbent for extraction of 
multiclass pharmaceuticals, next to the copolymer sorbents of Isolute ENV+, Strata-X 
and Chromabond HR-X [51,55,62]. Sorbents of sol-gels and carbon nanotubes are used 
less frequently [63]. SPE has generally been performed offline, thus prior to separation 
and detection of pharmaceuticals. Currently, on-line SPE is emerging as an effective 
technique, either coupled online with an LC-system or as a fully automated system 
[51,64-66]. According to Trenholm et al. [66], online systems provide a rapid, sensitive 
and robust alternative method to traditional off-line SPE, demanding smaller solvent 
volumes. Drawbacks of online systems are the capital cost for commercial systems, the 
limited sample size resulting in higher detection limits and the possible contamination of 
the SPE cartridge [51,62,66].  
A promising extraction and clean-up technique for pharmaceuticals in environmental 
matrices is the use of molecularly imprinted polymers (MIPs) [62]. Due to specific 
cavities designed for a template molecule, MIP sorbents provide an increased selectivity 
and specificity for target analytes [67]. Consequently, the level of co-extracted matrix 
compounds is reduced, which leads to less matrix effects and a better sensitivity [68]. The 
use of MIPs as a selective sorbent in a SPE procedure (MISPE) has been successfully 
applied for several therapeutic classes [69-71]. However, the sorbent material must be 
custom-made and multiclass analysis is not achievable using this technique [62]. Two 
other approaches enabling extraction, clean-up and concentration of pharmaceuticals in 
aqueous samples simultaneously, are solid-phase (SPME) and liquid-phase (LPME) 
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microextraction. These techniques have been frequently applied for extraction of 
pharmaceuticals from aqueous samples [72-75]. A reduction in processing time, labour, 
costs and matrix effects is achieved using SPME and LPME, however, the sensitivity and 
precision tend not to be as good as the commonly used SPE techniques [62,72]. Stir-bar 
sorptive extraction (SBSE), a related technique of SPME which is usually followed by 
liquid or thermal desorption (LD or TD) in combination with GC, has recently been 
applied for detection of ibuprofen, naproxen and ketoprofen [76]. 
Even with advanced detectors such as high resolution or triple quadrupole mass 
spectrometers (QqQ-MS), good chromatographic separation is desired for the 
quantification of pharmaceuticals in environmental matrices down to ng L-1 concentration 
levels [62]. GC is the preferred technique for separation of non-polar and volatile 
pharmaceuticals, while for GC-analysis of the more polar pharmaceuticals a 
derivatization step is required using typical derivatizing agents such as acid anhydrides, 
benzyl halides, alkylchloroformates, diazomethane and silylating reagents including N-
methyl-N-(trimethylsilyl) trifluoroacetamide (MSTFA) or N-methyl-N-(tert-
butyldimethylsilyl) trifluoroacetamide (MTBSTFA) [19,51,77]. Despite the benefits of 
GC with respect to selectivity and sensitivity, the loss of analytes during the time-
consuming derivatization process and the background noise are a matter of concern 
[19,62,78]. Therefore, in recent years LC has become the preferred technique for 
multiclass pharmaceutical analysis [19,51,62]. Current LC analysis use reversed-phase 
columns and mobile phases consisting of acetonitrile, methanol and water. Generally, 
solvent modifiers in the form of proton acceptors (e.g. ammonium acetate) and/or proton 
donors (e.g. formic acid) are added to the mobile phase to enhance ionisation efficiencies 
of basic and acidic pharmaceuticals, respectively [48]. The main negative aspect for LC 
analysis of pharmaceuticals in environmental matrices, is the occurrence of matrix 
effects. Due to co-extracted matrix constituents, the mass spectrometric analysis may 
suffer from signal suppression or enhancement, thereby disturbing adequate 
quantification [79]. Nowadays, the development of ultra-high performance liquid 
chromatography (U-HPLC) enabled faster separation of compounds in comparison to 
conventional LC, due to the use of columns packed with sub-2 µm particles. U-HPLC 
provides improved speed of analysis, as well as a better resolution, an increased 
sensitivity and a reduction of matrix effects [56,57,62]. In general, considerably improved 
separation of pharmaceuticals in complex matrices could be obtained using U-HPLC 
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[51]. An alternative to chromatographic procedures is the use of capillary electrophoresis 
(CE). The importance of this technique is somewhat limited, due to the typically lower 
sensitivity using CE, even in combination with mass spectrometric detection techniques 
[80]. Nevertheless, recent studies have demonstrated the applicability of CE and its 
related technique based on elektrokinetic supercharging (EKS) for pharmaceutical 
analysis [81,82]. 
Identification and quantification of pharmaceuticals in environmental matrices is usually 
performed by mass spectrometric techniques. The most common interface for 
pharmaceutical analysis in environmental matrices is the electospray ionization (ESI) 
source [51,62,83]. In particular in case of complex environmental samples, the ESI 
efficiency can be affected by the co-extracted sample components, resulting in ionization 
suppression or enhancement effects and subsequent poor analytical accuracy and 
reproducibility [83]. These effects can be reduced by extensive clean-up procedures prior 
to LC-MS analysis, improved chromatographic separation and by dilution of the final 
extract. However, the most common technique is the compensation of matrix effects by 
the use of isotope-labelled internal standards, enabling reliable quantification [78,83]. 
Nevertheless, evaluation of matrix effects is usually included in the validation study of 
new analytical approaches for pharmaceutical analysis using ESI [46,48,52]. The second 
“soft” ionization technique atmospheric pressure chemical ionization (APCI) has been 
used less often for pharmaceutical analysis. APCI has been reported to be less susceptible 
to matrix effects, however, generally minor sensitivity is obtained as compared to ESI 
[62,83].  
With respect to MS, the most commonly applied mass analyzers for pharmaceutical 
analysis are the QqQ mass detectors, providing precise quantification and high selectivity 
and sensitivity [52,60,62]. Using QqQ technology, typical limits of detection are in the 
low ng L-1 concentration range [48,57,62,73]. Concerning the performance and 
confirmation criteria for residues in complex matrices, the European Union Commission 
Decision 2002/657/EC was established, including a system of identification points [84]. 
An ion (or precursor ion) contributes one point, and each multiple reaction monitoring 
(MRM) product ion yields 1.5 point [84]. Using QqQ, the minimum of four identification 
points is accomplished easily, by comparing two MRM precursor-to-product ion 
transitions [62]. Also ion trap mass analyzers have been reported in literature as excellent 
detection apparatus for pharmaceutical analysis [55,85-87]. Using ion trap instruments, a 
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minimum of four identification points is obtained by detection of the precursor ion, as 
well as at least two product ions. Recent advances in instrumentation resulted in a gain in 
popularity of the high-resolution full scan analysis. Time-of-flight (ToF) and Orbitrap-
based MS proved to be very suitable alternatives to triple quadrupole instruments, 
enabling the accurate mass screening of a virtually unlimited number of analytes, being 
targeted as well as untargeted compounds [88]. Thanks to the high mass resolution, 
advantages of these instruments include increased selectivity and reduced false positives. 
In addition, the full scan data permits retrospective analysis of an unlimited number of 
pharmaceuticals [62,89]. So far, the use of single ToF and Orbitrap instruments for 
analysis of pharmaceuticals in environmental matrices is rather limited [89,90]. More 
common, the combination of two mass spectrometric techniques with complementary 
features has been used. These highly sophisticated MS analyzers or so-called hybrid 
tandem mass spectrometers constitute the latest trend in environmental chemistry, 
increasing the instruments versatility and the scope of the method [89]. In addition, 
sensitivities approaching that of QqQ systems are offered using these hybrid MS 
technology [62]. The hybrid systems that have been used for pharmaceutical analysis, 
include triple quadrupole/linear ion trap MS (QTRAP or QLIT) [59,64,72,89,91-93], 
quadrupole/time-of-flight MS (QToF) [94-97], and ion trap/Orbitrap MS [6]. Criteria 
within CD 2002/657/EC [84] related to the reliable identification and confirmation of 
pharmaceuticals using high-resolution MS systems are however incomplete. Therefore, 
additional criteria to be implemented were suggested by Nielen et al. [98]. In general, 
very high mass accuracy (< 5ppm) is offered by modern ToF and Orbitrap systems, 
providing reliable identification and quantification of pharmaceuticals in environmental 
matrices [90,96]. 
Mass spectrometric techniques are applied upon gas chromatographic separation of the 
pharmaceuticals as well. GC-MS is typically performed using electron impact (EI) 
ionization, in full scan mode for identification and in selected-ion-monitoring (SIM) 
mode for quantification purposes. Limits of quantification (LOQs) in the low ng L-1 
concentration range have been obtained, and no obvious matrix effects were observed 
using GC-MS [53,77,78].  
Less expensive detection techniques, as compared to MS, include the use of fluorescence 
detection (FLD), ultraviolet (UV) detection, diode array detection (DAD) and 
immunoanalytical techniques. Several recent studies have reported the use of these 
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techniques for pharmaceutical analysis in aqueous matrices [70,74,99-101]. Generally, 
rather low sensitivities are obtained using these techniques, limiting their use for aqueous 
matrices containing high amounts of pharmaceuticals such as wastewaters. 
3.1.2 Sediment analysis 
Despite the rather low lipophilicity of pharmaceuticals, interaction of the polar functional 
groups of pharmaceuticals with organic matter and/or minerals may result in adsorption 
to solids [53]. Furthermore, the application of sewage sludge as a fertilizer to agricultural 
land and the reuse of manure containing veterinary medicines may lead to the 
introduction of pharmaceuticals into the soil as well [51,102]. Therefore, in accordance 
with aqueous samples, the presence of pharmaceuticals in sediment, soil and sewage 
sludge has been studied extensively. Analytical methods for the determination of specific 
groups of pharmaceuticals including NSAIDs [103], anti-depressants [104], antibiotics 
[105] and β-blockers [106], as well as multiclass methods [92,102] have been reported in 
literature in recent years. The main difference with water analysis is related to the sample 
preparation and extraction part. Generally, pharmaceuticals are extracted from dried solid 
samples by conventional Soxhlet extraction [107], microwave-assisted (micellar) 
extraction (MA(M)E) [108,109], ultrasonic extraction [53,78,110,111], supercritical fluid 
extraction (SFE) [103], or pressurized liquid extraction (PLE) [92,102,112]. Nowadays, 
Soxhlet extraction has become less attractive due to its time- and solvent-consuming 
properties [51]. All five techniques were compared for the determination of four NSAIDs 
in river sediment [103]. Based on extraction efficiencies, average solvent consumption 
and extraction time, MAE was found to be the most effective extraction method. 
However, the most commonly used approaches seem to be ultrasonic extraction and PLE, 
providing good extraction efficiencies and demanding less extraction time and solvents 
[51,113]. Typically, mixtures of water and rather polar solvents (e.g. methanol and 
acetonitril) are used for achieving good recoveries during extraction [78,92,111]. An 
additional clean-up step by means of SPE is usually required. Finally, analysis of extracts 
is performed using the techniques described in the previous section [53,107,112]. 
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3.1.3 Biota analysis 
The presence of pharmaceuticals in aquatic organisms has been rarely studied, due to 
both the complexity of the matrix and the levels at which pharmaceuticals occur. Ramirez 
et al. [114] reported a screening method for the detection of 23 pharmaceuticals in fish 
tissue, based on extraction using a 1:1 mixture of 0.1 M aqueous acetic acid and methanol 
before analysis using LC-MS/MS. Another study described the use of MAME and SPE 
followed by UV-DAD of six pharmaceuticals in molluscs [108]. Four tetracycline 
antibiotics could be determined in fish muscle by SPME coupled to HPLC-photodiode 
array detector [115]. More recent, PLE and SPE followed by U-HPLC coupled to QqQ 
MS enabled the quantification of 11 pharmaceuticals in tissue of marine organisms [116]. 
To the best of our knowledge, no more attention has been paid to the analysis of 
pharmaceuticals in aquatic organisms. To obtain more information regarding their 
presence in marine organisms, an increasing demand exists for reliable analytical 
methods allowing the quantification of these micropollutants in biotic matrices [79]. 
3.1.4 Passive samplers 
The conventional techniques of sampling, based on the collection of discrete grab or spot 
samples of water, are used in most aquatic monitoring programmes [117]. Although these 
conventional sampling techniques are very useful, generally, the determination of time-
weighted average (TWA) concentrations over extended sampling periods of pollutants in 
the aquatic environment is not possible. As a result, the use of passive samplers, which 
are designed to obtain TWA concentrations, has gained in popularity. In addition, these 
techniques mimic biological uptake in a more straightforward manner by determining the 
pollution level of contaminants in relation to their freely dissolved concentration 
[118,119]. With respect to pharmaceuticals, the use of passive sampling devices such as 
polar organic chemical integrative samplers (POCISs; see Figure I.6) and Chemcatcher® 
passive samplers have been recently reported in literature [91,120-122]. Also 
poly(ethylene-co-vinyl acetate-co-carbon monoxide) (PEVAC) and polydimethylsiloxane 
(PDMS) has been used as passive sampling material for pharmaceuticals in the aquatic 
environment [90,119]. However, an important negative aspect of the passive sampler 
approach involves the need for laboratory calibration studies to enable correct 
concentration calculations [120].  
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After exposure, the passive sampler devices are usually extracted using polar organic 
solvents, such as methanol, acetone, acetonitrile, ethyl acetate and mixtures [91,119-122]. 
Upon evaporation to dryness, analysis could be performed by routine GC-MS or LC-MS 
methods [120-122]. Additionally, the use of QToF-MS, QLIT-MS and Orbitrap-MS for 
analysis of pharmaceuticals in passive sampler extracts has recently been reported in 
literature as well [90,91,119]. The suitability of high-resolution full scan analytical 
techniques for this application is high, since these MS instruments enable the examination 
of the presence in the sampler extracts of an infinite number of analytes, targeted as well 
as non-a priori selected pharmaceuticals. 
 
 
Figure I.6. Exploded view of a POCIS showing the sorbent layer contained between two membrane 
disks sandwiched between two support rings [324].  
3.2 Personal care products 
In general, the methodologies for PCP analysis in environmental samples are quite similar 
as those described for pharmaceuticals [51]. Therefore, only a shortened discussion was 
provided within this study. The typical applications are discussed for each group of PCPs.  
3.2.1 Water analysis 
3.2.1.1 UV filtering compounds 
UV absorbing compounds are increasingly applied as a result of a growing concern about 
UV radiation and skin cancer. This group includes benzophenones, salicylates, 
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cinnamates, camphor derivates, triazines, benzotriazoles, benzimidazole derivates, 
dybenzoyl methane derivates and others [123]. Sorptive extraction in combination with 
GC-analysis seems to be the proper analytical technology for determination of 
hydrophobic and volatile UV filtering compounds in water samples [51]. Recent studies 
have reported the use of SBSE for the extraction of PCPs from aqueous samples followed 
by TD-GC-MS [124,125] or LD-(U-HPLC)-MS [126]. SBSE followed by direct analysis 
in real-time mass spectrometry (DART-MS) provided a shorter analysis time, but 
detection limits are poorer and only semi-quantitative results can be obtained [127]. Other 
analytical approaches for PCP determination include microextraction by packed sorbent 
(MEPS) coupled directly to large volume injection-GC-MS [128], SPME with on-fibre 
derivatization by silylation followed by GC–MS/MS analysis [129] and SPE with GC-MS 
[130]. With respect to the benzophenones, derivatization of phenolic groups was needed 
to enable their detection in the low ng L−1 range [129]. All these GC methods are limited 
to those compounds that are volatile or can be derivatized for GC determination. If 
multiclass determination of UV filtering compounds in environmental samples is 
required, (U-)HPLC coupled to QqQ-MS is usually applied after a SPE step [126,131-
133].  
3.2.1.2 Insect repellents 
The group of insect repellents consists of chemically diverse substances [134]. N,N-
diethyl-m-toluamide (DEET) and 1-piperidinecarboxylic acid 2-(2-hydroxyethyl) 1-
methylpropyl ester (called Icaridin) have been reported as the most important analytes 
within this group [51]. These compounds have generally been analyzed with GC-MS 
[135]. Rodil and Moeder [134] enabled the detection of 8 insect repellents by SBSE 
followed by TD-GC-MS. However, several studies used SPE with subsequent LC-MS 
analysis as well [136,137]. Recently, SPE followed by LC–MS/MS using ESI in positive 
ion mode allowed the determination of 4 insect repellents obtaining limits of detection 
(LODs) in the low ng L-1 concentration range [132]. 
3.2.1.3 Fragrances 
The group of fragrances can be divided into nitro-aromatic musks, polycyclic musks and 
macrocyclic musks. Compounds of the nitro-aromatic and polycyclic musk classes are 
considered as ubiquitous, persistent and bioaccumulative pollutants, with the potential to 
generate toxicologically active compounds [138]. Recently, Bester [139] reviewed the 
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analytical approaches which have been used for the determination of fragrances. The use 
of SPE as sample preparation technique has been reported only occasionally [140,141]. 
Due to their hydrophobic, volatile and lipophilic properties, other extraction techniques 
clearly benefit above SPE [139]. Liquid/liquid extraction (LLE) has been applied for 
extraction of fragrances [142,143] as well as SBSE with LD [138] and microwave-
assisted headspace SPME [144]. Typically, good chromatographic separation is obtained 
by GC, commonly followed by mass spectrometric detection [139].  
3.2.1.4 Preservatives  
The most common preservatives are the P-hydroxybenzoic esters or parabens, which are 
used in PCPs but also as preservatives in pharmaceuticals and food products. Typically, 
the high usage and low degradability of these compounds may lead to their prevalence in 
the environment, thereby exhibiting estrogenic activities [135,145]. Therefore, parabens 
have been typically analyzed together with other EDCs using SPE followed by LC-MS or 
GC-MS [146,147]. So far, little efforts have been made for the separate determination of 
this group of compounds in environmental matrices.  
3.2.1.5 Disinfectants 
The main compounds within the group of disinfectants are triclosan and triclocarban, 
which are often used in soap, toothpaste, and other consumer products. Especially 
triclosan has been frequently analysed as a marker compound in many studies. The 
different analytical approaches applied for this compound were reviewed by Peck [135]. 
Obviously, the combination of LLE or SPE with GC-MS has been routinely applied for 
detection of triclosan in aqueous matrices, while some studies report the use of SPE 
followed by LC-MS as well. Both the use of various derivatization procedures and the use 
of LC methods have been suggested to improve the analytical performance upon analysis 
of triclosan [51]. 
3.2.1.6 Multiclass methods 
As stated before, in recent years a trend may be observed towards multi-residue methods 
[5]. Modern analytical equipment enables the determination of high numbers of analytes 
within one analytical run. With respect to PCPs, several analytical methods have been 
reported on the simultaneous determination of several groups of PCPs. Recently the 
simultaneous determination of preservatives and disinfectants in water by LC-MS/MS 
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was reported by Gonzalez-Marino [148], while Cuderman and Heath [149] described the 
determination of UV filters and antimicrobial agents or disinfectants in environmental 
water samples using SPE with GC-MS. Upon SPE using two polymeric cartridges (Oasis 
HLB and Bond Elut Plexa), a U-HPLC–(ESI)-MS/MS run of 9 minutes was developed 
for the simultaneous determination of 4 preservatives, 2 antimicrobial agents and 5 UV 
filters by Pedrouzo et al. [126]. Furthermore, analytical methods for PCPs have been 
regularly performed in combination with pharmaceuticals and EDCs. A selection of 9 
important pharmaceuticals and PCPs were simultaneously extracted by SPE using Oasis 
HLB cartridges with subsequent GC-MS detection [150]. Another comprehensive 
approach was reported by Guitart and Readman [151], who described a method for the 
determination of some PPCPs, phenolic EDCs and steroids by SPE using Oasis HLB 
cartridges followed by GC-MS, obtaining detection limits in the low ng L-1 concentration 
range for all compounds. 
3.2.2 Sediment analysis 
Several PCPs (e.g., triclosan, triclocarban, most UV-filtering compounds) show affinity 
to solid matrices such as sediment, SPM and sewage sludge. As a consequence, to allow a 
correct evaluation of the ecological impact of these substances, the evaluation of their 
prevalence in solid matrices is important. Therefore, several analytical approaches have 
been reported in recent literature. Rodil et al. [152] developed a methodology for the 
determination of UV filtering compounds based on the use of non-porous polymeric 
membranes in combination with PLE followed by detection with LC–atmospheric 
pressure photoionisation (APPI)–MS/MS. Fast determination of synthetic polycyclic 
musks in sewage sludge and sediment was enabled by microwave-assisted headspace 
SPME followed by GC-MS [153]. In accordance with the analysis of aqueous samples, 
multiresidue methods are gaining in popularity for sediment analysis as well. A new 
analytical strategy for the determination of UV filtering compounds, four preservatives 
and two antimicrobials in sewage sludge was reported by Nieto et al. [154]. The 
combination of PLE and U-HPLC-MS/MS resulted in detection limits below 10 ng g-1. 
More recently, a sensitive method has been developed and validated for the determination 
of diverse groups of hormone-like PPCPs and steroid hormones in sewage sludge as well 
[155]. Sample extraction was performed by ultrasonic-assisted extraction followed by 
SPE and analysis with U-HPLC-MS/MS. 
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3.2.3 Biota analysis 
It has been demonstrated that environmental exposure to pseudopersistent PCPs resulted 
in accumulation of the parent compounds, their metabolites, or both in tissues of aquatic 
organisms [156]. Balmer et al. [157] demonstrated low but detectable concentrations of 
UV filtering compounds in fish, obtained upon extraction of 20 g samples with 
dichloromethane/cyclohexane (1:1) followed by gel-permeation chromatography (GPC) 
and GC-MS analysis. More recently, Zenker et al. [158] reported an analytical strategy 
for the determination of UV filtering compounds in fish. One gram of fish tissue was 
suspended in 5 mL of methanol and 5 mL of acetonitrile. Next, the mixture was 
homogenized, centrifuged, sonicated and filtrated before LC–ESI-MS/MS analysis. 
Nakata et al. [159] reported an analytical method for analysis of synthetic musks in fish. 
Briefly, sample tissues were extracted with dichloromethane/hexane (8:1) using a Soxhlet 
apparatus, before GPC and GC-MS analysis. In general, analytical methods for the 
determination of PCPs in biotic tissue are limited in scope. However, two analytical 
methods have been developed for the determination of a group of ten extensively used 
PCPs in fish [156]. The methods consisted of extraction with acetone, clean-up with silica 
gel, GPC and derivatization before analysis by GC–SIM–MS or GC–MS/MS techniques.  
3.3 Pesticides 
Within this study, only those analytical techniques developed for environmentally 
prevalent more polar pesticides were considered. The chemical classification of these 
modern pesticides is quite complex, since they are characterized by such a variety of 
chemical structures and functional groups [24]. The most relevant groups of polar 
pesticides include the organonitrogen pesticides (ONPs) and the organophosphorus 
pesticides (OPPs), both covering a wide group of compounds. These pesticides are 
universally applied and have replaced the withdrawn group of the organochlorine 
pesticides (e.g. chlordane, dieldrin, DDT) [5]. In literature, numerous studies have been 
conducted on the analysis of pesticide-residues in environmental matrices [24]. Still, the 
determination of modern pesticides and their degradation products at very low 
concentration levels in real samples is complicated because of their polarity and 
thermolability. In addition, there is a need to significantly improve the sensitivity and 
selectivity of the analytical methodologies to meet the requirements established in 
Directive 98/83/EC regarding water for human consumption which has to comply with 
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the 100 ng L-1 legislation concentration for individual pesticides [160,161]. Therefore, an 
overview of the various approaches and recent trends used for determination of the more 
polar pesticides in environmental samples is given below. The pesticides considered 
within this doctoral work are shown in Figure I.7. 
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Figure I.7. Chemical structures of the targeted pesticides within this doctoral thesis. 
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PTFE and regenerated cellulose (RC) filters. On the other hand, as much studies reported 
analytical approaches without this previous treatment step [164,165]. In addition, the pH 
of the water samples was only rarely adjusted [162]. Regarding the extraction and 
enrichment of pesticides, several strategies have been reported. The use of conventional 
LLE has been recommended by the US EPA because of the high degree of enrichment 
[166,167]. The main drawbacks of LLE include low extraction efficiencies for polar 
compounds, the time-consuming aspect, the need for large quantities of solvents and for 
further clean-up, and the risk for emulsion forming during agitation [168]. To eliminate 
some of these inconveniences, LLE has been replaced by miniaturized liquid extraction 
procedures such as LPME [169], single-drop microextraction (SDME) [170] and 
membrane-assisted solvent extraction [171,172]. However, the most popular extraction 
technique is, in accordance with other polar micropollutants, the use of SPE, combining 
both isolation and enrichment of the target compounds [167]. A wide range of 
commercially available SPE sorbents have been applied, with the polymer-based OASIS 
HLB as the most distributed adsorbent [96,173-176]. The automated approach, namely 
online SPE, has been recently applied for extraction of pesticides as well 
[27,162,164,177]. The typical scheme of a fully automated online SPE system (with 
subsequent LC-MS/MS detection) is shown in Figure I.8. Commonly used online 
enrichment cartridges are PLRP-S columns, consisting of stable polymeric reversed phase 
material [27,164]. SBSE, SPME and MIPs have been employed only sporadically for 
pesticide extraction [161,179-182]. Finally, the use of multiwalled carbon nanotubes as 
solid-phase extractant have been reported once, obtaining LODs in the µg L-1 range [183]. 
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Figure I.8. Typical scheme of a fully automated online SPE system (with LC-MS/MS detection). 
 
In accordance with pharmaceutical analysis, both LC and GC have been applied for the 
separation of pesticides. Nowadays, the tendency towards the use of more polar, less 
volatile and less thermostable pesticides has stimulated the application of LC in pesticide 
residue analysis. In addition, the introduction of U-HPLC has led to higher 
chromatographic resolutions and shorter analysis times [163]. On the other hand, high 
usage pesticides are still volatile and thermostable, and consequently GC amenable 
[184,185]. Therefore, GC-based analytical methods for pesticide analysis are these days 
still reported in literature [165,184,186].  
Most recently published analytical approaches for the determination of pesticides in 
environmental matrices rely on detection with MS. Both APCI and ESI have been applied 
as ionization sources, with generally much wider applications using ESI [173,184]. Upon 
ionization, QqQ technology is the most frequently applied MS-tool for quantitative 
pesticide analysis in aqueous matrices [27,163,165,187]. The MS-MS fragmentation 
pattern is a powerful tool for reliable compound identification, thereby offering high 
sensitivity and selectivity [188]. In general, the lowest LODs, ranging from the pg L-1 to 
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ng L-1 concentration level, were achieved by online SPE coupled to LC–MS/MS using a 
QqQ instrument [27,173,189]. The combination of quadrupole with linear ion trap 
technology (QTRAP) has been repeatedly used as well, providing excellent sensitivity 
and selectivity for pesticide analysis [89,91,161,164,190]. Since QqQ and ion trap 
systems operate at unit resolution, their capability for analysis of non-target screening of 
pesticides and retrospective analysis is limited [191]. To obtain more information on the 
actual pesticide composition in water samples, including target as well as untargeted 
substances, the application of full scan high resolution MS instruments for screening 
purposes has gained widespread acceptance [186]. The use of ToF and QToF instruments 
for both pesticide screening and quantification has been frequently reported in recent 
literature, providing reliable accurate mass measurements and high sensitivity in full scan 
mode [96,175,176,182,186]. Accurate mass measurements using Orbitrap MS, whether or 
not in combination with a linear ion trap MS (LIT/Orbitrap), has hardly been used for 
pesticide analysis so far [90,192]. In addition, some detection techniques of less 
importance have been reported in literature: detection with UV [183], DAD and 
fluorescence detection [181]. The use of GC analysis with flame ionization detection 
(GC-FID) [193], surface-assisted laser desorption ionization MS detection (SALDI-MS) 
and enzyme-linked immunosorbent assay (ELISA) detection [194] have been reported in 
literature as well. 
3.3.2 Sediment analysis 
Much less efforts have been addressed for the detection of polar pesticides in sediment, 
soil and sewage sludge samples. In recent years, the conventional methods for pesticide 
extraction from solid matrices including Soxhlet or mechanical shaking, have been 
replaced by advanced extraction techniques such as PLE and sonication [25;195-197]. 
Typically, rather polar extraction solvents are used, such as acetonitrile, acetone and 
methanol and mixtures. Additional clean-up steps include the use of (dispersive) SPE or 
HPLC fractionation, obtaining extracts ready for analysis. Finally, analysis of the extracts 
is performed using the techniques described in the previous section. 
3.3.3 Biota analysis 
Very few literature reports on the detection of polar pesticides in aquatic organisms as 
well. Lehotay et al. [198] monitored more than 60 pesticides in oysters originating from 
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Chesapeake Bay (Maryland, USA). Oyster tissue was blended with acetonitrile and a 
series of SPE cartridges were used for clean-up. Analysis was performed using GC-MS 
on a quadrupole instrument in SIM mode. The obtained LODs for oyster samples were < 
5 ng g-1 wet weight. More recently, Buisson et al. [199] described an analytical procedure 
for detection of pesticides in oysters as well. Oyster samples were first homogenized with 
an Ultra Thurax unit, then extracted by accelerated solvent extraction using acetonitrile, 
and finally purified on a Florisil column. Analysis was performed using LC-ESI-MS. 
Another study reported an analytical procedure for the determination of 29 herbicides and 
related metabolites in freeze-dried clams [25]. Using a mixture of 4:1 methanol/water, the 
analytes were extracted with ultrasonication and manual agitation. After centrifugation, 
removal of methanol and reconstitution in water, the extracts were cleaned and 
concentrated using Oasis HLB cartridges. Analysis was performed using LC-QqQ-MS, 
obtaining LODs for simazine, atrazine and terbuthylazine of 0.21, 0.042 and 0.012 ng g-1, 
respectively. Wille et al. [116] reported recently an analytical approach based on PLE and 
SPE followed by U-HPLC coupled to QqQ MS for the quantification of 14 pesticides in 
tissue of marine organisms, obtaining LOQs between 1 and 10 ng g−1. 
3.3.4 Passive sampling 
In agreement with pharmaceutical monitoring, the introduction of passive samplers has 
enabled the determination of the TWA pesticide concentration in aqueous matrices. Still, 
only few studies are available in literature regarding the use of passive sampling devices 
for the more polar pesticides. POCISs and Chemcatcher® passive sampling devices have 
been designed for the sampling of polar contaminants. Their use for polar pesticide 
sampling has been illustrated in literature recently [200-203]. In addition, PEVAC, 
PDMS and membrane assisted passive samplers (MAPS) have been used for pesticide 
sampling in the aquatic environment as well [90,119]. 
3.4 Endocrine disruptors 
Many environmental pollutants act as endocrine disruptors, being regulated pollutants 
such as dioxins, polycyclic aromatic hydrocarbons (PAHs), polychlorinated biphenyls 
(PCBs) and organochlorine pesticides (OCPs), as well as new emerging more polar 
pollutants such as estrogenic compounds, APEOs, BPA and phthalates [34]. Since the 
present review deals with the various approaches used for determination of emerging 
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pollutants, only the analytical chemistry of the emerging EDCs is reviewed below. The 
analytical approaches of the PPCPs (section 3.1 and 3.2) and pesticides (section 3.3), 
which may induce endocrine disruption as well, were discussed above.   
3.4.1 Estrogenic compounds 
The group of natural and synthetic estrogens of which E1, βE2, αE2, E3 and EE2 are 
important representatives, have been identified as the class with the highest EDC 
potential [34]. Consequently, a lot of research has been devoted to the analysis of these 
estrogenic compounds [204]. The recently published (beginning from 2005) analytical 
approaches to quantify estrogens in environmental matrices have been summarized in 
Table I.1 for aqueous matrices and in Table I.2 for solid matrices, as an attempt to limit 
the number of pages in this review. The analytical approaches for estrogenic compounds 
regularly include the simultaneous detection of other classes of EDCs such as PPCPs, 
APEOs, phthalates, BPA or phyto-estrogens. 
3.4.1.1 Water analysis 
As can be seen from Table I.1, chemical analysis of aqueous samples generally required a 
pre-treatment as well as an extraction step. Sample pre-treatment typically included 
filtration, while pH adjustment and addition of chemical preservatives occurred only 
sporadically. However, filtration has not been executed in case of LLE [32,205], SBSE 
[206,207], SPME [208] or extraction using MIPs [209]. These latter extraction techniques 
have only been rarely applied, since the use of SPE for isolation and concentration of 
estrogens is mostly preferred. Typical SPE sorbents used for estrogens are Oasis HLB 
(hydrophilic-lipophilic balanced copolymer) [205,210] and octadecyl silica bonded 
phases [211,212]. Vulliet et al. [213] compared Strata C18-E with the 
styrenedivinylbenzene Strata-X for extraction of a wide group of steroids. Both sorbents 
exhibited comparable retention capacities towards all analytes. Extraction disks, which 
supply a larger contact area between the sorbent and the matrix, have been used for 
steroid extraction from aqueous samples as well [34,214]. Additionally, also on-line SPE 
using Oasis HLB [215] or PLRP-s [216] sorbents have been applied for estrogen 
extraction. Upon extraction, further clean-up steps using silica gel [211,217], Florisil 
[32,218] or NH2 cartridges [214,219] were regularly applied.   
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Analysis of estrogens has been performed using LC-MS as well as GC-MS (Table I.1). 
Prior to GC-MS analysis, derivatization of the hydroxyl or carbonyl groups is carried out, 
to enhance the thermal stability and volatility of the compounds and to reduce the polarity 
due to decreasing dipole-dipole interactions [204]. The most common derivatization 
technique for estrogens consists of silylation using derivatization mixtures of MSTFA or 
N,O-bis(trimethylsilyl) trifluoroacetamide (BSTFA) [204]. Derivatization prior to LC-MS 
analysis is only rarely executed, since estrogens can be analyzed directly using LC 
techniques [34,215]. Therefore, LC-MS based methods for detection and quantification of 
steroids have been increasingly applied [204]. So far, only few U-HPLC-MS methods 
have been reported in literature [219,220]. Recently, Kozlik et al. [212] reported the use 
of capillary liquid chromatography (cLC) for estrogen analysis, which is a promising 
approach towards green chemistry that preserves the separation advantages of classical 
LC. Combined with MS, sufficiently high sensitivity was obtained using this technique. 
As can be deduced from Table I.1, QqQ-MS has been frequently applied upon LC 
separation [211,212,213,216,219]. Farré et al. [219], who compared LC-QqQ-MS, U-
HPLC-ToF-MS and ELISA for estrogen analysis in water samples, concluded that the 
highest sensitivity was obtained after an appropriate sample pre-treatment followed by 
LC-QqQ-MS. On the other hand, the UPLC–QTOF-MS/MS method provided a shorter 
analysis time and improved selectivity for confirmation and screening purposes, while the 
ELISA technique could be directly applied, without previous sample extraction or clean-
up, obtaining relatively low detection limits. Besides ELISA, other bioanalytical 
techniques such as RYA (Recombinant Yeast Assay), E-screen assay and ER-CALUX 
(estrogen responsive chemically activated luciferase expression) have been applied as 
well [205,207,220,221]. Bioanalytical techniques generally intend to determine the total 
estrogenic potency and are frequently complemented with chromatographic (LC or GC) 
analyses [34]. Finally, diode-array detectors and fluorescence detectors have only rarely 
been used, mainly due to their minor sensitivity and selectivity [204,206].  
 
  
Table I.1. Recent analytical approaches to quantify estrogens in aqueous matrices. 
Matrix EDCs studied Sample pre-treatment Extraction method Derivatization Analytical method Ref. 
Seawater E1, E2, E3, EE2, daidzein, genistein, BPA, 
NP, OP 
Filtration SPE HLB - LC-MS/MS [222] 
Wastewater E1, E2, EE2 Filtration Online SPE HLB Dansyl chloride LC-MS/MS [215] 
Wastewater E1, E2, E3, EE2, PPCPs, other steroids pH adjustment (pH 2) and filtration SPE HLB - LC-MS/MS [223] 
Wastewater E1, αE2, βE2, E3, EE3, other steroids Filtration and pH adjustment (pH 3.4) SPE Strata-X and silica clean-up - LC-MS [217] 
Surface- and 
groundwaters 
E1, αE2, βE2, E3, EE3, other steroids Filtration and pH adjustment (pH 3) SPE Strata C18-E - LC-MS/MS [213] 
Surface and wastewater E1, βE2, EE2 Filtration (influent) SPE C18 and silica gel (influent) - LC-MS/MS [224] 
Waste-, surface and 
drinking water 
E1, E2, E3, EE2, DES, other steroids, 
PPCPs, pesticides 
Filtration Online SPE PLRP-s (cross linked 
styrenedivinylbenzene) 
- LC-MS/MS [216] 
Surface and wastewater E1, βE2, EE2, other steroids, BPA, OP, NP Filtration SPE C18 + silica gel (steroids) and 
HLB (phenols)  
- LC-MS/MS [211] 
Surface water βE2 - MIPs - LC-MS [209] 
Surface water E1, βE2, E3, EE2, DES - In-tube SPME - LC-MS/MS [208] 
Surface and wastewater E1, αE2, βE2, E3, EE2, conjugated forms Filtration SPE HLB and Florisil clean-up - LC-MS/MS [218] 
Surface water E1, αE2, βE2, E3, EE2 Filtration Discovery DSC-18Lt column - cLC-MS/MS [212] 
Wastewater E1, βE2, EE2, progesterone Filtration SPE HLB / HPLC fractionation - UPLC-MS/MS  [220] 
Waste-, surface and well 
water 
E1,βE2, E3, EE2 Filtration SPE C18 and NH2 - LC-MS/MS / ELISA [225] 
Waste-, surface and well 
water 
E1, E2, E3, EE2, daidzein, genistein Filtration SPE C18 and NH2 - ELISA / LC-MS/MS / UPLC–
QTOF  
[219] 
Well water E1, αE2, βE2, EE2, DES, MeEE2, other 
steroids 
- SBSE-LD - LC-DAD [206] 
  
Matrix EDCs studied Sample pre-treatment Extraction method Derivatization Analytical method Ref. 
Wastewater E1, βE2, E3, EE2 Addition of formaldehyde, filtration 
and pH adjustment (pH 3-5)  
SPE HLB + LC-NH2 MSTFA + mercaptoethanol + 
NH4I (for GC) 
GC-MS / LC-MS/MS [226] 
Effluent and surface 
water 
E1, βE2, E3, EE2, MeEE2, other steroids Addition of formaldehyde, filtration 
and pH adjustment (pH 3-5)  
SPE HLB MSTFA + mercaptoethanol + 
NH4I 
GC-MS [227] 
Surface water E1, αE2, βE2, EE2 pH adjustment (pH 7) SPE C18XF Speedisk + Si and NH2 MSTFA GC -MSn [214] 
Water E1, βE2, other steroids, OP, NP, BPA, 
phthalates 
Addition of sodium carbonate and 
acetic anhydride 
SBSE-TD - GC-MS [207] 
Surface water and 
effluent 
E1, E2, EE2, BPA, OP, NP Filtration SPE HLB BSTFA + 1% TMCS + 
pyridine 
GC-MS [210] 
Surface, waste- and 
seawater 
E1, αE2, βE2, E3, EE2, MeEE2, NP, OP, 
BPA 
Filtration SPE HLB BSTFA GC- MSn [228] 
Wastewater E1, αE2, βE2, EE2, MeEE2, other steroids, 
NP, BPA, phthalates, phytoestrogens  
- LLE with dichloromethane and clean-
up with Florisil 
BSTFA:trimethyl-
chlorosilane (99:1) 
GC-HRMS (magnetic sector) [32] 
Surface and tap water E1, EE2, NP, PPCPs Filtration in case of high turbid 
samples 
SPE HLB MTBSTFA GC-MS [229] 
Wastewater E1, αE2, βE2, other steroids, OP, NP, BPA, 
phthalates, one pharmaceutical 
Filtration and pH adjustment (pH 2-3) SPE HLB BSTFA GC-MS / E-screen assay [230] 
Wastewater E1, αE2, βE2, E3, EE2, MeEE2, other 
steroids, OP, NP, BPA, phthalates, 
phytoestrogens  
Filtration in case of Yeast Assay LLE with dichloromethane BSTFA GC-HRMS (magnetic sector)/ 
Recombinant Yeast Assay 
[205] 
Surface water EE2 Filtration and pH adjustment (pH 7) - - Immunoassay method [231] 
Rain, surface and 
wastewater 
E1, αE2, βE2, EE2, OP, NP, BPA, 
phthalates 
Filtration - - ER-CALUX [221] 
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3.4.1.2 Solid matrices and passive samplers 
Estrogenic compounds are medium polar to relatively non-polar substances, with log Kow 
values in the range 2.5 to 5.3 [232]. Consequently, sorption of estrogens to suspended 
matter and tendency to accumulate in sediments can be expected [233]. Estrogen 
extraction is usually performed by use of polar or medium polar organic solvents or their 
mixtures [232]. Ultrasound-assisted extraction [228,232,234], PLE [226,233,235] and 
microwave-assisted solvent extraction (MASE) [235] have been applied to enhance the 
extraction efficiency and to shorten the extraction time (Table I.2). Further purification is 
usually needed and carried out by SPE, HPLC fractionation or GPC [33]. Few studies 
have reported on the analysis of estrogens in biota. Budzinski et al. [236] reported an 
analytical approach for estrogen analysis of fish plasma and bile, while a bioanalytical 
approach (ER-CALUX) was developed by Vethaak et al. [221]. Recently, several studies 
described the use of passive samplers for estrogenic compounds as well [230,237,238]. 
As shown in Table I.2, GC-MS analysis with preceding derivatization has been used more 
frequent as compared with LC-MS for estrogen analysis in solid samples. In addition, 
Hajkova et al. [232] described different GC-MS procedures for underivatized analytes as 
well. It was found that GC×GC hyphenated with ToF-MS provided unequivocal 
identification of target analytes due to a better resolution. A high resolution LC-ToF-MS 
method has been reported in literature as well [235]. 
 
 
  
Table I.2. Recent analytical approaches to quantify estrogens in solid matrices, including sediment, biota and passive samplers. 
Matrix EDCs studied Sample pre-treatment Extraction method Derivatization Analytical method Ref. 
Sediment E1, αE2, βE2, E3, EE2, other steroids Freeze-dried Sonication with ACN/H2O, SPE EDS-1, 
GPC and Florisil clean-up  
 LC-MS/MS [234] 
Sediment E1, βE2, EE2 - MASE, SPE Strata X-AW and silica gel  LC-ToF-MS / LC-MS/MS [235] 
Sediment E1, βE2, E3, NP, OP, BPA Freeze-dried Ultrasonic extraction with methanol, SPE 
HLB + HPLC fractionation 
 LC-MS/MS / YES assay and 
ELISA 
[239] 
Biosolids and sludge E1, βE2, other steroids, OP, NP, BPA, 
phthalates 
Addition of water, 
Na2CO3,acetic 
anhydride; fltration and 
oven-dried 
SBSE-TD - GC-MS [207] 
Soil E1, αE2, βE2, E3 Air dried and sieved PLE (acetone or ethylacetate) + SPE C18 MSTFA:hexane (1:5) GC-MS [240] 
Sediment E1, βE2, E3, EE2, DES Drying Sonication (hexane–acetone) + SPE HLB  GC-MS / (GC x) GC-ToF-MS [232] 
Sludge samples E1, βE2, E3, EE2 Freeze-dried and sieved PLE with methanol:acetone (1:1) and SPE 
HLB + LC-NH2 
MSTFA + 
mercaptoethanol + NH4I 
GC-MS / LC-MS/MS [226] 
Suspended solids and sediment E1, αE2, βE2, E3, EE2, MeEE2, NP, OP, BPA Freeze-dried Ultrasonic assisted extraction with 
methanol:acetone (1:1) and SPE Florisil 
BSTFA GC- MSn [228] 
Sediment and suspended solids E1, αE2, βE2, EE2 Sieved and freeze-dried PLE (acetone/methanol) + HPLC fraction.  MSTFA GC- MSn [233] 
Fish plasma and bile E1, βE2, other steroids Centrifugation SPE C18 and NH2 MSTFA + 
mercaptoethanol + NH4I 
GC-MS [236] 
Sediment and biota E1, αE2, βE2, EE2, OP, NP, BPA, phthalates Filtration   ER-CALUX [221] 
Passive samplers E1, βE2, EE2, BPA, PPCPs - POCIS  - GC-MS [237] 
Passive samplers E1, αE2, βE2, E3, EE2, MeEE2, BPA, OP, NP - POCIS BSTFA GC- MSn [238] 
Wastewater E1, αE2, βE2, other steroids, OP, NP, BPA, 
phthalates, one pharmaceutical 
- EmporeTM SDB-RPS BSTFA GC-MS / E-screen assay [230] 
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3.4.2 Alkylphenolethoxylates and bisphenol A 
Alkylphenolethoxylates (APEOs) belong to the class of the non-ionic surfactants, which 
are molecules consisting of a hydrophobic, usually an alkyl or alkylaryl chain, and a 
hydrophilic part which can vary largely. Both the surfactants as the metabolites 
octylphenol (OP) and nonylphenol (NP) are relatively persistent and have been shown to 
cause endocrine disruption [241]. Since bisphenol A (BPA) is routinely analysed together 
with the APEOs (and metabolites), this well-known EDC was considered in this section 
as well. 
3.4.2.1 Water analysis 
With respect to the analysis of water samples, degradation of APEOs is expected to 
occur. The most common procedure for conserving APEOs is through acidification of the 
sample to a pH below 3 [242]. In addition, it is essential to process water samples as 
quickly as possible [241]. In accordance with the extraction of many of the emerging 
pollutants, SPE has replaced LLE and may be considered as the most abundantly applied 
extraction technique for APEOs and BPA. Polymer based sorbents were preferred above 
C18 cartridges, since both the long-chain APEOs as the metabolites OP and NP were 
retained. For example, Loos et al. [243] reported the use of Oasis HLB cartridges for the 
extraction of alkylphenols (APs), APEOs, ethoxycarboxylate metabolites and BPA. Using 
Oasis HLB cartridges, frequently lower recoveries were obtained for NP, a very 
environmentally important compound within this group because of its endocrine 
disrupting potency. Therefore, sequential SPE or elution using solvents with different 
desorption potential and polarity has been successfully applied to cover a broad range of 
APEOs [242,244]. Recently, an on-line column-switching SPE application was reported 
for the detection of BPA in water samples as well [245]. Besides, the use of more specific 
extraction techniques for APEOs and BPA such as SBSE, SPME, LPME and dispersive 
liquid-liquid microextraction (DLLME) have been reported [207,246-248]. Wang and 
Schnute [249] reported a U-HPLC-QTRAP method without previous sample preparation 
for the simultaneous quantification of NP and BPA, obtaining detection limits in the 
range of 0.04 to 0.057 µg L-1.  
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Both GC-MS, with preceding derivatization, as well as LC-MS analysis have been 
employed for analysis of aqueous samples [249]. LC analysis is anyhow preferred for the 
longer chain APEO substances, since these are not volatile enough for GC-analysis. 
However, quantification of APEOs can be a matter of concern when using LC separation 
with C18 columns, since co-elution can be expected for the APEOs only differing in 
ethoxylate chain length [242]. In case of LC-MS, QqQ-MS has been regularly applied 
[245,250], while also accurate mass measurements of APEOs using QToF-MS have been 
reported [251]. The use of UV and fluorescence detection have been applied for the 
determination of BPA and NP in water as well [248,252].  
3.4.2.2 Solid samples and passive samplers 
The physicochemical profiles suggest that some APEOs and degradation products exert a 
strong affinity to SPM and organic matter. Additionally, they have the tendency to bind to 
sediments and to accumulate in aquatic organisms, due to their high lipophilicity and 
lower water solubilities [242]. Extraction from sediment can be performed by Soxhlet 
extraction [250], sonicated-assisted extraction [253], SFE [254], MAE [255] and PLE 
[256]. The latter technique offers several advantages as compared to the other methods, 
and was therefore found to be the main extraction technique for these compounds in 
sediment matrices. Further purification of the obtained extract is usually performed by 
SPE [242].  
With respect to biota, only few studies have been conducted. Tavazzi et al. [257] 
described a PLE method followed by LC-MS analysis for the determination of OP, NP 
and BPA in fish liver. The use of passive samplers, by means of POCIS samplers, for the 
determination of BPA, NP and three steroids has been reported in literature as well [251]. 
3.5 Phthalates 
Phthalates are nowadays considered as ubiquitous environmental pollutants [258]. As a 
result, considerable attention must be paid to the possible occurrence of sample 
contamination, which is a major problem throughout the analytical process. Phthalates 
present in laboratory equipment could contribute to sample contamination and result in 
systematic errors and false positives [258,259]. Consequently, very specific analytical 
approaches, as shortly discussed below, are required to ensure the reliability of analytical 
results. 
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3.5.1 Water analysis 
Prior to analysis, extraction of phthalates from aqueous samples is needed. To this end, 
the use of traditional techniques including LLE [32,260] and SPE [230,260,261] have 
only rarely been reported. More common, extraction based on (in-tube) SPME using 
polymer coated fibers has been successfully applied [258,263-267]. Penalver et al. [265] 
compared different fibers to optimize a SPME method for the most common phthalates, 
obtaining the best results using the polydimethylsiloxane–divinylbenzene fiber. An 
important advantage of the use of SPME for phthalate extraction includes the reduced risk 
for secondary contamination during sample handling [266]. Other techniques such as 
SBSE [207,268] and LPME [269] have also been applied for extraction of phthalates, as 
well as DLLME [270]. Finally, a novel method, which is termed ionic liquid cold-
induced aggregation dispersive liquid–liquid microextraction (IL-CIA-DLLME), has 
been recently applied for analysis of phthalates as well [271]. Upon sample pre-treatment, 
phthalates have been determined with GC-MS and LC-MS equipment [259]. LC-methods 
coupled to DAD or UV detectors have been applied for quantification of phthalates in 
water samples as well [258,262].  
3.5.2 Solid matrices 
Several different methods for the extraction of phthalates from sediment or sludge 
samples have been reported: Soxhlet extraction [37,272,273], ultrasonic assisted liquid 
extraction [274,275] and PLE [276]. Due to the complexity of the sample matrix, sample 
preparation frequently included an additional clean-up step based on SPE with C18 
sorbent [275] or GPC with further fractionation using silica gel [37,272].  
With respect to phthalate extraction from biota samples, recent literature is very limited. 
Chaler et al. [273] reported an analytical approach based on alkaline digestion with 
subsequent fractionation on an alumina/silica column. To the best of our knowledge, no 
other recent studies have examined the analysis of phthalates in aquatic organisms. 
Both GC and LC have been employed for phthalate analysis in environmental matrices 
[273,276]. Recently, the successful application of a GC-APCI-ToF-MS method has been 
reported as well [274]. 
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3.5.3 Passive samplers 
The use of passive samplers consisting of styrene-divinylbenzene EmporeTM SDB-RPS 
disks for the determination of 15 EDCs including several phthalates in wastewaters was 
reported by Tan et al. [230] [Table I.2]. Also semi-permeable membranes charged with 
Tenax TA have been applied as passive sampling devices for monitoring phthalates in the 
aquatic environment [277]. Prior to GC-MS analysis, the targeted phthalates were 
thermally desorbed from the sampler with a helium stream.  
3.6 Perfluorinated compounds 
The occurrence of PFCs in the aquatic system has been extensively studied in literature. 
Still, the quality of data obtained from analysis of PFCs in environmental matrices is a 
major issue of concern [278,279]. Very recent, the final report of the third interlaboratory 
study on PFCs in environmental matrices was published [279]. A relatively wide variance 
in PFC data of aqueous samples could be observed. This is probably caused by a 
combination of problems which are characteristic for PFC analysis, namely the 
occurrence of cross contamination, matrix interferences and branched isomers. These 
inconveniences render quantitative analysis of PFCs in environmental matrices, which is 
reviewed below, to a challenging task. 
3.6.1 Water analysis  
Several sampling and sample pre-treatment aspects have been assessed as essential for 
straightforward analysis of PFCs. At first, the sampling depth may affect PFC 
concentration results. A decreasing PFC concentration with increasing water depth has 
been reported by Yamashita et al. [280] and Ju et al. [281]. This can be associated with 
their surface-active character and, in case of ocean waters, with the global ocean 
circulation system [280,282]. Secondly, the sample equipment should be carefully 
selected to avoid contamination with and adsorption of PFCs [282]. Prior to sampling, it 
was suggested to rinse sample bottles using (semi-)polar solvents [5,283]. Acidification 
of samples for conservation purposes was discouraged to prevent volatilisation and 
adsorption to the sample container [284]. Besides, filtration of water samples is a matter 
of concern for PFC-analysis as well. The surface-active nature of these substances may 
result in sorption to the filter material [41]. Furthermore, several filters are sources of 
contamination for PFOA and perfluorononanoate (PFNA) [285]. Therefore, except in 
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case of water samples visibly containing particulate matter, it was suggested to avoid 
filtration as a sample preparation step. Schultz et al. [286] recommended centrifugation as 
an alternative sample clean-up step.  
Generally, low concentrations (pg – ng L-1) are found in water samples, requiring pre-
concentration and isolation of PFCs. To this end, LLE and SPE both followed by solvent 
evaporation have been frequently reported in literature [287]. The common use of these 
techniques appeared from the third interlaboratory study on PFCs as well [279]. Within 
this final report, it was found that SPE was predominantly used for nearly 80% of the 
water samples (Figure I.9) [279]. Both techniques were compared by Gonzalez-Barreiro 
et al. [288]. Using LLE, the overall PFC concentration (aqueous and particulate fraction) 
can be determined since filtration is avoided, however, this technique is limited to long 
chain PFCs (C≥8). Apparently, SPE was best suited for PFCs with less than 10 carbon 
atoms, including the most important contaminants PFOS and PFOA [288]. An SPE 
approach enabling the determination of short as well as long chain PFCs was described 
by Taniyasu et al. [289]. Based on the latter publication, the ISO 25101/2006 method 
[290] has been established using weak anion exchange (Oasis WAX) SPE cartridges. The 
use of C18 and certainly Oasis HLB cartridges for PFC enrichment has been frequently 
reported as well [288,291-295]. Alternatively, also direct determination of PFCs from 
aqueous samples has been reported [286,296]. Without sample pre-treatment, PFCs were 
quantified using large-volume injection, thereby obtaining LOQs in the 1 ng L-1range. 
 
 
Figure I.9. Methods used for water extraction according to the final report of the third 
interlaboratory study on PFCs in environmental matrices [279]. 
 
13%
78%
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According to Jahnke and Berger [287], LC coupled to quadrupole MS in negative 
ionization mode is the preferred instrumental method for the determination of ionic PFCs 
in environmental matrices, including PFCAs and PFSAs. Upon LC-separation, QqQ-MS 
allows excellent quantification of PFCs at very low concentration levels [282]. 
Controversially, it has been reported that the use of MSn (using QqQ or IT-MS) for the 
detection of PFSAs, including the major contaminant PFOS, is complex and less efficient 
[297,298]. Since these substances exhibit a very high stability even at extreme conditions 
(e.g., high collision energies), the use of QqQ-MS or IT-MS typically results in PFOS-
fragments of [FSO3]- and [SO3]-, with m/z ions of 99 and 80 respectively. Unfortunately, 
interferences that co-elute with PFOS could be observed with the same retention time and 
one similar transition [297,299]. Therefore, another powerful analytical approach for PFC 
determination involves the use of full scan high resolution accurate mass measurements. 
(Q)ToF-MS has been reported to be the optimal detector for quantification of PFCs, 
combining high selectivity with high sensitivity [300]. Recently, LC-ToF-MS was 
applied for the determination of 14 PFCs in surface-, sewage- and seawater with LOQs 
varying from 2 to 200 ng L−1 [295]. In addition, high resolution MS using an Orbitrap 
instrument has proved his excellent applicability for PFC-determination as well, however, 
this has not been published in literature earlier [297]. Alternatively, the ionic PFCAs and 
PFSAs may be analyzed with GC as well [287]. This however needs to be preceded by a 
derivatization with a mixture of 2,4-difluoroaniline and N,N-dicyclohexylcarbodiimide 
[301] or with iso-propanol [302]. The non-ionic PFCs such as the fluorotelomer alcohols 
and fluoroalkyl sulphonamides are, due to their higher volatility, directly amenable to 
GC. Langlois et al. [302] reported a high-resolution gas chromatographic (HRGC) 
method for both ionic and non-ionic PFCs. In this context, the separation of PFOS-
isomers was performed using the high resolution of a capillary GC-column coated with 
5%-phenyl-95%-methylpolysiloxane. 
In literature, specific measures have been described to overcome some characteristic 
difficulties during PFC-analysis. At first, background contamination in the analytical 
blanks is a major problem in the analysis of PFCs, especially when the low ng L-1 
concentration range is targeted [289,296,303]. Therefore, it was suggested to avoid the 
use of teflon materials throughout the extraction procedure, to clean and dry all glass 
material, to replace the internal parts of the HPLC system made of PTFE with stainless 
steel and polyether ether ketone (PEEK), and to place an additional HPLC column 
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between the pump and the injector to separate sample PFCs and PFCs originating from 
the system [287,294,295,303]. Secondly, the limited use of mass labelled analogues to 
compensate for ionisation effects can contribute to the occurrence of deviating analytical 
results. For this reason, it is highly recommended to use an isotopically labelled internal 
standard for every single PFC that requires quantification [279]. Finally, the occurrence 
of branched isomers should be taken into consideration as well. For example, technical 
PFOS contains up to 30% differently branched isomers [302]. These branched isomers 
may have varying ionization efficiencies, resulting in a systematic quantification bias of 
PFCs [299]. Recently, a HPLC-MS/MS method for isomer-specific quantification of 
PFCs in water samples has been reported. The examination of PFC isomer profiles may 
be interesting to study the environmental fate of PFCs and to distinguish historical from 
recent contamination as well [304]. 
3.6.2 Solid matrices 
Since the first report on the global distribution of PFOS was published in 2001, a large 
number of studies have been dedicated to the detection of PFCs in biota [43]. The most 
important techniques to extract PFCs from solid matrices include ion pair extraction (IPE) 
and solid-liquid extraction (SLE). Several recent studies use the IPE methods reported by 
Hansen et al. [305] and Giesy and Kannan [43], which consisted of ion-pairing of PFCs 
with tetrabutylammonium hydrogen sulphate (TBA) followed by extraction with methyl-
tert-buthyl ether (MTBE) [306-308]. However, according to the recent interlaboratory 
study on PFCs in environmental matrices, SLE using a medium polar solvent such as 
methanol or acetonitrile is nowadays considered as the foremost applied approach for 
PFC extraction from biotic tissue (Figure I.10) [279].  
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Figure I.10. (Left) Methods used for extraction and (right) further clean-up of a fish sample, 
according to the final report of the third interlaboratory study on PFCs in environmental matrices 
[279].  
 
The SLE sediment method of Powley et al. [309] and the altered version for biotic 
samples [310] have been regularly adopted or modified by environmental chemists 
[278,295]. Further clean-up of the obtained extract is usually performed by SPE or 
treatment with activated carbon (ENVIcarb), to reduce possible interferences 
[295,311,312]. This appeared from the interlaboratory study on PFCs in environmental 
matrices as well (Figure I.10). Another popular extraction method in this context is the 
approach of Berger and Hauskas [313], consisting of extraction with methanol/water 
(50/50; 2mM ammonium acetate) followed by filtration. Malinsky et al. [314] included a 
freezer-incubation step of the acetonitrile/tissue extracts to facilitate protein precipitation 
for improved analyte recoveries. The use of PLE for PFC extraction has been reported 
once in literature by Llorca et al. [315], who compared three different sample preparation 
techniques for PFC analysis in fish. It was found that PLE using water as extraction 
solvent with subsequent SPE was chosen above IPE as described by Hansen et al. [305] 
and alkaline digestion followed by SPE as described by Taniyasu et al. [289]. Finally, 
microextraction with tetrahydrofuran has been successfully applied as well for analysis of 
PFCs in biota [316].  
In general, extraction methods similar to those for biota are used for sediment and sewage 
sludge samples. Bao et al. [317] performed sediment extraction with TBA and MTBE, 
while a SLE method using 9 mL of methanol and 10 mL of a 1% glacial acetic acid 
solution was applied by Gomez et al. [318]. Also Ahrens et al. [319] used methanol as 
extraction solvent for PFC extraction from sediments. So far, the use of PLE for sediment 
samples has not been reported in literature. 
48%
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In recent years, PFC analysis has typically been performed using LC coupled to different 
mass spectrometric techniques such as ion-trap MS [311,320], tandem-MS [321], QqQ-
MS [317,322], ToF-MS [295] or QTRAP-MS [314,323]. The use of U-HPLC for PFC 
analysis in solid matrices has been reported once in literature [318]. Also the separation 
and quantification of the PFC isomers has been demonstrated before [314,323]. Just as for 
aqueous matrices, it has been reported that correct quantification of PFCs in solid 
matrices is challenging [278]. Therefore, the above mentioned measures to enable 
accurate quantification in aqueous matrices should be taken into consideration for solid 
samples as well. With respect to the quantification aspect, it has been demonstrated that 
analytical results obtained with extracted matrix-matched calibration differ only slightly 
from solvent (unextracted) calibration [314]. This definitely facilitates quantification, 
especially when only limited clean control matrix samples are available. 
3.6.3 Passive samplers 
To the best of our knowledge, the use of passive samplers for PFC-monitoring in the 
aquatic environment has not been reported before.  
 
4. CONCEPTUAL FRAMEWORK OF THIS STUDY 
Nowadays, a growing public and scientific concern exists regarding the widespread 
occurrence of micropollutants in the aquatic environment. In light of the possible toxic, 
genotoxic and/or endocrine disrupting properties that many of these micropollutants may 
exert, their potential to cause adverse effects in marine organisms should not be 
neglected. Moreover, the ingestion of contaminated seafood has been proposed as a major 
source of direct human exposure to many micropollutants. Despite these facts, limited 
efforts have been made so far to investigate their prevalence on a quantitative basis in 
marine ecosystems. To study and evaluate the fate, effects, and environmental and human 
risks posed by these polar micropollutants in aquatic ecosystems, information regarding 
their presence in the marine environment is urgently needed. 
Therefore, the main goal of the present study was to investigate the prevalence of targeted 
CECs including pharmaceuticals, PFCs and pesticides in the Belgian marine 
environment. This implies the need for new reliable analytical methods for their 
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determination in environmental matrices. Therefore, the specific objectives of this 
doctoral thesis were as follows: 
 To develop and validate a new analytical method to enable the quantification of 
pharmaceuticals in aqueous samples from the Belgian coastal zone 
 To develop and validate a new analytical method for the quantification of PFCs in 
aqueous samples from the Belgian coastal zone 
 To develop new extraction procedures and analytical methods for the 
quantification of pharmaceuticals, pesticides and PFCs in marine biota originating 
from the Belgian coastal zone 
 To develop and validate a new analytical method for the quantification of 
pharmaceuticals and pesticides in passive sampling devices deployed in the 
Belgian coastal zone 
 To support the integrated risk assessment of CECs in the Belgian coastal zone by 
comparison of the obtained concentrations with regulatory standards or 
ecotoxicity data 
 
This doctoral thesis consists of 4 research chapters, preceded by a general introduction to 
the subject in Chapter I. In this chapter, an elaborate literature review is presented of the 
various analytical approaches used for the determination in environmental matrices of the 
most important groups of CECs, including pharmaceuticals and personal care products 
(PPCPs), pesticides, EDCs, phthalates and PFCs. Chapters II and III describe the 
development and validation of new analytical methods for quantification in aqueous 
samples of pharmaceuticals and PFCs, respectively, as well as application thereof to 
water samples originating from the Belgian coastal zone. Within Chapter IV, a new 
method for quantification of pharmaceuticals, PFCs and pesticides in marine organisms is 
presented. In addition, these optimized procedures were applied to M. edulis samples 
originating from different locations in the Belgian coastal zone. Chapter V aimed at the 
development and application of a new analytical procedure for quantification of a high 
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number of pharmaceuticals and pesticides in passive sampling devices. Finally, in 
Chapter VI, the obtained monitoring results of the CECs are discussed in terms of their 
distribution in the Belgian coastal zone, bioaccumulation potential and possible 
environmental risk. In addition, general conclusions are drawn and future research 
recommendations are formulated. 
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CHAPTER II 
VALIDATION AND APPLICATION OF AN LC-MS/MS METHOD FOR THE 
SIMULTANEOUS QUANTIFICATION OF 13 PHARMACEUTICALS IN SEAWATER 
Abstract 
Knowledge of the presence of micropollutants such as pharmaceuticals, in coastal areas, 
is very limited. Therefore, the main objective of this study was to optimize and validate a 
new analytical method for the quantitative analysis of 13 multiclass pharmaceuticals in 
seawater. Target compounds included antibiotics, non-steroidal anti-inflammatory drugs, 
β-blockers, lipid regulators and one psychiatric drug. A combination of solid-phase 
extraction and liquid chromatography coupled with multiple mass spectrometry enabled 
their detection at the low nanogram per litre level. The limits of quantification varied 
between 1 and 50 ng L-1 and for most components the linearities were more than 0.99 
(n=7). The recoveries and precision obtained in seawater, between 95–108% and 16-27 
RSD% respectively, were satisfactory. This method was applied to seawater and estuarine 
water samples collected in the Belgian coastal zone, to assess the prevalence of common 
pharmaceuticals in this marine environment. Seven pharmaceuticals, including 
compounds of which the presence in marine environments had not been reported earlier, 
were detected, with salicylic acid and carbamazepine being the most abundant, in 
concentrations up to 855 ng L-1. 
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1. INTRODUCTION 
Pharmaceuticals are the active ingredients of medicinal products used in human and 
veterinary medicine and include approximately 3,000 different compounds with a large 
variation in chemical structure, function and behaviour [1,2]. In Belgium, the 
consumption of reimbursed pharmaceuticals available at the pharmacy level ranges 
between 0.001 and 6 tons per year depending on the individual pharmaceutical 
(Table II.1) [3] (H. Beyers, personal communication). Pharmaceuticals for human use are 
excreted - either in their native form or as metabolites - and discharged into the sewer 
system [4,5]. Via sewage, pharmaceuticals reach the wastewater treatment plant 
(WWTP), where most pharmaceuticals are, according to current literature, not completely 
removed [6,7]. As a result of WWTP effluents, land application of sewage sludge, 
improper disposal and manufacturing processes, pharmaceuticals are introduced into 
natural aquatic systems [8,9]. These different pathways may result in a continuous release 
of pharmaceuticals into the aquatic environment. Consequently, there is growing public 
and scientific concern regarding the occurrence and potential effects of pharmaceuticals 
in the aquatic environment. 
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Table II.1. Physico-chemical properties of the targeted compounds [6,27,28,45] and their annual 
consumption at pharmacy level in 2007 in Belgium [3] (n.d. = no data). 
Compounds  MW 
(g/mol) 
Log Kow pKa Consumption 
(kg/yr) 
NSAIDs      
Salicylic acid 138.12 2.43 3.50 11 
Mefenamic acid 241.28 4.16 4.20 n.d. 
Ketoprofen 254.28 3.22 4.45 199 
Diclofenac 296.15 3.91 4.15 3 360 
Lipid regulators     
Clofibric acid 214.65 2.58 3.00 n.d. 
Bezafibrate 361.83 3.85 3.60 176 
Antibiotics     
Sulfamethoxazole 253.28 0.68 5.70 453 
Trimethoprim 290.32 0.65 6.60 n.d. 
Chloramphenicol 323.13 1.14 5.50 1 
Ofloxacin 361.37 0.35 6.20 322 
Neuroactive compounds     
Carbamazepine 236.27 2.3 13.90 6 107 
β-blockers     
Propranolol 259.34 3.03 9.49 2 320 
Atenolol 266.34 0.46 9.16 2 232 
 
As pharmaceuticals are designed to exert specific effects at low doses and to resist 
metabolic degradation, their possible biological activity in aquatic organisms and their 
persistence cannot be excluded [4,5]. Moreover, the continuous environmental input of 
these compounds, and resulting mixtures, may induce unnoticed adverse effects on 
aquatic and terrestrial organisms [10,11]. Although several studies have reported standard 
ecotoxicity data for pharmaceuticals [8,12,13], in general their environmental 
significance, pertaining to environmental effects, is largely unknown [14]. However, a 
preliminary risk assessment database for common pharmaceuticals with a focus on 
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marine and estuarine environments is nowadays available to provide information on 
pharmaceutical threats to the environment [6]. 
Regulatory guidance to assess the presence of pharmaceuticals in the aquatic environment 
is still lacking. The Water Framework Directive (2000/60/EC) [15] and its daughter 
directive (2008/105/EC) [16] lay down environmental quality standards for a list of 
priority substances, but pharmaceuticals are not included. Furthermore, the OSPAR lists 
of chemicals of priority action and of substances of possible concern include, 
respectively, two and 19 pharmaceuticals [17]. However, these listed pharmaceuticals are 
used in fairly small quantities and their occurrence in the environment is limited [9]. 
Currently, no guidance is established for widely used and widespread occurring 
pharmaceuticals such as carbamazepine and diclofenac. 
Nevertheless, in recent years, numerous monitoring studies have demonstrated the 
occurrence of pharmaceuticals in aquatic systems. They have been detected in WWTP 
influents and effluents and in freshwater systems in the nanogram per litre up to the 
microgram per litre range [18–21]. More rarely, pharmaceuticals have been detected in 
drinking water [22,23] and groundwater samples [21,24], mostly in the nanogram per litre 
range and occasionally at microgram per litre levels. In contrast to the extensive literature 
describing the occurrence and persistence of pharmaceuticals in freshwater systems, little 
attention has been paid to their prevalence and quantification in marine ecosystems 
[25,26]. 
Therefore, the main objective of this study was to develop a quantitative analytical 
method for pharmaceuticals in seawater. On the basis of data on the current use in 
Belgium (Table II.1), 13 environmentally relevant pharmaceuticals were selected from 
five different therapeutic classes. These included four antibiotics (sulfamethoxazole, 
ofloxacin, trimethoprim and chloramphenicol), four nonsteroidal anti-inflammatory drugs 
(NSAIDs) (mefenamic acid, diclofenac, salicylic acid, and ketoprofen), two β-blockers 
(propranolol and atenolol), two lipid regulators (bezafibrate and clofibric acid) and one 
psychiatric drug (carbamazepine). The physicochemical properties of the pharmaceuticals 
considered in this study are presented in Table II.1 [6, 27, 28]. Secondly, an extensive 
validation study was carried out to demonstrate the applicability of this analytical 
approach. To this end, the method developed was applied to marine water samples taken 
from the North Sea and the Scheldt estuary. In this way, the presence of pharmaceuticals 
in the Belgian marine environment and their transfer to estuarine and marine ecosystems 
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was examined. This study is part of the INRAM project (www.vliz.be/projects/inram), a 
4-year project that aims to use an integrated approach to assess the risks of 
micropollutants in the Belgian coastal zone. 
 
2. EXPERIMENTAL 
2.1 Study area and sampling 
The study area is located in the three Belgian coastal harbours (Ostend, Nieuwpoort and 
Zeebrugge), the Scheldt estuary and the offshore coastal area of Belgium. An overview of 
the study area and the sampling stations is depicted in Fig. II.1. Ten sampling stations 
were selected in three coastal harbours; four in the harbour of Zeebrugge (ZB01–ZB04) 
and three in the harbours of Nieuwpoort (NP01 - NP03) and Ostend (OO02 - O04) each. 
In each harbour, one sampling station was representative for the major freshwater inputs 
into the harbour, while a second sampling location represented the water at the harbour 
mouth, and at least one station between these points was sampled as well. An additional 
station was selected at the Sluice Dock in Ostend (OO01) since at this location 
aquacultural activities take place. Two stations were sampled in the Scheldt estuary: one 
station located at the river mouth near Vlissingen, the second more upstream near 
Antwerp. Six sampling stations were chosen in the Belgian coastal area: three (W01–
W03) were located close to the harbour mouths of Ostend, Nieuwpoort and Zeebrugge; 
the remaining three (W04–W06) were situated more offshore. Four sampling campaigns 
were carried out: in May and December 2007, April 2008 and June 2009. 
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Figure II.1. Sampling stations in the North Sea (W01-W06), the Scheldt estuary (S01 and S22) and in 
the harbours of Nieuwpoort (NP1-NP3), Ostend (OO01-OO04) and Zeebrugge (ZB01-ZB04).  
 
Harbour stations were sampled using the Zeekat, a rigid inflatable boat. North Sea and 
Scheldt estuary stations were sampled with the larger research vessels Belgica, Zeeleeuw 
and Scheldewacht. Water was sampled at each sampling site using Go-Flo® bottles 
(General Oceanics, Miami, FL, USA) at a depth of 4–5 m. Go-Flo® bottles avoid sample 
contamination at the surface, internal contamination, loss of sample on the deck and 
exchange of water from different depths. In accordance with Noppe et al. [29], samples 
were acidified to prevent bacterial or algal growth and were stored at 4 °C in the dark 
before analysis. 
2.2 Reagents and chemicals 
Ketoprofen (purity 99.0%), mefenamic acid (purity better than 99.0%), carbamazepine 
(purity better than 99.0%), diclofenac (purity better than 99.0%), bezafibrate (purity 
98.0% or better), salicylic acid (purity better than 99.0%), clofibric acid (purity 97.0%), 
atenolol (purity 98.0% or better), trimethoprim (purity 98.0% or better), chloramphenicol 
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(purity 99.0% or better), and sulfamethoxazole (purity 99.0%) were purchased from 
Sigma-Aldrich (St. Louis, MO, USA). Ofloxacin (purity better than 99.0%) was obtained 
from ICN Biomedicals (Aurora, OH, USA) and propranolol (purity better than 99.0%) 
was purchased from Eurogenerics (Brussels, Belgium). The synthetic isobutcar 61 [4-
3(isobutylamino-2-hydroxypropoxy)-carbazole] was found to be a very suitable internal 
standard for this application as it corrected sufficiently for any matrix effects in the 
sample preparation and mass spectrometry (MS). 
Acetone, methanol and formic acid were of analytical grade and were purchased from 
VWR (Merck, Darmstadt, Germany). High performance liquid chromatography (HPLC)-
grade acetonitrile and water were obtained from VWR(Merck, Darmstadt, Germany) and 
Acros Organics (Fairlawn, NJ, USA), respectively. Primary stock solutions of all 
individual analytes were prepared in ethanol at a concentration of 1 ng μL-1. Working 
standard mixture solutions were prepared by appropriate dilution of the stock solutions in 
ethanol. All solutions were stored at -20 °C in the dark. 
2.3 Extraction and clean-up 
The extraction technique developed is based on the method of Gómez et al. [30] and 
Nebot et al. [31]. Prior to extraction, the pH of the water samples was adjusted to 7.0 ± 
0.5 using solutions of HCl (1 M) and NaOH (1 M). Seawater samples of 1 L were filtered 
through a Whatman filter paper (GF/C diameter 47 mm, particle retention 1.2 μm, Merck, 
Darmstadt, Germany) to avoid clogging of the sorbent. The filters were washed with 2 
mL methanol to prevent loss of the compounds of interest. The methanol extract was 
collected and added to the filtered sample. Prior to extraction, the internal standard 
isobutcar 61 was added to every sample at a final concentration of 50 ng L-1. 
Subsequently, solid-phase extraction (SPE) was carried out using Chromabond HR-X 
cartridges (3 mL, 200 mg, Macherey-Nagel, Düren, Germany). The cartridges were 
preconditioned with 5 mL methanol and 5 mL Milli-Q water. After they had been loaded 
with 1 L of the filtered sample pooled with the methanol from the filter washing, the 
cartridges were rinsed twice with 5 mL Milli-Q water. Subsequently, the cartridges were 
dried under a vacuum for 30 min. Elution was performed using 5 mL acetone and 2 × 5 
mL methanol. Next, the extracts were dried using nitrogen and the residues were 
reconstituted in 300 μL acetonitrile/0.02 M formic acid (50/50) before transfer to liquid 
chromatography (LC)–MS vials. 
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2.4 Chromatographic and mass spectrometric instrumentation 
Analysis was carried out using HPLC. The apparatus comprised an 1100 series 
quaternary gradient pump and autosampler (Hewlett Packard, Palo Alto, CA, USA). 
Chromatographic separation was achieved using a Nucleodur® C18 Isis HPLC column (5 
μm particle size, 250 mm×4.0 mm, Macherey-Nagel, Düren, Germany). The void volume 
of the system was 2.5 mL. A filter (porosity 2 μm, 4 mm; Alltech, Waukegan, IL, USA) 
and a precolumn (Nucleodur® C18 Isis, Macherey-Nagel, Düren, Germany) were used to 
prevent rapid deterioration of the analytical column. The mobile phase consisted of a 
mixture of 0.02 M formic acid (solvent A) in water and acetonitrile (solvent B). A linear 
gradient of 0.3 mL min-1 was used starting with a mixture of 60% solvent A and 40% 
solvent B for 5 min. The acetonitrile percentage was increased linearly from 40 to 100% 
in 20 min. Twenty microlitres was injected onto the LC-MSn system. Analytes were 
detected with an LCQ DECA ion trap mass spectrometer equipped with an electrospray 
ionization (ESI) interface (Thermo Finnigan, San Jose, CA, USA) using the optimized 
MS parameters described in “Results and discussion”. The optimal ionization source 
working parameters were as follows: sheath gas flow rate, 80 arbitrary units (a.u.); 
auxiliary gas, 20 a.u.; capillary temperature 350 °C; capillary voltage, -14 V; and tube 
lens offset, 20 V. Chromatograms and spectra were recorded and processed using 
Xcalibur® 2.0 (Thermo Finnigan, San Jose, CA, USA). 
2.5 Validation of the method 
For environmental sample analysis, rigorous validation procedures are usually not well 
defined. Similar to reported studies on pharmaceuticals in water [11,20,32], we validated 
the method developed according to Commission Decision 2002/657/EC [33] concerning 
the determination of analytes in products of animal origin. Also SANCO/825/00 revision 
7 [34] was used as a guideline for the validation of this new analytical method. In general, 
validation includes the evaluation of linearity, specificity, selectivity, recovery, matrix 
effects and the determination of the limit of quantification (LOQ). Because the method 
was particularly aimed at examining marine waters, seawater was used to validate the 
method. On the basis of preliminary results, blank seawater samples contained low levels 
of some of the target analytes. The calibration curves were corrected for these 
concentrations. In addition, none of the pharmaceuticals were detected in reagents or 
Milli-Q water. 
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2.6 Quality assurance 
Before and after analysis of a series of samples, a standard mixture (1 ng on column) of 
the target pharmaceuticals was injected to check the instrument parameters of the LC-
ESI-MSn system. Quality control of the method was performed by analysis of a blank 
sample, together with a linear calibration curve constructed using 1 L seawater samples 
spiked with standard solutions at seven concentrations between 1 and 1,000 ng L-1. This 
was performed for every series of samples. These calibration curves were used for 
quantification. 
 
3. RESULTS AND DISCUSSION 
3.1 Method development 
3.1.1 Extraction of the target pharmaceuticals 
Irrespective of the log Kow and pKa values of the substances studied (Table II.1), an 
extraction procedure aiming at the recovery of all target analytes in an efficient and 
repeatable manner was developed. To obtain a concentrated extract suitable for analysis, 
extraction of pharmaceuticals in water is generally executed using SPE [20,27,31,35]. 
SPE includes the extraction of the analytes by means of a solid sorbent and is usually 
performed off-line. Preliminary experiments were performed to evaluate the extraction 
efficacy of different types of SPE sorbents: OASIS HLB (3 mL, 60 mg, Waters, Milford, 
MA, USA), Strata-x (33 μm polymeric reversed phase, 6 mL, 200 mg, Phenomenex, 
USA), Bakerbond Speedisk extraction disk (H2O-phobic and H2O-philic, J.T. Baker, 
Deventer, The Netherlands) and Chromabond HR-X (3 mL, 200 mg, Macherey-Nagel, 
Düren, Germany) cartridges. Of all the cartridges, Chromabond® HR-X exhibited the best 
performance in simultaneously retaining all the analytes at a pH of 7. Indeed, Zhang and 
Zhou [36] demonstrated similar extraction recoveries at pH 4.2 and at pH 10.3; therefore, 
a pH of 7.0 was selected for the water samples to obtain an analytical compromise for the 
best retention for all analytes. The SPE procedure using Chromabond HR-X cartridges, 
which consist of a hydrophobic polystyrene-divinylbenzene copolymer, was therefore 
optimized. In the final extraction protocol, prior to elution, the SPE cartridges were rinsed 
twice with 5 mL of Milli-Q water. In marine analytical chemistry an additional advantage 
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of the washing step is the removal of remaining sea salt from the cartridge. Higher 
recovery rates were achieved by including this washing step (data not shown). Optimal 
elution of the pharmaceuticals was achieved using acetone followed by methanol. The 
most optimal elution solvent was selected on the basis of analytical characteristics such as 
peak area, resolution and signal-to-noise ratio. 
3.1.2 Detection 
Owing to the limited volatility of the pharmaceuticals, LC was the preferred 
chromatographic technique used in this study to achieve separation of the target analytes. 
Good chromatographic separation of the compounds under investigation was achieved 
using a C18 Isis reversed-phase LC column as the stationary phase. The retention 
mechanism of this column is based on steric and hydrophobic interactions and resulted in 
the optimized separation of all analytes. A mixture of acetonitrile and 0.1% formic acid in 
water proved superior as opposed to other solvent modifiers such as ammonium acetate.  
Mass spectra were obtained using direct infusion of each standard in the mobile phase. 
The following operational parameters of the MS detector were optimized: MS ion mode, 
collision energy (eV), isolation width (m/z) and activation Q. ESI was used as the 
ionization source in both negative and positive ion mode by injecting the final extract 
twice. Detection of the negative precursor ion [M-H]- was performed for 
chloramphenicol, salicylic acid, bezafibrate, clofibric acid and mefenamic acid, whereas 
detection of the positive precursor ion [M+H]+ was performed for the other compounds of 
interest. Precursor and product ions and collision energies are presented in Table II.2. The 
isolation width was set at 2.0 m/z, except for chloramphenicol, clofibric acid and 
diclofenac (3.0 m/z). For the activation Q, the default value of 0.25 was used, except for 
salicylic acid (0.35). MSn was performed for all precursor ions and allowed reliable 
confirmation of the target analytes. Figures II.2 and II.3 show the chromatograms and 
spectra obtained for the pharmaceuticals detected in positive and negative ionization 
mode, respectively (100 ng L-1 spiked in seawater). 
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Table II.2. Precursor and product ions (m/z) and collision energy (eV) of the pharmaceuticals and 
internal standard (*) considered. 
Compound Precursor ion Product ions MS² (MS³) Coll. E MS² (MS³) 
Salicylic acid 137 93 (65) 37 (47) 
Mefenamic acid 240 196 (180) 38 (45) 
Ketoprofen 255 209; 177 26 
Diclofenac 297 278; 250 30 
Clofibric acid 213 127; 85 26 
Bezafibrate 360 274 (154) 28 (40) 
Sulfamethoxazole 254 188; 156; 147 40 
Trimethoprim 291 230; 258; 123 40 
Chloramphenicol 321 194; 257; 176 28 
Ofloxacin 362 318; 344 45 
Carbamazepine 237 194; 220; 192 35 
Propranolol 260 183; 116; 157 32 
Atenolol 267 225; 190; 208; 249 35 
Isobutcar 61 (*) 313 222; 130; 196 32 
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Figure II.2. Chromatograms and spectra of the pharmaceuticals detected in positive ion mode (100 
ng L-1 spiked in seawater). 
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Figure II.3. Chromatograms and spectra of the pharmaceuticals detected in negative ion mode (100 
ng L-1 spiked in seawater). 
 
3.2 Validation study 
3.2.1 Identification/selectivity 
Identification and confirmation of the compounds was performed according to the 
procedure prescribed by Commission Decision 2002/657/EC [33]. Compounds were 
identified on the basis of their relative retention time, which is the ratio of the retention 
time of the analyte to that of the internal standard. In addition, the ion ratios of the 
precursor and product ions in the spectrum obtained upon chromatographic analysis were 
taken into account when the peak in the chromatogram had a signal-to-noise ratio of at 
least 3:1. Commission Decision 2002/657/EC [33] also describes a system of 
identification points. Detection of precursor and product ions yields, respectively, one and 
1.5 identification points. To obtain a minimum of four identification points, MS3 
fragmentation was required for salicylic acid, bezafibrate and mefenamic acid. 
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3.2.2 Specificity 
The specificity of our method was evaluated through the analysis of seawater samples 
spiked with each compound separately and of seawater samples spiked with a mixture of 
all compounds at a concentration of 100 ng L-1. The specificity of the analytical approach 
was confirmed since no interferences were demonstrated by using LC-MSn as described 
“Experimental”. No other significant peaks with a signal-to-noise ratio of 3 or more were 
observed at the specific retention times of the target pharmaceuticals, indicating a high 
specificity of the analytical method. 
3.2.3 Linearity and limit of quantification  
Linearity was evaluated by seven-point calibration curves (six replicates) in seawater. 
Seawater samples (1 L) were spiked with a standard mixture obtaining concentrations of 
1; 5; 10; 50; 100; 500 and 1,000 ng L-1 of the different pharmaceuticals. The mean 
correlation coefficients (n=6) of the calibration curves were 0.99 or higher for the target 
analytes, indicating good linearity in the concentration range 1–1,000 ng L-1 (Table II.3). 
This is in accordance with the correlation coefficients reported in the literature for the 
same pharmaceuticals in freshwater [20,30]. Despite the high salinity of our sample 
matrix, the linearity of the analytical method in seawater was not affected. To 
demonstrate the flexibility of our analytical procedure, besides seawater, calibration 
curves were also constructed in tap water. Correlation coefficients of 0.99 or higher were 
found for all compounds.  
LOQs were determined using spiked matrix samples and were defined as the lowest 
detectable concentrations of the calibration curves with a signal-to-noise ratio of at least 
10 [21,27,30,31]. The LOQs obtained for the target compounds (Table II.3) varied 
between 1 and 50 ng L-1 in seawater and were the same in tap water (chromatograms and 
spectra not shown). These LOQs are considered acceptable and are comparable to 
previously reported LOQs for the same pharmaceuticals. Indeed, similar LOQs (between 
1 and 20 ng L-1) were reported for bezafibrate, clofibric acid, sulfamethoxazole, 
carbamazepine, propranolol, chloramphenicol and thrimethoprim [32,37]. Gómez et al. 
[30] reported comparable LOQs for atenolol and diclofenac.  
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Table II.3. Validation results: limits of quantification (LOQ), correlation coefficients (R²), recovery 
and precision in seawater and tap water of the targeted pharmaceuticals. 
Compound LOQ R² Seawater (n=42) Tap water (n=6) 
 (ng L-1)  
Recovery 
(%) 
RSD 
(%) 
Recovery 
(%) 
RSD    
(%) 
Salicylic acid 5 ≥ 0.99 108 27 98 14
Mefenamic acid 5 ≥ 0.99 95 20 92 14
Ketoprofen 50 ≥ 0.99 103 18 109 9
Diclofenac 50 ≥ 0.99 101 17 104 14
Clofibric acid 5 ≥ 0.99 97 18 94 10
Bezafibrate 5 ≥ 0.99 98 27 93 11
Sulfamethoxazole 10 ≥ 0.99 100 19 106 17
Trimethoprim 10 ≥ 0.99 108 19 96 12
Chloramphenicol 5 ≥ 0.99 101 17 102 10
Ofloxacin 50 ≥ 0.99 97 18 92 14
Carbamazepine 5 ≥ 0.99 101 19 100 5
Propranolol 1 ≥ 0.99 107 18 94 7
Atenolol 50 ≥ 0.99 104 16 105 14
 
3.2.4 Recovery and precision  
Because no certified reference material was available, recoveries and intermediate 
precision (samples were measured on different days) were determined using seawater 
samples spiked with known amounts of the analytes (six replicates of seven 
concentrations: 1, 5, 10, 50, 100, 500 and 1,000 ng L-1). The intermediate precision of the 
method was determined by calculating the relative standard deviation (RSD). Table II.3 
summarizes the recovery and precision results. According to SANCO/825/00 revision 7 
[34], typically a recovery within the range 70–110% and a repeatability of RSD≤20% are 
required. The mean recoveries (in the 95–108% range) were satisfactory for all the target 
pharmaceuticals. Zhang and Zhou [36] described the increasing extraction efficiency in 
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SPE of carbamazepine, sulfamethoxazole, propranolol and diclofenac owing to the 
increasing salt concentration. Taking this into account, we can explain the recovery rates 
of 100% or more of nine pharmaceuticals in this study. Except for bezafibrate and 
salicylic acid (RSDs of 27%), the analytical method was sufficiently precise for 
quantitative analysis of the pharmaceuticals (RSDs between 16 and 20%). The RSDs of 
bezafibrate and salicylic acid were somewhat higher at the lowest concentrations. This 
can be attributed to the unavailability of a representative blank sample and consequently 
to the variation of its presence in unspiked water samples. As can be seen from Table II.3, 
the method developed allows quantification of the target analytes in tap water as well. 
The recoveries (between 92 and 109%) and RSDs (17% or less) in tap water were 
satisfactory.  
3.2.5 Matrix effects 
Since the ESI part of the mass spectrometer may be subject to signal suppression or 
enhancement due to co-extracted matrix constituents [10], the validation study included 
the evaluation of matrix effects. Concerning the analysis of seawater samples, these 
matrix constituents include mainly particulate components, sea salt and other impurities. 
Despite the thorough optimization of our sample preparation protocol to avoid matrix 
effects, these were still observed following our analytical procedure. Therefore, the 
matrix effects were studied by comparing the calibration curves for the different 
compounds, in seawater and in tap water. In addition, standard mixtures in mobile phase 
containing concentrations equal to the spiked matrix sample concentrations were brought 
onto column. A signal enhancement was observed in seawater for several analytes 
(ofloxacin, propranolol, chloramphenicol, salicylic acid, bezafibrate, clofibric acid). On 
the other hand, ion suppression effects due to matrix constituents were also observed for a 
number of analytes (atenolol, trimethoprim, sulfamethoxazole and mefenamic acid). The 
influence of the matrix was negligible for carbamazepine, diclofenac and ketoprofen. No 
significant variations in matrix effects between the different samples were observed. The 
proper correction for matrix effects implies the use of one (labelled) internal standard per 
analyte. However, the commercial availability of reference standards is rather low, and 
according to the literature satisfactory results can be obtained using only one or two 
internal standards to correct for all compounds [11]. Therefore, with every series of 
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samples, calibration curves were prepared in the sample matrix to minimize the matrix 
effect on the quantification of the analytes.  
3.3 Application to North Sea samples 
The method developed was applied to water samples collected during the INRAM project 
(see “Study area and sampling”). Six offshore samples, 11 harbour samples and two 
samples from the Scheldt estuary were collected and analysed. This was repeated four 
times: in May and December 2007, April 2008 and June 2009. As can be deduced from 
Table II.4, seven different pharmaceuticals were detected. The other pharmaceuticals 
were not detected at any of the sampling stations. Sulfamethoxazole and trimethoprim 
were found up to concentrations of 96 and 29 ng L-1, respectively. Other antibiotics could 
not be detected. The widely used NSAID salicylic acid was detected very often. Salicylic 
acid, the deacylated, more active form of acetylsalicylic acid, was detected in more than 
90% of all samples at a concentration up to 855 ng L-1. The β-blocker propranolol was 
found in half of the samples at levels up to 24 ng L-1, whereas atenolol was detected only 
six times up to 293 ng L-1. Bezafibrate was detected at concentrations below 18 ng L-1 
and residues of the psychiatric drug carbamazepine were frequently found at levels up to 
321 ng L-1. Salicylic acid and carbamazepine may be considered as the most relevant 
compounds for the North Sea and Scheldt estuary since they were detected most often 
and at the highest concentrations. 
 
  
Table II.4. Detected concentrations (ng L-1) of the pharmaceuticals of interest in water sampled in May and December 2007, April 2008 and June 2009 at the 
different sampling locations in the North Sea, the Scheldt estuary and Belgian harbours, (n.d. = not detected; n.m. = not measured). 
Compound 
Sampling period 
Station                  
W01 W02 W03 W04 W05 W06 S01 S22 OO1 OO2 OO3 OO4 NP1 NP2 NP3 ZB1 ZB2 ZB3 ZB4 
Salicylic acid 
May 2007 
December 2007 
April 2008 
June 2009 
 
126 
660 
102 
263 
 
26 
276 
56 
412 
 
53 
106 
62 
n.d. 
 
65 
68 
88 
227 
 
18 
26 
65 
237 
 
n.d. 
59 
49 
60 
 
51 
135 
91 
307 
 
372 
229 
71 
264 
 
246 
598 
203 
481 
 
855 
365 
74 
222 
 
n.m. 
234 
43 
374 
 
161 
104 
67 
n.d. 
 
44 
99 
44 
306 
 
31 
94 
46 
n.d. 
 
11 
121 
n.m. 
177 
 
48 
136 
114 
16 
 
130 
142 
87 
312 
 
110 
271 
80 
310 
 
41 
197 
146 
n.d. 
Bezafibrate 
May 2007 
December 2007 
April 2008 
June 2009 
 
n.d. 
n.d. 
8 
n.d. 
 
n.d. 
n.d. 
n.d. 
n.d. 
 
n.d. 
n.d. 
n.d. 
n.d. 
 
n.d. 
n.d. 
n.d. 
n.d. 
 
n.d. 
n.d. 
n.d. 
n.d. 
 
n.d. 
n.d. 
n.d. 
n.d. 
 
n.d. 
n.d. 
6 
n.d. 
 
16 
5 
n.d. 
n.d. 
 
5 
n.d. 
5 
n.d. 
 
18 
7 
9 
18 
 
n.m. 
12 
7 
10 
 
6 
11 
6 
n.d. 
 
n.d. 
n.d. 
n.d. 
n.d. 
 
n.d. 
n.d. 
n.d. 
n.d. 
 
n.d. 
n.d. 
n.m. 
n.d. 
 
n.d. 
n.d. 
6 
n.d. 
 
n.d. 
n.d. 
6 
n.d. 
 
n.d. 
n.d. 
5 
n.d. 
 
n.d. 
n.d. 
n.d. 
n.d. 
Sulfamethoxazole 
May 2007 
December 2007 
April 2008 
June 2009  
 
n.d. 
n.d. 
n.d. 
n.d. 
 
n.d. 
n.d. 
n.d. 
n.d. 
 
n.d. 
n.d. 
n.d. 
n.d. 
 
n.d. 
n.d. 
n.d. 
n.d. 
 
n.d. 
n.d. 
n.d. 
n.d. 
 
n.d. 
n.d. 
n.d. 
n.d. 
 
n.d. 
n.d. 
n.d. 
n.d. 
 
n.d. 
30 
96 
n.d. 
 
n.d. 
n.d. 
n.d. 
n.d. 
 
n.d. 
n.d. 
43 
n.d. 
 
n.m. 
39 
21 
n.d. 
 
n.d. 
27 
15 
n.d. 
 
n.d. 
13 
15 
n.d. 
 
n.d. 
n.d. 
n.d. 
n.d. 
 
n.d. 
n.d. 
n.d. 
n.d. 
 
n.d. 
n.d. 
n.d. 
n.d. 
 
n.d. 
n.d. 
n.d. 
n.d. 
 
n.d. 
n.d. 
n.d. 
n.d. 
 
n.d. 
n.d. 
n.d. 
n.d. 
Trimethoprim                    
  
May 2007 
December 2007 
April 2008 
June 2009   
n.d. 
n.d. 
n.d. 
n.d. 
n.d. 
n.d. 
n.d. 
n.d. 
n.d. 
n.d. 
n.d. 
n.d. 
n.d. 
n.d. 
n.d. 
n.d. 
n.d. 
n.d. 
n.d. 
n.d. 
n.d. 
n.d. 
n.d. 
n.d. 
n.d. 
n.d. 
n.d. 
n.d. 
n.d. 
n.d. 
n.d. 
n.d. 
n.d. 
n.d. 
n.d. 
n.d. 
15 
n.d. 
29 
n.d. 
n.m. 
n.d. 
n.d. 
13 
n.d. 
n.d. 
n.d. 
n.d. 
n.d. 
n.d. 
n.d. 
n.d. 
n.d. 
17 
n.d. 
n.d. 
n.d. 
n.d. 
n.m. 
n.d. 
n.d. 
n.d. 
n.d. 
n.d. 
n.d. 
n.d. 
n.d. 
n.d. 
n.d. 
n.d. 
n.d. 
n.d. 
n.d. 
n.d. 
n.d. 
n.d. 
Carbamazepine 
May 2007 
December 2007 
April 2008 
June 2009 
 
18 
19 
16 
11 
 
n.d. 
n.d. 
14 
n.d. 
 
n.d. 
n.d. 
4 
n.d. 
 
7 
10 
12 
7 
 
n.d. 
n.d. 
n.d. 
n.d. 
 
n.d. 
n.d. 
n.d. 
n.d. 
 
5 
18 
27 
14 
 
321 
154 
185 
129 
 
31 
29 
30 
21 
 
119 
19 
64 
50 
 
n.m. 
32 
35 
36 
 
16 
30 
36 
20 
 
29 
68 
48 
19 
 
15 
54 
20 
7 
 
n.d. 
37 
n.m. 
n.d. 
 
11 
14 
30 
10 
 
10 
12 
25 
13 
 
11 
17 
23 
20 
 
11 
24 
20 
16 
Propranolol 
May 2007      
December 2007 
April 2008 
June 2009  
 
n.d. 
1 
n.d. 
n.d. 
 
n.d. 
n.d. 
n.d. 
n.d. 
 
n.d. 
n.d. 
n.d. 
n.d. 
 
n.d. 
n.d. 
n.d. 
n.d. 
 
n.d. 
n.d. 
n.d. 
n.d. 
 
n.d. 
n.d. 
n.d. 
n.d. 
 
n.d. 
1 
3 
n.d. 
 
22 
10 
22 
15 
 
5 
3 
2 
n.d. 
 
24 
6 
21 
13 
 
n.m. 
9 
11 
3 
 
3 
9 
12 
n.d. 
 
6 
12 
3 
n.d. 
 
3 
12 
2 
n.d. 
 
n.d. 
7 
n.m. 
n.d. 
 
1 
1 
3 
n.d. 
 
n.d. 
1 
3 
n.d. 
 
n.d. 
4 
2 
n.d. 
 
1 
3 
2 
n.d. 
Atenolol 
May 2007 
December 2007 
April 2008 
June 2009 
 
n.d. 
n.d. 
n.d. 
n.d. 
 
n.d. 
n.d. 
n.d. 
n.d. 
 
n.d. 
n.d. 
n.d. 
n.d. 
 
n.d. 
n.d. 
n.d. 
n.d. 
 
n.d. 
n.d. 
n.d. 
n.d. 
 
n.d. 
n.d. 
n.d. 
n.d. 
 
n.d. 
n.d. 
n.d. 
n.d. 
 
89 
293 
188 
n.d. 
 
n.d. 
n.d. 
n.d. 
n.d. 
 
88 
n.d. 
82 
n.d. 
 
n.m. 
n.d. 
n.d. 
n.d. 
 
n.d. 
80 
n.d. 
n.d. 
 
n.d. 
n.d. 
n.d. 
n.d. 
 
n.d. 
n.d. 
n.d. 
n.d. 
 
n.d. 
n.d. 
n.m. 
n.d. 
 
n.d. 
n.d. 
n.d. 
n.d. 
 
n.d. 
n.d. 
n.d. 
n.d. 
 
n.d. 
n.d. 
n.d. 
n.d. 
 
n.d. 
n.d. 
n.d. 
n.d. 
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Many studies have reported the presence of pharmaceuticals in rivers and in influents and 
effluents of WWTPs [18–20,35]. The concentrations observed depend on the therapeutic 
class. The presence of antibiotics in surface water is generally reported in the low 
nanogram per litre concentration range, whereas several NSAIDs reach microgram per 
litre levels. The levels of salicylic acid measured in our study are within the same order of 
magnitude as those reported in the literature for freshwater samples. Detected 
concentrations of β-blockers and lipid regulators in the Belgian coastal zone are rather 
low in comparison with concentrations detected in surface water [18,38]. On the other 
hand, carbamazepine occurs at high levels and is detected very often. This can be 
explained by its low removal efficiency in WWTPs [21,37]. With regard to marine 
waters, Buser et al. [39] and Weigel et al. [25,40] reported the presence of clofibric acid 
and carbamazepine in the North Sea at concentrations of approximately 1 and 2 ng L-1, 
respectively. More recent, Togola and Budzinski [41] reported higher concentrations for 
carbamazepine, diclofenac and ketoprofen in the Mediterranean Sea. However, in general, 
monitoring data for pharmaceuticals in the marine environment are rather sparse. This 
may reflect the absence of a method to extract and identify multiclass pharmaceuticals in 
marine systems [40]. In this study, a novel multiclass analytical method for 
pharmaceuticals was developed that clearly showed the ubiquitous character of several 
pharmaceutical compounds in seawater and as a result in the marine environment as well. 
These findings will assist to further research within the INRAM project, in which risk 
assessments of the pharmaceuticals detected for the marine environment will be 
performed. 
The concentrations of some pharmaceuticals under investigation show large temporal 
variations. However, except for salicylic acid at W01 and W02, the same general picture 
of lower concentrations in the North Sea (W01 – W06) in comparison with the harbours 
and the Scheldt estuary could be noticed. We suggested that, owing to both dilution and 
degradation, there is little transport from the Scheldt estuary and the harbours to the open 
sea. Also previous studies on oestrogens, nonyl phenol ethoxylates, and polychlorinated 
biphenyls reported the limited transport from the Scheldt estuary to the North Sea [42–
44]. At sampling locations OO02 and S22, target pharmaceuticals were detected most 
frequently and at the highest concentrations. OO02 is situated at the mouth of the river 
Noord-Ede and the canal Bruges-Ostend in the harbour of Ostend (in the middle of the 
Belgian coastal zone), whereas S22 is located in the Scheldt estuary in Antwerp. Several 
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WWTPs are located close to OO02 and in Flanders the effluents of more than 65 WWTPs 
are discharged into the Scheldt estuary. Furthermore, the WWTPs with the largest 
capacity are located near the Scheldt estuary: Deurne, Ghent and Antwerp (approximately 
200,000 inhabitant equivalent) (Aquafin, personal communication). It may be concluded 
that both locations receive major inputs of contaminated industrial and domestic 
wastewater, probably resulting in the increased presence of the target pharmaceuticals.  
 
4. CONCLUSION 
In this study, an analytical method for the quantification of important pharmaceuticals in 
seawater was developed and optimized. A combination of SPE and LC-MSn enabled the 
detection and quantification of multiclass pharmaceuticals of widely differing chemical 
structures in seawater at the low nanogram per litre level. The method was validated 
according to the laboratory quality assurance criteria developed in accordance with 
Commission Decision 2002/657/EC and SANCO/825/00 revision 7 [33,34]. Application 
of the procedure to North Sea and Scheldt estuary samples confirmed the occurrence of 
seven pharmaceuticals in the marine environment up to the low microgram per litre level. 
Frequently detected compounds were salicylic acid, carbamazepine and propranolol. Two 
antibiotics were detected occasionally: sulfamethoxazole and thrimethoprim. Little 
transport of pharmaceuticals could be observed from the Scheldt estuary and the harbours 
to the open sea. In general, it may be concluded that the results of this 2-year monitoring 
study are quite novel and may provide relevant insights into the field of pharmaceutical 
analysis in the marine environment. 
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Abstract 
Perfluorinated compounds (PFCs), which are extensively used in a wide variety of 
applications because of their specific surfactant properties, have recently appeared as an 
important new class of global environmental pollutants. Quantitative analysis of PFCs in 
aqueous matrices remains, however, a challenging task. During this study, a new 
analytical method for the determination of 14 PFCs in surface-, sewage- and seawater 
was developed and validated. The target analytes were extracted using solid-phase 
extraction followed by liquid chromatography coupled to a time-of-flight mass 
spectrometer (LC–ToF-MS). The use of very narrow mass tolerance windows (<10 ppm) 
resulted in a highly selective MS-technique for the detection of PFCs in complex aqueous 
matrices. Validation of this analytical method in surface-, sewage and seawater resulted 
in limits of quantification (LOQs) varying from 2 to 200 ng L−1, satisfying recoveries (92-
134%) and precision (6-19 RSD%), and good linearity (R2 = 0.99 for most analytes, n=8). 
Analysis of samples of the North Sea, the Scheldt estuary, and three harbours of the 
Belgian coastal region led to the detection of four different PFCs. Perfluorooctane 
sulfonate (PFOS) was found to be the most abundant PFC in levels up to 39 ng L−1.  
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1. INTRODUCTION 
Perfluorinated compounds (PFCs) constitute a large group of chemicals characterized by 
a fully fluorinated hydrophobic carbon chain attached to various hydrophilic heads [1]. 
The chemical class of PFCs includes the perfluoroalkyl carboxylates, the perfluoroalkyl 
sulfonates, the perfluoroalkyl sulfonamides, and related products. Their chemical and 
thermal stability and surface tension lowering properties make them very useful for a 
wide variety of applications and products: as additives in fire-fighting foam and food 
packaging, as fat and water repellents for textile, paper and leather treatment, as 
performance chemicals, and as polymerization aid for the production of fluorinated 
polymers such as polytetrafluoroethylene (PTFE) and polyvinylidene fluoride (PVDF) 
[1,2]. Within the group of PFCs, perfluorooctane sulfonate (PFOS), the final degradation 
product of the frequently used sulfonated fluorochemicals, has been identified as the most 
important contaminant [2]. Moreover, PFOS fulfils the criteria of a persistent organic 
pollutant (POP) under the Stockholm convention [3]. As a result, EU legislation 
established the PFOS directive 2006/122/EC [4] which aims at ending the use of PFOS.  
In general, PFCs have been reported as extremely persistent environmental contaminants 
with bioaccumulative and toxic properties [5,6]. Consequently, the concern about the 
environmental fate and prevalence of PFCs has increased in recent years. Recent 
monitoring studies have reported the widespread occurrence of PFCs in water [7], air [8], 
and biological matrices [9]. In surface water [10–12] as well as in wastewater [13,14], 
PFCs have generally been detected in the ng L−1 up to µg L−1 concentration range. 
Furthermore, PFCs have been found in seawater and open ocean waters, implying the 
transport of PFCs from surface water through estuaries to coastal regions and 
consequently to open oceans [15–17]. According to Van Leeuwen et al. [18], the quality 
of data obtained from analysis of PFCs in environmental matrices is a major issue of 
concern. The occurrence of branched isomers, matrix interferences, and cross 
contamination rendered quantitative analysis of PFCs in aqueous matrices a challenging 
task. To the best of our knowledge, the use of accurate mass high-resolution mass 
spectrometric techniques for the quantification of PFCs in water samples has not been 
reported earlier [19].  
Therefore, in this study, an analytical methodology was developed using liquid 
chromatography (LC) coupled to a time-of-flight mass spectrometer (ToF-MS). ToF-MS 
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provides sensitive full scan data and allows the detection of the target PFCs by accurate 
mass measurements, resulting in a highly selective MS-technique. Fourteen 
environmentally relevant PFCs were selected, including four perfluoroalkyl sulfonates, 
nine perfluoroalkyl carboxylic acids and perfluorooctane sulphonamide. A validation 
study was carried out to demonstrate the applicability of this analytical approach. Finally, 
the developed method was applied to marine water samples from the North Sea and 
Scheldt estuary to examine the presence of PFCs in the Belgian marine environment. 
 
2. MATERIALS AND METHODS 
2.1 Study area and sampling 
The study area and sampling method were already described in Chapter II, section 2.1 
and Figure II.1. However, the sampling campaign for PFC-analyis of water samples was 
carried out in June 2009 and the water samples were stored at 4 °C in the dark without 
adjustment of the pH.  
2.2 Reagents and chemicals 
Fourteen PFCs were examined in this study: four perfluorosulfonates (potassium 
perfluoro-1-butane sulfonate, sodium perfluoro-1-hexane sulfonate, sodium perfluoro-1-
octane sulfonate, and sodium perfluoro-1-decane sulfonate), nine perfluorocarboxylates 
(perfluoro-n-pentanoic acid, perfluoro-n-hexanoic acid, perfluoro-n-heptanoic acid, 
perfluoro-n-octanoic acid, perfluoro-n-nonanoic acid, perfluoro-n-decanoic acid, 
perfluoro-n-undecanoic acid, perfluoro-n-dodecanoic acid, and perfluoro-n-tetradecanoic 
acid) and perfluoro-1-octane sulfonamide. All analytical standards were purchased from 
Wellington Laboratories (Guelph, Ontario, Canada) with chemical purities of more than 
98%. Six 13C-labelled internal standards were used as well: sodium perfluoro-1-[1,2,3,4-
13C4] octane sulfonate, perfluoro-n-[1,2-13C2] hexanoic acid, perfluoro-n-[1,2,3,4-13C4] 
octanoic acid, perfluoro-n-[1,2,3,4,5-13C5] nonanoic acid, perfluoro-n-[1,2-13C2] decanoic 
acid, and perfluoro-n-[1,2-13C2] dodecanoic acid.  
Methanol was purchased from Rathburn Chemicals (LTd Walkerburn, Scotland), while 
HPLC-grade water was obtained from Biosolve (Biosolve Chemicals, The Netherlands). 
Ammonium acetate (2.5mM) in water was obtained from dilution of LC–MS 
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Chromasolv® water containing 0.1% ammonium acetate (Sigma–Aldrich 
Laborchemikalien GmbH, Seelze). Except for PFOSA, primary stock solutions of all 
individual analytes were prepared in methanol at a concentration of 50 µg mL−1. PFOSA 
was purchased in nonane at the same concentration. Working standard mixture solutions 
were prepared by appropriate dilution of the stock solutions in methanol. All solutions 
were stored at −20 °C in the dark. 
2.3 Extraction and clean-up 
The sample preparation protocol was based on the ISO 25101/2006 method [20], which 
was in its turn derived from the method of Taniyasu et al. [21]. Sewagewater samples and 
water samples, visibly containing particulate matter, were filtered through a glass fibre 
paper (GF 52 Ø110mm, Schleicher & Schuell, Dassel, Germany) prior to extraction. 
Depending on the aqueous matrix, different volumes of water were extracted. In case of 
surface- and sewagewater, 50 mL water was extracted, while 250 mL was used for 
seawater samples. The 13C-labelled internal standards were supplemented to every sample 
prior to extraction to a final concentration of 100 ng L−1. Solid-phase extraction was 
carried out using OASIS HLB cartridges (6cm3, 200 mg, Waters, Milford, MA). The 
cartridges were pre-conditioned with 2 mL methanol and 2 mL Biosolve water. After 
loading, the cartridges were rinsed with 2 mL Biosolve water for surface- and 
sewagewater. For seawater, 3× 2 mL Biosolve water was applied. Subsequently, the 
cartridges were dried under vacuum for 10min. Elution was achieved using 2× 2 mL 
methanol. Next, extracts were concentrated to 0.5 mL under a gentle stream of nitrogen. 
Finally, 0.5 mL of 2.5mM ammonium acetate in water was added before transfer to LC–
MS vials. Samples were stored at 4 °C before analysis. 
2.4 Chromatographic and mass spectrometric instrumentation 
The LC-apparatus comprised of a 1200 series binary gradient pump and a 1100 series 
autosampler (Hewlett Packard, Palo Alto, CA, USA). Chromatographic separation was 
achieved using a Luna® C18 (2) HPLC column (5µm particle size, 250 mm×2.0 mm; 
Phenomenex Inc., Utrecht). The mobile phase consisted of a mixture of (A) 2.5mM 
ammonium acetate in water and (B) methanol. A linear gradient of 0.3 mL min−1 was 
used starting with a mixture of 50% A and 50% B, increasing to 90% B in 10min. This 
ratio was kept for 6min before reversion to the initial conditions.  
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Analytes were detected with a time-of-flight mass spectrometer equipped with a dual 
electrospray ionisation interface (ESI MSD ToF, Agilent Technologies, Santa Clara, CA, 
USA). The mass spectrometer was operated in the negative ion mode. Instrument 
parameters were: drying gas temperature of 325 °C, drying gas flow of 5 L min−1, 
nebuliser pressure of 20 psi, capillary voltage of 3500 V, and chamber voltage of 3000 V. 
Before analyzing a series of samples, the ToF-MS apparatus was tuned and calibrated 
using the ESI Tuning Mix (Agilent Technologies, Santa Clara, CA, USA). During 
analysis, a reference solution was pumped into the MS system at a rate of 50 µL min−1 
using a separate sprayer connected to a 1100 series pump (Hewlett Packard, Palo Alto, 
CA, USA). This reference solution consisted of purine with a m/z ratio of 119.0363 and 
HP- 0921 (hexakis(1H,1H,3H-tetrafluoropropoxy)phosphazine) with a m/z ratio of 
980.0164 in ACN/H20 (95/5) (Agilent Technologies, Santa Clara, CA, USA). Accurate 
mass measurements could only be achieved if these reference masses were detectable. 
Chromatograms and spectra were recorded and processed using Agilent MassHunter 
Quantitative Analysis® software (Agilent Technologies, Santa Clara, CA, USA).  
2.5 Validation of the method 
To demonstrate the applicability of this analytical approach, a validation study was 
carried out. Besides the validation procedure of the accredited lab of the Flemish 
Environment Agency (FEA), the SANCO/2007/3131 document [22] was also used as 
guideline for the validation of this new analytical method. Validation comprised the 
assessment of specificity/selectivity, linearity, recovery, precision, and the limits of 
detection (LODs) and quantification (LOQs). Eight-point calibration curves were 
constructed in surface water (six replicates). To demonstrate the multi-matrix capacity of 
our analytical procedure, a limited identical validation study was performed using sea- 
and sewagewater as well (four replicates). Representative water samples, being water 
from the river Kale – which is a small river near Ghent – for surface water, coastal water 
from the North Sea for seawater, and wastewater from industrial plants for sewagewater 
were used to this purpose. These water samples were spiked with a standard mixture at 
final concentrations of 5; 7.5; 10; 20; 50; 100 and 250 ng L−1 and analysed as described in 
Sections 2.3 and 2.4. In addition, blank samples were analysed as well.  
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2.6 Quality assurance 
Before and after analysis of a series of samples, a standard mixture (0.5 ng on column) of 
the targeted PFCs and the internal standards was injected to check the instrument 
parameters of the LC–ToF-MS system. Quality control of the method was performed by 
analysis of a blank sample, together with a linear calibration curve constructed using 
matrix samples spiked with standard solutions at seven concentration levels in the range 
of 5 and 250 ng L−1. This was performed for every series of samples. The obtained 
calibration curves were used for quantification.  
 
3. RESULTS AND DISCUSSION 
3.1 Background contamination 
Background contamination in the analytical blanks is a major problem in the analysis of 
PFCs [21,23,24]. Contamination from laboratory products and instrumentations 
containing polytetrafluoroethylene and perfluoroalkoxy compounds, is hard to avoid. 
Therefore, as suggested in literature [23,25], several measures were taken to minimize 
this kind of contamination. Teflon materials were avoided throughout the extraction 
procedure. All glass material was cleaned and placed in a drying oven (400 °C) in 
advance. Furthermore, an additional HPLC column was placed between the pump and the 
injector. As a result, PFCs originating from tubing or solvents, obtained extra retention 
and were thus separated from the target PFCs in the sample. Thanks to the elimination of 
these potential sources of contamination, none of the target compounds were detected in 
instrumental (direct injection of the mobile phase) and procedural blanks (extracted 
samples of Biosolve water).  
In addition, due to the ubiquitous character of PFOS, analysis of unspiked water samples, 
i.e. water from the river Kale for surface water, coastal water from the North Sea for 
seawater, and wastewater from industrial plants for sewagewater, frequently resulted in 
its detection in the low ng L−1 concentration range. For the validation of our new 
analytical method, the calibration curves were corrected for these concentrations.  
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3.2 Optimization of sample preparation 
De Voogt and Sáez [25] suggested to avoid filtration because of the surface-active nature 
of PFCs. For this reason, filtration was only executed in case of sewagewater samples and 
water samples, visibly containing particulate matter, to avoid clogging of the cartridge 
during SPE. Preconcentration was necessary to determine low concentrations of PFCs in 
the water samples. To this end, solid-phase extraction is certainly the most suitable and 
commonly used technique [17,21,23,26,27].  
Optimization of the SPE-procedure was performed by varying the sample volume, sample 
pH and the type of SPE cartridge. Dependent on the aqueous matrix, different sample 
volumes were extracted. For detection in surface- and sewagewater, a sample volume of 
50 mL was found to be sufficient to meet satisfying LODs of ≤10 ng L−1 for the major 
contaminants PFOS and PFOA. Compared to limnic systems, concentrations of most 
organic pollutants in the open sea are low [28]. Therefore, the sample volume was 
increased to 250 mL for PFC-analysis in seawater samples, resulting in LODs of ≤5ng 
L−1 for PFOS and PFOA (Table III.1).  
 
  
Table III.1. Validation results: limits of detection (LODs) and quantification (LOQs) in ng L-1, correlation coefficients (R²), recoveries (%), and intra-
laboratory reproducibility (RSD %) of the targeted PFCs in surface water, sea- and sewagewater. (* could not be quantified in this aqueous matrix) 
Compound Surface water Seawater Sewage water 
 LOD LOQ R² Recovery R.S.D. LOD LOQ R² Recovery R.S.D. LOD LOQ R² Recovery R.S.D. 
PFBS 50 100 0.99 95 14 20 40 0.99 100 6 50 100 0.99 102 8 
PFHxS 10 20 0.99 92 10 1 2 0.99 108 7 5 10 0.99 99 9 
PFOS 7.5 15 0.99 92 14 1 2 0.99 101 7 5 10 0.99 96 16 
PFDS 20 40 0.99 108 26 10 20 0.99 96 18 10 20 0.99 113 13 
PFPA* - - - - - 50 100 0.99 97 7 100 200 0.99 100 7 
PFHxA 50 100 0.99 102 8 20 40 0.99 103 12 50 100 0.99 98 6 
PFHpA 10 20 0.99 99 10 10 20 0.99 101 8 10 20 0.99 100 7 
PFOA 7.5 15 0.99 95 13 5 10 0.99 99 10 10 20 0.99 103 11 
PFNA 10 20 0.99 95 13 10 20 0.99 102 11 20 40 0.99 100 8 
PFDA 20 40 0.99 98 18 10 20 0.99 103 11 20 40 0.99 101 9 
PFUnA 50 100 0.98 103 16 10 20 0.99 103 17 50 100 0.99 99 12 
PFDoA 20 40 0.98 123 23 80 160 0.98 104 19 50 100 0.99 99 13 
PFTeA 100 200 0.95 134 12 100 200 0.96 100 18 100 200 0.99 93 13 
PFOSA 10 20 0.99 99 17 5 10 0.99 98 7 20 40 0.99 105 18 
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For solid-phase extraction of PFCs in water samples, the use of Oasis HLB or Oasis 
WAX cartridges has been reported by several studies [7,21,29–32]. Therefore, these two 
types of cartridges were examined within this study. The choice of the SPE-sorbent was 
mainly determined by the obtained recovery rates. Adjusting the sample pH to 3, Oasis 
WAX provided good results for the majority of the target analytes. However, using the 
Oasis HLB cartridges at neutral sample pH, higher recoveries for all target PFCs were 
obtained. Therefore, the Oasis HLB sorbent was selected for further experiments. These 
cartridges allow extraction of acidic, neutral, and basic analytes at neutral pH due to a 
combination of hydrophilic and lipophilic characteristics [33]. The Oasis HLB cartridges 
were rinsed with 2 mL of Biosolve water before elution (3× 2 mL for seawater samples). 
Washing the cartridges has been shown to remove interfering matrix components and 
remaining sea salt (in the case of seawater samples) from the cartridge [34,35]. Optimal 
elution of the PFCs was achieved using methanol.  
3.3 LC–ToF-MS optimization 
A Luna® C18 (2) HPLC column was used for chromatographic separation of the analytes. 
The stationary phase of this LC column consists of ultrapure metal-free silica (99.99% 
purity) bounded to C18-groups. The performance of the column was evaluated by the 
separation efficiency for the structurally related PFCs. Good chromatographic separation 
of the compounds under investigation was achieved using the Luna C18 (2) column. In 
addition, high peak efficiencies, measured as peak width at the baseline, were obtained 
using this column (Fig. III.1).  
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Figure III.1. Chromatograms and spectra of PFHxS, PFOS, PFOA and PFOSA (the four analytes 
detected in the seawater samples) in seawater spiked at 10 ng L-1, as well as their calibration curves 
between 1 and 250 ng L-1 (n=8). 
 
With respect to PFC-analysis, Berger et al. [36] compared three different MS-techniques 
coupled to LC: ion-trap MS, triplequadrupole MS, and ToF-MS. ToF-MS was reported to 
be the optimal detector for quantification of PFCs, combining high selectivity with high 
sensitivity. For analysis of PFCs, LC–ToF-MS has been applied as a screening [37] and 
confirmation [38,39] technique in biological matrices. To our knowledge, the use of ToF-
MS for the quantification of PFCs in water samples has not been published earlier. The 
ToF-MS system used during this study, is capable of producing spectra with a mass 
resolution of 4000 (at m/z 200) to >10,000 (at m/z 2722) (Agilent Technologies, technical 
overview). According to Van der Heeft et al. [40], the mass resolving power needs to be 
greater than 10,000 for the entire mass range to qualify for high resolving power MS. 
However, Kauffmann and Butcher [41] concluded that a mass resolution of 5000–10,000 
is sufficient to discriminate analytes from co-eluting sample matrix compounds. The 
exact masses, the mean measured masses, and the mean mass errors of the detected PFCs 
at LOD-level were calculated and presented in Table III.2. Except for PFPA and PFBS, 
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the mean mass errors were below 5 ppm. Generally, using ToF-MS with a mass 
resolution of 10,000 FWHM (full width at half maximum; ׽5000 mass resolution), a 
deviation of the detected mass of 10ppm is acceptable [42]. In conclusion, our ToF-MS 
application enabled the use of a very narrow mass tolerance window of ±5 ppm, thus 
providing a high mass accuracy.  
 
Table III. 2. Characteristics of the PFC-analysis using a ToF-MS: theoretical masses, mean measured 
masses, mean mass errors, and internal standards used. 
Compound 
Theoretical m/z  
[M-H]- ion 
Mean measured  
m/z 
Mean mass  
error (ppm) 
Internal standard 
PFBS 298.9430 298.9459 6.0 13C4PFOS 
PFHxS 398.9366 398.9375 2.3 13C4PFOS 
PFOS 498.9302 498.9319 3.8 13C4PFOS 
PFDS 598.9233 598.9243 2.0 13C4PFOS 
PFPA 262.9755 262.9772 5.4 13C2PFHxA 
PFHxA 312.9728 312.9734 3.0 13C2PFHxA 
PFHpA 362.9696 362.9701 2.7 13C4 PFOA 
PFOA 412.9664 412.9684 4.8 13C4 PFOA 
PFNA 462.9632 462.9649 4.0 13C5PFNA 
PFDA 512.9600 512.9625 4.8 13C2PFDA 
PFUnA 562.9563 562.9584 3.8 13C2PFDA 
PFDoA 612.9531 612.9554 3.7 13C2PFDoA 
PFTeA 712.9467 712.9479 3.4 13C2PFDoA 
PFOSA 497.9457 497.9467 2.1 13C4PFOS 
 
The use of isotopically labelled internal standards for PFC analysis is highly 
recommended [43]. However, ionization suppression caused by internal standards may 
occur and result in lower sensitivity [43,44]. Therefore, the internal standard 
concentration (100 ng L−1) was kept quite low. For six PFCs, the corresponding 13C-
labelled internal standards were used, while the most appropriate internal standard 
available was used for the other compounds (Table III.2). 
Analytes were identified on the basis of their relative retention time, which is the ratio of 
the retention time of the analyte to that of the internal standard. In addition, the accurate 
mass of the deprotonated molecular ions ([M−H]−) in the spectrum was taken into 
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account when the chromatographic peak of interest had a signal-to-noise ratio of at least 
3:1. As mentioned before, errors in measured masses of known compounds are generally 
in the range of 5–10 ppm [42,45]. Therefore, within this study, a maximum mass error of 
10ppm was allowed. Upon identification, area ratios were determined by integration of 
the area of an analyte under the obtained chromatograms in reference to the integrated 
area of the internal standard (Fig. III.1). The analyte concentrations were calculated by 
fitting their area ratios in an eight-point calibration curve, established by matrix samples 
spiked with a standard mixture obtaining concentrations in the range of 0–250 ng L−1. 
3.4 Validation study 
According to Van Leeuwen et al. [18], the quality of data obtained from analysis of PFCs 
in environmental matrices is a major issue of concern. Therefore, a validation study was 
carried out to demonstrate the method’s performance. The method was evaluated for 
specificity/selectivity, linearity, recovery, intra-laboratory reproducibility, and limits of 
detection (LODs) and quantification (LOQs). Matrix-matched calibration curves, in 
which the analytes were spiked into the representative aqueous matrix, were used for 
quantification. As such, the study of matrix-induced suppression or enhancement effects 
could be neglected. 
3.4.1 Specificity/selectivity 
The specificity of our method was evaluated through the analysis of water samples spiked 
with each compound separately, and of water samples spiked with a mixture of all 
compounds at a concentration of 100 ng L−1. The specificity of the analytical approach 
was confirmed since no interferences were demonstrated by using LC–ToF-MS as 
described above. No other significant peaks with a signal-to-noise ratio of 3 or more were 
observed at the specific retention times of the targeted PFCs, suggesting a high specificity 
of the analytical method. This was in accordance with previous reports, since excellent 
specificity for unequivocal compound identification is guaranteed when using a ToF-MS 
system [37]. 
3.4.2 Linearity 
Linearity was evaluated in the 0–250 ng L−1 concentration range. Eight-point calibration 
curves were constructed in surface water (six replicates), sea- and sewagewater (both four 
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replicates). The water samples were spiked with a standard mixture obtaining 
concentrations of 5; 7.5; 10; 20; 50; 100 and 250 ng L−1. In addition, unspiked matrix 
samples were analysed as well, to check the occurrence of PFCs in blank samples. The 
mean regression coefficients (R2) of the calibration curves were calculated by plotting 
area ratio versus concentration. For most target compounds, regression coefficients of 
0.99 or higher were found, suggesting a good linear correlation (Fig. III.1 and 
Table III.1). Regression coefficients below 0.99 were found for the compounds with a 
longer carbon chain: R2 was 0.98 for PFUnA in surface water and for PFDoA in both 
surface and seawater, while R2 was 0.95 and 0.96 for PFTeA in surface and seawater, 
respectively. In addition, using the regression equation, the residuals were calculated as 
the difference of the obtained concentrations and the expected concentrations. Next, the 
obtained residuals were plotted versus the concentrations (data not shown). For all 
compounds, the residuals were randomly distributed, thus indicating a linear correlation 
in the 0–250 ng L−1 concentration range. 
3.4.3 Limits of detection (LODs) and quantification (LOQs) 
Limits of detection (LODs) and quantification (LOQs) were determined based on the 
outcome of the eight-point calibration curves of Section 3.4.2. The concentrations of the 
analytes were calculated using the overall equation of the calibration curves. The LOD 
was defined as the higher value of the following two alternatives: (1) the lowest 
detectable concentration of the calibration curve with a signal-to-noise ratio of at least 
3:1; (2) three times the standard deviation of the analytes concentration at the lowest 
detectable concentration level. The LOQs were defined as the final LOD multiplied by 2. 
This procedure was executed for the different aqueous matrices. The obtained LOQs of 
the targeted PFCs varied from 15 to 200 ng L−1 in surface water, from 2 to 200 ng L−1 in 
seawater, and from 10 to 200 ng L−1 in sewagewater (Table III.1). Thanks to the higher 
sample volume, the LOQs were lower in seawater samples. Since the method was in 
particular optimized for the detection of PFOS and PFOA in surface water, the two major 
contaminants within the group of PFCs, their LOQs were the lowest: i.e. 15 ng L−1. 
Generally, higher LOQs were found for the analytes with both the shortest (PFBS, PFPA) 
and longest carbon chain length (PFUnA, PFDoA, and PFTeA). 
In general, these quantitation limits are considered acceptable and are comparable to 
previous reported LOQs for the same analytes. For example, Taniyasu et al. [46] 
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determined LODs between 4 and 60 ng L−1 for PFOS, PFHxS and PFBS. More sensitive 
methods are reported in literature as well, thanks to higher sample volumes or to the use 
of more sensitive mass spectrometers (triple-quadrupole mass spectrometers). The 
analysis of ppq (pg/L) concentrations of PFCs was reported by Yamashita et al. [15,23], 
Taniyasu et al. [21], and Ahrens et al. [17]. For example, the latter study reported method 
quantification limits of 0.004–0.367 ng L−1 for the same analytes. However, to obtain 
these LOQs, 5 L water samples were extracted, while the sample volume in this study 
varied between 50 and 250 mL. Once more, we would like to underline that none of the 
mentioned studies from the literature used accurate mass, high-resolution time-of-flight 
mass spectrometry to detect PFCs in aqueous matrices. 
3.4.4 Recovery and precision 
Since no certified reference material was available, trueness of the measurements and 
intra-laboratory reproducibility (samples were measured on different days and by 
different analysts) were assessed using blank matrix samples spiked at both the LOQ 
level and two times the LOQ level. This was performed in six replicates. The intra-
laboratory reproducibility of the method was determined by calculating the relative 
standard deviation (% RSD). Table III.1 summarizes the obtained results for the different 
matrices. According to SANCO/2007/3131 [22], typically a recovery within the range of 
70–120% and a reproducibility RSD ≤20% are required. As can be deduced from 
Table III.1, except for PFDoA and PFTeA in surface water, all obtained recoveries were 
satisfactory. The obtained RSD values indicated satisfying precision for most analytes in 
the different matrices. Except for PFDS and PFDoA in surface water, the analytical 
method was sufficiently precise for quantitative analysis of the selected PFCs in all three 
matrices.  
3.5 Application to North Sea samples 
The developed method was applied to water samples collected during the INRAM project 
(see Section 2.1). Six offshore samples, 11 harbour samples and 2 samples of the Scheldt 
estuary were collected in June 2009. As can be seen from Table III.3, four different PFCs 
were detected in all waters samples. The other PFCs were not detected at any of the 
sampling stations. PFOS was detected in every sample in levels up to 39 ng L−1, while 
PFOSA was found once at a concentration of 26 ng L−1 at sampling location S22 in 
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Antwerp. PFHxS and PFOA were frequently detected up to concentrations of 13 and 24 
ng L−1, respectively, both at sampling location S22 (Antwerp). 
  
Table III.3. Detected concentrations (ng L-1) of the PFCs of interest in water sampled at the different sampling locations in the Belgian coastal zone: harbour of 
Nieuwpoort (NP1-3), harbour of Ostend (OO1-4), harbour of Zeebrugge (ZB1-4), the North Sea (W01-W06), and the Scheldt estuary (S01: near Vlissingen, S22: near 
Antwerp) (n.d. = not detected). 
 Sampling stations 
 W01 W02 W03 W04 W05 W06 S01 S22 NP1 NP2 NP3 OO1 OO2 OO3 OO4 ZB1 ZB2 ZB3 ZB4 
PFHxS <LOQ n.d. n.d. <LOQ n.d. n.d. 4 13 n.d. n.d. n.d. <LOQ 7 3 2 <LOQ <LOQ <LOQ <LOQ 
PFOS 4 2 <LOQ 3 <LOQ <LOQ 5 39 4 3 2 7 13 6 4 5 5 3 4 
PFOA n.d. n.d. n.d. n.d. n.d. n.d. <LOQ 24 n.d. n.d. n.d. n.d. <LOQ n.d. n.d. n.d. n.d. n.d. n.d. 
PFOSA n.d. n.d. n.d. n.d. n.d. n.d. n.d. 26 n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. 
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Despite the limited monitoring study, certain differences could be observed between the 
sampling stations in the study area. As can be seen from Table III.3, the harbour of 
Ostend and in particular the Scheldt estuary were most contaminated with PFCs. Analysis 
of the S22-sample resulted in the detection of four different PFCs, up to 39 ng L−1. Since 
S22 is located in the industrial zone of Antwerp, large inputs of PFCs could be expected. 
Samples of the North Sea (W01–W06) were the least contaminated with PFCs. At these 
locations, only PFOS could be quantified in concentrations below 5 ng L−1. These 
concentrations of PFOS were in the same range as those reported in previous studies of 
the German Bight, which is the south-eastern bight of the North Sea [17,47,48]. In 
accordance with Ahrens et al. [17], a decreasing contamination of PFCs with increasing 
distance from the coast, could be observed.  
Compared to the derived PNEC values of 25 µg L−1 for PFOS [49] and 250 µg L−1 or 
1.25 mg L−1 for PFOA [49,50], adverse risks to aquatic organisms are not anticipated 
from these measured concentrations. However, the possible combined effects that the 
abundance of several PFCs may cause, possibly even with other micropollutants, cannot 
be excluded. Next to these toxicity thresholds, two studies determined a health-based 
guidance for PFOA in drinking water as well. According to the US Safe Drinking Water 
Act [51], these studies reported drinking water equivalent levels (DWEL: the lifetime 
exposure level of a contaminant at which adverse health effects are not anticipated to 
occur, assuming 100% exposure from drinking water). Tardiff et al. [52] found DWELs 
for PFOA ranging from 0.88 to 2.4 µg L−1, while a guidance value of 0.040 µg L−1 was 
recommended by Post [53]. The detected PFOA concentrations did also not exceed these 
drinking water levels.  
 
4. CONCLUSION 
A validated analytical method for the determination of 14 PFCs in surface, sewage and 
seawater is presented. The analytical procedure consisted of SPE applied to the water 
samples followed by LC–ToF-MS. The use of very narrow mass tolerance windows (<10 
ppm) resulted in a highly selective MS-technique for the detection of PFCs in complex 
aqueous matrices. The LOQs varied between 2 and 200 ng L−1 and recoveries obtained in 
surface water (92–134%) were satisfactory. Application of the method to North Sea and 
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Scheldt estuary samples confirmed the occurrence of several PFCs in the marine 
environment in levels up to 39 ng L−1.  
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CHAPTER IV 
DEVELOPMENT OF ANALYTICAL STRATEGIES USING U-HPLC-MS/MS AND 
LC-TOF-MS FOR THE QUANTIFICATION OF MICROPOLLUTANTS IN MARINE 
ORGANISMS 
Abstract 
Organic micropollutants such as pharmaceuticals, perfluorinated compounds (PFCs), and 
pesticides, are important environmental contaminants. To obtain more information 
regarding their presence in marine organisms, an increasing demand exists for reliable 
analytical methods for quantification of these micropollutants in biotic matrices. 
Therefore, we developed extraction procedures and new analytical methods for the 
quantification of 14 pesticides, 10 PFCs, and 11 pharmaceuticals in tissue of marine 
organisms, namely blue mussels (Mytilus edulis). This paper presents these optimized 
analytical procedures and their application to M. edulis, deployed at five stations in the 
Belgian coastal zone. The methods consisted of a pressurized liquid extraction and solid-
phase extraction (SPE) followed by ultra high performance liquid chromatography 
coupled to triple quadrupole mass spectrometry for pharmaceuticals and pesticides, and 
of a liquid extraction using acetonitrile and SPE, followed by liquid chromatography 
coupled to time-of-flight mass spectrometry for PFCs. The limits of quantification of the 
three newly optimized analytical procedures in M. edulis tissue varied between 0.1 and 10 
ng g−1, and satisfactory linearities (≥0.98, n=7), recoveries (90–106%) and precision (9-
26 RSD%) were obtained. Application of these methods to M. Edulis revealed the 
presence of five pharmaceuticals, two PFCs, and seven pesticides at levels up to 490, 5, 
and 60 ng g−1, respectively. The most prevalent micropollutants were salicylic acid, 
paracetamol, perfluorooctane sulfonate, chloridazon, and dichlorvos.  
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1. INTRODUCTION 
Due to increasing anthropogenic activities and the release of various types of 
contaminants, marine ecosystems worldwide are subjected to a continuous pollution 
pressure [1]. The introduction of the European Reach Legislation has led to the 
development of less persistent, bioaccumulative, or toxic chemicals [2]. Generally, these 
newly designed chemicals could be characterized as hydrophilic compounds. As a 
consequence, the emerging more polar anthropogenic contaminants, such as 
pharmaceuticals, perfluorinated compounds (PFCs), and pesticides have recently gained 
more attention. Pharmaceuticals, PFCs, and pesticides are, to a large extent, dissolved in 
the water column. Consequently, several studies have demonstrated the occurrence of 
these micropollutants in marine and estuarine waters [3–7]. As such, these hydrophilic 
micropollutants are directly bioavailable to filter-feeding organisms including mussels 
and oysters. In light of the possible toxic, genotoxic and/or endocrine disrupting 
properties of some of these micropollutants, their potential to cause adverse effects in 
marine organisms should not be neglected [8,9]. Moreover, the ingestion of contaminated 
seafood forms a major source of human exposure to micropollutants [10–12]. To study 
and evaluate the fate, effects, and environmental and human risks posed by these polar 
micropollutants in aquatic ecosystems, information regarding their presence in marine 
organisms and more particular in species that are important in terms of human 
consumption such as mussels is urgently needed.  
Biotic samples are complex matrices demanding extensive extraction and clean-up 
procedures to obtain extracts amenable to analysis. In addition, relatively low 
concentrations may be expected to occur in these matrices. As a result, the occurrence of 
the above-mentioned micropollutants in marine organisms has been rarely studied and an 
increasing demand exists for reliable analytical methods allowing the quantification of 
these micropollutants in biotic matrices [13]. Analytical methods for the quantification of 
PFCs in biotic samples have been reported in literature [14–16]. Nevertheless, within this 
study, the existing method of Powley et al. [17] was adapted and optimized for this 
application, because of the significantly different sample matrix and detection technique. 
Also, the study area, which is suspected to be highly polluted with PFCs [18], offered an 
additional motivation to include the PFCs as a target group of contaminants within this 
study. Until now, only few studies are available for the analysis of pharmaceuticals in 
marine organisms. Ramirez et al. [19] reported a screening method for the detection of 23 
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pharmaceuticals in fish tissue, while Cueva-Mestanza et al. [20] described an analytical 
method for the detection of six pharmaceuticals in mollusks. With respect to the more 
polar pesticides, such as atrazine, simazine, chloridazon, Carafa et al. [21] reported an 
analytical procedure for the detection of 29 pesticides in clams. To the best of our 
knowledge, little attention has been paid to the prevalence of pesticides in marine 
organisms-aside from the organochlorine pesticides. Because an in depth evaluation of 
the presence of a wide range of pharmaceuticals and polar pesticides in this specific 
matrix was intended, new analytical procedures needed to be developed to enable the 
quantification of these compounds in a reliable and sensitive manner.  
The objective of this study was to develop new extraction procedures and analytical 
methods for the quantification of 14 of the most intensively applied pesticides in 
Belgium, and 11 of most frequently used pharmaceuticals in Belgium [6] in blue mussels 
(Mytilus edulis). The existing analytical approach [17] for the detection of the most 
important PFCs in biotic samples was optimized for this specific biotic matrix as well. 
The analytical procedure for analysis of pharmaceuticals and pesticides consisted of a 
pressurized liquid extraction (PLE) and solid-phase extraction (SPE), followed by ultra 
high-performance liquid chromatography coupled to triple quadrupole mass spectrometry 
(U-HPLC-QqQ-MS/MS). For the detection of PFCs, liquid extraction, and SPE were 
applied followed by liquid chromatography coupled to time-of-flight mass spectrometry 
(LC-ToF-MS).  
 
2. MATERIAL AND METHODS 
2.1 Study area and sampling 
M. edulis was collected in the Eastern Scheldt (ES) from subtidal plots and 50 M. edulis 
organisms were transplanted to cages deployed at different stations in the Belgian coastal 
zone. Two cage experiments were conducted during 2008. A long-term cage experiment 
ran from February till July 2008 at five stations: the marinas of Nieuwpoort (NP), 
Oostende (OO), and Zeebrugge (ZB2), the outport of Zeebrugge (ZB1), and one station 
situated in open sea at the Nieuwpoortbank (SEA; Fig. IV.1). M. edulis was sampled 
monthly to determine body concentrations of the target micropollutants. A short-term 
cage experiment was set up in November 2008. Cages with M. edulis, also originating 
DETECTION OF CECS IN BIOTA 
124 
from subtidal plots in the Eastern Scheldt, were deployed at the same stations, but not at 
the SEA-station, for 6 weeks. All cage-organisms were removed from the shell, 
homogenized, and these composite biotic samples were freeze-dried and stored at 4 °C 
prior to analysis.  
 
Figure IV.1. Study area of the Mytilus edulis cage experiments in the Belgian coastal zone.  
 
2.2 Reagents and chemicals 
The analytical method for pharmaceutical analysis included 11 compounds. Paracetamol 
(99%), ketoprofen (99%), carbamazepine (>99%), diclofenac (>99%), salicylic acid 
(>99%), clofibric acid (97%), atenolol (≥98%), trimethoprim (≥98%), and 
chloramphenicol (≥99%) were purchased from Sigma-Aldrich (St-Louis,MO, USA). 
Ofloxacin (>99%) was obtained from ICN Biomedicals Inc. (Ohio, USA), while 
propranolol (>99%) was purchased from Eurogenerics (Brussel, Belgium). The synthetic 
isobutcar 61 (4-3(isobutylamino-2-hydroxypropoxy) carbazole) and two deuterated 
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pharmaceuticals, atenolol-d7 (≥95%) and salicylic acid-d4 (≥98%) from Toronto Research 
Chemicals Inc. (North York, ON, Canada), were used as internal standard.  
Fourteen pesticides were included in this study. Dichlorvos (>98%), dimethoate (>99%), 
diazinon (>98%), pirimicarb (≥99%), linuron (>99%), metolachlor (≥98%), chloridazon 
(≥99%), chlorpyriphos (>99%), simazine (>99%), isoproturon (>99%), terbutylazine 
(>98%), and diuron (>99%) were obtained from Sigma-Aldrich (St-Louis, MO, USA), 
while atrazine (>99%) and kepone (≥98%) were purchased from Chem Service (West 
Hester, PA, USA). Isoproturon-d6 (>99%) and atrazine-d5 (>99%) from Sigma-Aldrich 
(St-Louis, MO, USA) were used as internal standard.  
Ten PFCs were examined in this study: four perfluorosulfonates (potassium perfluoro-1-
butane sulfonate (PFBS), sodium perfluoro-1-hexane sulfonate (PFHxS), sodium 
perfluoro-1-octane sulfonate (PFOS), and sodium perfluoro-1-decane sulfonate (PFDS)) 
and six perfluorocarboxylates (perfluoro-n-heptanoic acid or PFHpA, perfluoro-n-
octanoic acid or PFOA, perfluoro-n-nonanoic acid or PFNA, perfluoro-n-decanoic acid or 
PFDA, perfluoro-n-undecanoic acid or PFUnA, and perfluoro-n-dodecanoic acid or 
PFDoA). All analytical PFC-standards were purchased from Wellington Laboratories 
(Guelph, Ontario, Canada) with chemical purities of more than 98%. Five 13C-labelled 
internal standards were used as well: sodium perfluoro-1-[1,2,3,4-13C4]octane sulfonate, 
perfluoro-n-[1,2,3,4-13C4] octanoic acid, perfluoro-n-[1,2,3,4,5-13C5]nonanoic acid, 
perfluoro-n-[1,2-13C2]decanoic acid, and perfluoro-n-[1,2-13C2]dodecanoic acid.  
Analytical grade reagents were used for extraction and purification purposes, and 
Optima® LC-MS grade for UHPLC-MS/MS analysis. They were obtained from VWR 
International (Merck, Darmstadt, Germany) and Fisher Scientific UK (Loughborough, 
UK), respectively. For LCToF-MS analysis, methanol was purchased from Rathburn 
Chemicals (LTd Walkerburn, Scotland), while HPLC-grade water was obtained from 
Biosolve (Biosolve Chemicals, The Netherlands). Ammonium acetate (2.5 mM) in water 
was obtained through dilution of LC-MS Chromasolv® water containing 0.1% ammonium 
acetate (Sigma-Aldrich Laborchemikalien GmbH, Seelze, Germany). Aqueous 
ammonium carbonate (Merck, Darmstadt, Germany; 2 mM) and aqueous formic acid 
(Merck, Darmstadt, Germany; 0.08%) were prepared by appropriate dissolution or 
dilution in ultrapure water (Arium 611 UV system, Sartorius Stedim Biotech, Aubagne, 
France).  
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Primary stock solutions of the pharmaceuticals and pesticides were prepared in ethanol at 
a concentration of 1mg mL−1, while methanol was used for the PFCs. Working standard 
mixture solutions were prepared by appropriate dilution of the stock solutions in ethanol 
and methanol, respectively. All solutions were stored at −20 °C in the dark.  
2.3 Extraction and clean-up 
The sample preparation for pharmaceuticals consisted of a PLE, which was performed on 
a Dionex ASE® 350 Accelerated Extractor with Solvent Controller (Dionex Corp., 
Sunnyvale, CA, USA). A cellulose filter (27 mm, Dionex Corp.) was placed on the 
bottom of a 22-mL stainless steel extraction cell. Each cell was filled with 9.5 g of 
aluminium oxide 90 aktiv neutral (Dionex Corp.). A mixture of 1 g of freeze-dried biotic 
sample with 1.5 g of diatomaceous earth (DE, ASE® Prep Diatomaceous Earth, Dionex 
Corp.) was placed on top of the aluminum oxide. The internal standards were added prior 
to extraction to a final concentration of 200 ng g−1. A combination of acetonitrile/water 
(3/1) with 1% formic acid was used as the extraction solvent. Extraction was carried out 
at 100 °C for three cycles of each 10 min. The extract (±45 mL) obtained by accelerated 
solvent extraction (ASE) was evaporated under nitrogen at 55 °C to a final volume of 5 
mL and further diluted to 100 mL with ultra-pure water. Next, SPE was carried out using 
Strata-X cartridges (6 mL, 200 mg, Phenomenex B.V., Utrecht, Netherlands). The 
cartridges were preconditioned with 5 mL of methanol and 5 mL of ultra-pure water. 
After loading, the cartridges were rinsed with 5 mL of ultra-pure water. Elution was 
performed using 2×3 mL of methanol. Finally, this eluate was evaporated under nitrogen 
at 55 °C and reconstituted in 50 μL of acetonitrile with formic acid (0.08%) and 250 μL 
aqueous formic acid (0.08%). Prior to U-HPLC-MS analysis, the extracts were 
centrifuged at 9,000 rpm for 10 min at 4 °C.  
A similar combination of PLE and SPE was optimized for pesticide extraction and clean-
up from biotic samples, with the following differences: the internal standards were spiked 
at a concentration of 100 ng g−1, and each extraction cell was filled with 0.25 g of sample, 
2 g of aluminium oxide, and 4.5 g of diatomaceous earth. Extraction was performed using 
1:1 acetonitrile/methanol, at 100 °C for three cycle times of 3 min. The ASE-extract 
obtained was evaporated to 0.5 mL before dissolving it in 10 mL of ultrapure water. SPE 
was carried out using Isolute ENV + cartridges (10 mL, 200 mg, Biotage, Uppsala, 
Sweden). The cartridges were preconditioned with 5 mL of methanol and 5 mL of ultra-
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pure water with methanol (5%). Elution was performed using 5 mL of methanol and 
acetonitrile. Next, the eluate was evaporated under nitrogen at 55 °C to dryness and 
reconstituted in 50 μL methanol and 150 μL of 2 mM aqueous ammonium carbonate. 
After centrifugation, the eluate was filtered using a 0.22-μm Syringe-Driven Filter Unit 
(Millipore, Carritwohill, Cork, Ireland).  
For analysis of PFCs in biotic samples, 1 g of freeze-dried sample, spiked with the 13C-
labelled internal standards at a concentration of 50 ng g−1, was extracted with 10 mL of 
acetonitrile by homogenization with an Ultra-Turrax dispersing unit (Ika, Staufen, 
Germany). After centrifugation at 5,000 rpm for 20 min at 4 °C, the supernatant was 
reduced to 5 mL by evaporation under nitrogen at 55 °C and subsequently diluted to 100 
mL with ultra-pure water. Next, SPE was carried out using OASIS HLB cartridges (6 mL, 
200 mg, Waters, Milford, MA). The cartridges were preconditioned with 2 mL of 
methanol and 2 mL of ultrapure water. After loading, the cartridges were rinsed with 5 
mL of ultra-pure water. Elution was performed using 3×2 mL of methanol and the eluates 
were centrifuged at 9,000 rpm for 10 min at 4 °C. Next, the eluates were evaporated to 
dryness under nitrogen at 55 °C. Finally, 0.25 mL of methanol and 0.25 mL of 2.5 mM 
aqueous ammonium acetate were added before transfer to LC-MS vials. Samples were 
stored at −20 °C before analysis. 
2.4 Chromatography 
For both the pesticides and pharmaceuticals, chromatographic separation was carried out 
using ultra high-performance liquid chromatography (U-HPLC). The apparatus 
comprised of an Accela™ High Speed LC and an Accela™ Autosampler (Thermo 
Scientific, San Jose, CA, USA). Chromatographic separation was achieved using a 
Nucleodur C18 Pyramid U-HPLC column (1.8 μm, 100×2 mm, Macherey-Nagel, Düren, 
Germany). For the pharmaceuticals, the mobile phase constituted of 0.08% aqueous 
formic acid (A), 0.08% formic acid in acetonitrile (B), and isopropanol (C). A linear 
gradient was used starting from 98% A and 2% B, which was held for 0.8 min. The 
percentage of acetonitrile was increased to 65% B in 30 s, and further to 100% B in 1 min 
and held for 4 min. Next, 90%B and 10%C were applied to the column for 2 min, before 
equilibration at initial conditions for 2 min. Pesticide separation was achieved using 
methanol (D) and aqueous ammonium carbonate (2 mM; E). The linear gradient started 
with a mixture of 98% E and 2% D for 1 min. The methanol percentage increased to 90% 
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in 30 s, and further to 100% in 3 min. Between samples, the column was allowed to 
equilibrate at initial conditions for 1 min.  
For PFC-analysis, the LC-apparatus comprised of a 1,200 series binary gradient pump 
and a 1,100 series autosampler (Hewlett Packard, Palo Alto, CA, USA). Chromatographic 
separation was achieved using a Luna® C18 (2) HPLC column (5 μm particle size, 
250×2.0 mm; Phenomenex Inc., Utrecht). The mobile phase consisted of a mixture of (F) 
2.5 mM aqueous ammonium acetate and (G) methanol. A linear gradient of 0.3 mL min−1 
was used starting with a mixture of 50% F and 50% G, increasing to 90% G in 10 min. 
This ratio was kept for 6 min before reversion to the initial conditions. 
2.5 Mass spectrometric detection 
Detection of pharmaceuticals and pesticides was carried out using a TSQ Vantage Triple-
Stage Quadrupole Mass Spectrometer (Thermo Electron) equipped with a heated 
electrospray ionization probe (HESI-II). The mass spectrometer operated by fast-
switching between positive and negative ion mode during analysis. The parameters as 
presented in Table IV.1 were found to be the optimal ionization source working 
parameters for the respective analytes. The mass resolution at the first (Q1) and third (Q3) 
quadrupole was set to 0.7 Da at full width at half maximum. The cycle time was adjusted 
to 0.5 and 0.9 s for pharmaceutical and pesticide analysis, respectively. Argon was used 
as collision gas, the collision gas pressure was set at 1.5 mTorr and the chrom filter peak 
width at 10 s. 
 
Table IV.1. HESI-II working parameters for ionization of the selected pharmaceuticals and 
pesticides. 
 Pharmaceuticals Pesticides 
Spray voltage (V) 3500 4000 
Capillary temperature (°C) 270 315 
Sheath gas pressure (arbitrary units, au) 25 25 
Auxiliary gas pressure (au) 5 5 
Ion sweep gas pressure (au) 2 2 
Vaporizer temperature (°C) 25 35 
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Perfluorinated compounds were detected with a time-of-flight mass spectrometer 
equipped with a dual electrospray ionization interface (ESI MSD TOF, Agilent 
Technologies, Santa Clara, CA, USA). The mass spectrometer was operated in the 
negative ion mode. Instrument parameters were: drying gas temperature of 325 °C, drying 
gas flow of 5 L min−1, nebuliser pressure of 20 psi, capillary voltage of 3,500 V, and 
chamber voltage of 3,000 V. Before analyzing a series of samples, the ToF-MS apparatus 
was tuned and calibrated using the ESI Tuning Mix (Agilent Technologies, Santa Clara, 
CA, USA). During analysis, a reference solution was pumped into the MS-system at a 
rate of 50 μL min−1 using a separate sprayer connected to a 1100 series pump (Hewlett 
Packard, Palo Alto, CA, USA). This reference solution consisted of purine with a m/z 
ratio of 119.0363 and HP-0921 (hexakis(1H,1H,3H-tetrafluoropropoxy) phosphazine) 
with a m/z ratio of 980.0164 in ACN/H20 (95/5; Agilent Technologies, Santa Clara, CA, 
USA). Accurate mass measurements could only be achieved if these reference masses 
were clearly present. Chromatograms and spectra were recorded and processed using 
Agilent MassHunter Quantitative Analysis® software (Agilent Technologies, Santa Clara, 
CA, USA). 
2.6 Identification and quantification 
The target analytes were identified based on their retention time relative to that of the 
internal standards. For pharmaceutical and pesticide analysis, using U-HPLC-QqQ-
MS/MS in the selected reaction monitoring mode (SRM), at least two transitions were 
monitored. The relative abundances of these specific transitions were compared with 
those of the standards and both product ions were used for quantification purposes. 
Identification of the PFCs, using LC-ToF-MS, was performed on the basis of their 
accurate mass. Within this study, a maximum mass error of 10 ppm was allowed [7].  
Upon identification, area ratios were determined by integration of the area of an analyte 
under the obtained chromatograms in reference to the integrated area of the internal 
standard. The analyte concentrations were calculated by fitting their area ratios in a 
seven-point calibration curve in tissue matrix. To this end, freeze-dried M. Edulis samples 
were spiked with a standard mixture obtaining seven final concentrations in the range of 
0.1 to 250 ng g−1 and with the appropriate concentrations of the respective internal 
standard mixtures. 
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2.7 Quality assurance 
Before and after analysis of a series of samples, a standard mixture (0.1 ng on column) of 
the targeted analytes and the internal standards was injected to check the instrument 
performance of the LC-ToF-MS and U-HPLC-QqQ-MS/MS systems. Quality control of 
the method was performed by analysis of a blank sample, together with linear calibration 
curves constructed using matrix samples spiked with standard solutions at seven 
concentration levels ranging from 0.1 to 250 ng g−1. This was performed for every series 
of samples at least in duplicate.  
 
3. RESULTS AND DISCUSSION 
3.1 Sample preparation 
3.1.1 Pharmaceuticals 
Many studies describe analytical methods for the detection of pharmaceuticals in water. 
For marine organisms, however, only few studies are available [19,20]. Extraction of 
environmental matrices such as biotic tissue and sediment, is conventionally performed 
by means of Soxhlet extraction or sonication, demanding long extraction times and large 
solvent volumes [22]. In recent years, techniques such as microwave-assisted extraction 
(MAE) and PLE are gaining in popularity [20]. The latter extraction technique has been 
reported in several recent studies about the detection of pharmaceuticals in soil, sediment, 
and sewage sludge [23–25]. Since preliminary experiments using classical solid/liquid 
extraction versus PLE and MAE provided higher extraction recoveries for the target 
pharmaceuticals in case of PLE application, this technique was selected and further 
optimized for pharmaceutical extraction from biotic tissue.  
To obtain the optimal extraction parameters, subsequent experiments were performed 
using 1 g of freeze-dried biotic tissue spiked at 250 ng g−1. Selection of the optimal 
parameters was based on the resulting peak area, signal-to- noise ratio and peak shape of 
each analyte upon U-HPLCMS/MS analysis, but also on visual characteristics of the 
extract such as colour and turbidity. 
First, different extraction solvents were tested (acetone, methanol, acetone/methanol 
(1:1), n-hexane, acetone:ethyl acetate (1:1), acetonitrile+1% formic acid, acetonitrile: 
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water (3:1)+1% formic acid). This is of crucial importance, since all pharmaceuticals of 
interest should be simultaneously extracted, irrespective of their chemical structure or 
physico-chemical properties. A mixture of acetonitrile/water (3:1) with 1% formic acid 
provided the best results. Second, the optimal temperature (60–100–140–180 °C), static 
time (3–5–10–15 min), and number of extraction cycles (1–2–3) were investigated. Three 
cycles of 10 min were found to be optimal for the extraction of the target 
pharmaceuticals. Moreover, it was found that 100 °C resulted in slightly higher recoveries 
compared to 60 °C or 140 °C. The flush volume, which is the amount of solvent flushed 
through the sample cell after extraction, was evaluated as well. Since previous studies at 
our laboratory showed slightly better recoveries when using a flush volume of 60%, as 
proposed by the manufacturer, this flush volume was further applied during this study as 
well [26]. Next, the addition of Al2O3 to the extraction cell was evaluated. Since Al2O3 is 
known to inhibit the co-extraction of lipids and other hydrophobic matrix constituents, 
addition of different quantities (0–4–6–9.5 g) of Al2O3 to the PLE cells was tested. 
Cleaner extracts were obtained by inserting 9.5 g of Al2O3 into the PLE cells. For fine 
powdery samples, such as freeze-dried biotic tissue, it is recommended to mix the sample 
with diatomaceous earth to inhibit the aggregation of the sample and to improve the 
solvent–matrix interactions. Therefore, 1.5 g diatomaceous earth was inserted into the 
extraction cell as well. The sample mass was tested by analysis of 1, 3 or 5 g of freeze-
dried M. edulis tissue spiked at 250 ng g−1. It was found that increasing the sample mass 
to 3 or 5 g, resulted in lower extraction efficiencies and turbid extracts. Therefore, further 
experiments were conducted using 1 g of tissue.  
Due to the complexity of biotic samples, further cleanup was required following PLE to 
allow sufficiently high S/N ratios and peak resolution upon U-HPLC-MS/MS analyses. 
Several techniques have been described in literature for the clean-up of pharmaceuticals 
from complex matrices: gel permeation chromatography [27,28], solid-phase micro-
extraction [29], and solid-phase extraction [23–25,30,31]. In this study, we applied the 
most adequate technique, namely SPE. Indeed, SPE has shown good performance in 
extraction of pharmaceuticals from various aqueous matrices and simultaneously allows 
the concentration of the sample. Several SPE-cartridges were tested: Strata-X, 
Chromabond HR-X (6 mL, 200 mg, Marchery-Nagel, Düren, Germany), and Oasis HLB 
(6 mL, 200 mg, Waters, Milford, MA). The peak areas obtained upon extraction with the 
three SPE-cartridges were shown in Figure IV.2. Except for ofloxacin, peak areas were 
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highest using the Strata-X cartridges. Based on these results, S/N ratios and the clarity of 
the final extract, it was decided to retain the Strata-X columns for this application. 
 
 
Figure IV.2. Peak areas of the pharmaceuticals obtained upon extraction with three different SPE 
cartridges.  
 
3.1.2 Pesticides 
Pang et al. [32] determined more than 400 pesticides in grain by accelerated solvent 
extraction using acetonitrile as extraction solvent, followed by SPE. Besides, Carafa et al. 
[21] described an analytical procedure for 29 pesticides in clams. This method included 
extraction with ultrasonication using a mixture of methanol and water (4:1) followed by 
SPE using Oasis HLB cartridges. In this study, the combination of PLE and SPE was 
again selected, because of its excellent performance in extraction of pharmaceuticals from 
biotic tissue, and since PLE proved more efficient in extraction of our selected pesticides.  
First, the optimal PLE-parameters were determined by analysis of a 1 g freeze-dried M. 
edulis sample spiked at 100 ng g−1 by using a similar approach to that described above. 
Some significant differences resulting in better analytical results upon U-HPLC-MS/MS 
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with the application of the pharmaceuticals were identified. A sample mass of 0.25 g was 
found to be sufficient. Two and 4.5 g Al2O3 and diatomaceous earth, respectively, were 
inserted in the cell. A mixture of methanol and acetonitrile (1:1) was found to be the 
optimal extraction solvent for extraction of the target pesticides at a temperature of 100 
°C. An extraction time above 10 min did not significantly increase the extraction 
efficiency of the analytes. Three cycles of 3 min were found to be sufficient. Further 
clean-up was again performed by SPE. The choice of the SPE-sorbent was determined 
based on the recovery rates (S/N ratio and peak area) obtained and clarity of the extract. 
The Isolute ENV + cartridges provided the best results over Strata-X, Chromabond HR-
X, and Chromabond Easy (6 mL, 200 mg, Macherey-Nagel, Düren, Germany).  
3.1.3 Perfluorinated compounds 
Our analytical procedure is based on the study of Powley et al. [17] on quantification of 
PFCs in biological samples, which is commonly used in this field [33]. The use of 
acetonitrile as extraction solvent was adapted from Powley et al. [17], while for clean-up 
and concentration of the extracts, SPE with Oasis HLB cartridges was performed. Oasis 
HLB cartridges have been repeatedly applied for PFC-extraction from aqueous samples 
[7,34,35] and their superiority above other SPE sorbents has been clearly demonstrated 
[7]. After SPE, clear extracts were obtained by centrifugation of the eluates.  
3.2 Chromatography and mass spectrometric detection 
3.2.1 Pharmaceuticals and pesticides 
According to literature [36,37], LC-MS/MS is the best tool for sensitive detection of 
pharmaceuticals from different therapeutic classes as well as for multi-residue pesticide 
analysis in complex environmental matrices. Therefore, new U-HPLC-MS/MS methods 
were developed allowing unequivocal confirmation and quantification of the targeted 
pharmaceuticals and pesticides. For both groups of micropollutants, rapid 
chromatographic separation was achieved using a Nucleodur C18 Pyramid U-HPLC 
column. Based on peak intensities, areas, S/N ratios, and peak resolution of the individual 
analytes, this column provided better results than the Hypersil Gold (1.9 μm, 50 and 
100×2.1 mm, Thermo Electron) and Acquity HSS T3 or HSS C18 (1.8 μm, 50 and 
100×2.1 mm, Waters, Milford, USA) UHPLC columns. The Nucleodur C18 Pyramid also 
exerted a better retention for the fast-eluting pharmaceutical atenolol. Too early elution of 
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compounds should be avoided, in order to prevent interference with the solvent peak. To 
this end, the mobile phase started with a gradient of 98% 0.08% aqueous formic acid and 
2% 0.08% formic acid in acetonitrile. For separation of pharmaceutical compounds using 
liquid chromatography, water and acetonitrile are commonly used solvents [36]. In 
addition, a higher ionization rate in positive ion mode may be obtained by adding formic 
acid to the mobile phase [36]. For 1 min, isopropanol was added to the mobile phase. The 
higher elution strength of isopropanol resolved the carry-over problem of ofloxacin and 
trimethoprim. All pesticides were separated within less than 5 min using a mobile phase 
consisting of aqueous ammonium carbonate (2 mM) and methanol. Methanol as eluent 
was preferred over acetonitrile because of its weaker elution strength, thus increasing the 
retention of the more polar pesticides. In line with Martins-Junior et al. [38] ammonium 
carbonate was selected as a buffer since it provided better chromatographic elution for 
polar pesticides than other additives (formic acid, acetic acid, ammonium hydroxide, 
ammonium acetate).  
As mentioned before, we selected triple quadrupole mass spectrometry to allow reliable 
quantification of the selected pharmaceuticals and pesticides in extracts of tissue. At first, 
compound-dependent parameters were optimized by direct infusion of individual analytes 
(10 ng μl−1) into the heated electrospray ionization source (HESI-II). Data acquisition was 
performed initially in full scan mode to determine an abundant precursor ion. Next, the 
MS/MS transitions (at least two), S-lens voltages, and collision energies were optimized 
for each individual compound (Table IV.2). Finally, the ionization source working 
parameters were optimized by direct infusion of a standard mixture (10 ng μl−1; 
Table IV.1). As such, the use of U-HPLC coupled to triple quadrupole mass spectrometry 
resulted in a rapid and selective multi-residue analytical method for the detection of 11 
pharmaceuticals and 14 pesticides (+internal standards) in biotic extracts. The obtained 
SRM chromatograms of a M. edulis sample fortified with the selected pharmaceuticals at 
100 ng g−1 are presented in Fig. IV.3. Some minor matrix components could be noticed 
within the retention time windows of several pharmaceuticals. This background noise did 
however not affect quantification or identification, since it was chromatographically 
resolved from the target compounds. With respect to the targeted pesticides, no 
interferences were observed at their specific retention time upon analysis of M. edulis 
tissue spiked with 100 ng g−1 (Fig. IV.4).   
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Table IV.2. SRM transitions, MS parameters, recoveries, and limits of quantification (LOQs) of the 
targeted pharmaceuticals and pesticides in Mytilus edulis extracts (n=21). 
Compound Int. tR Precursor ion Product S-lens Collision E Recovery (%) LOQ 
 Stand. (min) (m/z) (m/z) (V) (eV) (x ± RSD) ng g-1 
Pharmaceuticals         
Atenolol At 0.83 267.1 (+) 190.1, 145.0 102 18, 26 97 ± 13 1 
Paracetamol Sal 2.15 152.0 (+) 110.1, 65.1 52 16, 30 97 ± 26 2.5 
Trimethoprim Iso 2.25 291.1 (+) 261.1, 230.1 188 25, 23 101 ± 13 1 
Propranolol At 2.35 260.2 (+) 183.1, 116.1 138 18, 17 98 ± 13 1 
Ofloxacin Iso 2.35 362.1 (+) 318.2, 261.1 176 18, 27 102 ± 14 5 
Chloramphenicol Iso 2.58 321.0 (-) 257.1, 152.1 104 15, 19 95 ± 15 2.5 
Carbamazepine Sal 2.78 237.1 (+) 194.1, 193.1 93 19, 33 100 ± 11 1 
Salicylic acid Sal 2.85 137.0 (-) 93.1, 65.1 51 20, 32 103 ± 10 10 
Ketoprofen Sal 3.19 255.0 (+) 209.2, 105.0 295 14, 24 100 ± 12 5 
Clofibric acid Sal 3.46 213.0 (-) 127.1, 85.1 73 19, 13 100 ± 20 1 
Diclofenac Sal 3.55 296.0 (+) 250.1, 214.1 78 13, 34 98 ± 16 2.5 
Atenolol-d7 (At)  0.96 274.1 (+) 190.1, 145.0 111 19, 27 - - 
Isobutcar 61 (Iso)  2.36 313.8 (+) 222.1, 130.1 170 19, 20 - - 
Salicylic acid-d4 (Sal)  2.84 141.1 (-) 97.1, 69.2 52 19, 33 - - 
Pesticides         
Dimethoate Iso 2.87 230.0 (+) 199.0, 79.1 63 10, 34 104 ± 10 10 
Chloridazon Atr 2.90 222.0 (+) 104.1, 77.1 95 23, 36 104 ± 9 1 
Simazine Atr 3.11 202.1 (+) 132.1, 124.1 77 18, 18 100 ± 8 5 
Pirimicarb Iso 3.20 239.1 (+) 182.2, 72.2 74 15, 33 101 ± 10 1 
Isoproturon Iso 3.21 207.1 (+) 72.1, 46.2 78 19, 17 102 ± 8 1 
Dichlorvos Iso 3.23 221.0 (+) 109.1, 79.1 81 19, 28 100 ± 10 1 
Atrazine Atr 3.25 216.1 (+) 174.1, 68.1 83 17, 36 95 ± 19 1 
Diuron Iso 3.25 233.0 (+) 72.1, 46.2 71 18, 16 103 ± 8 1 
Linuron Atr 3.36 249.0 (+) 182.1, 160.1 83 16, 18 105 ± 11 1 
Terbutylazine Atr 3.41 230.2 (+) 174.1, 104.1 70 18, 33 100 ± 8 1 
Metolachlor Atr 3.61 284.1 (+) 252.2, 176.2 69 15, 24 101 ± 11 1 
Diazinon Iso 3.80 305.1 (+) 169.1, 97.0 87 20, 34 104 ± 17 1 
Kepone Atr 4.30 506.6 (-) 426.8, 424.8 157 21, 20 99 ± 19 1 
Chlorpyriphos Atr 4.64 349.8 (+) 199.9, 197.9 82 22, 21 98 ± 17 1 
Isoproturon-d6 (Iso)  3.21 213.1 (+) 78.2, 52.2 69 20, 19 - - 
Atrazine-d5 (Atr)  3.23 221.1 (+) 179.1, 101.1 79 19, 27 - - 
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Figure IV.3. SRM chromatograms of a Mytilus edulis sample fortified with the target 
pharmaceuticals at 100 ng g-1.  
 
Figure IV.4. SRM chromatograms of a Mytilus edulis sample fortified with the target pesticides at 100 
ng g-1.  
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3.2.2 Perfluorinated compounds 
For detection of PFCs in biotic tissue, an analytical methodology was developed using 
LC-ToF-MS. LC-ToFMS, which encompasses a high-resolution approach based on 
accurate mass measurements, has been shown superior for the detection of 
perfluorosulfonates as compared to tandem MS [39,40]. This specific class of PFCs, 
including the major contaminant PFOS, shows a very high stability even at extreme 
conditions (e.g., high collision energies) which makes the use of tandem MS for the 
detection of perflurosulfonates very complex and less efficient [39,40]. Based on our 
previously developed method in aqueous matrices [7], LC-ToF-MS was found to be a 
highly selective MS-technique for the detection of PFCs in complex environmental 
matrices. Also in literature, ToF-MS has proved to be the optimum quantitative method 
for PFCs [41] and excellent specificity for unequivocal compound identification after a 
crude sample clean-up is obtained using high-resolution ToF-MS [42].  
Good chromatographic separation of all compounds was achieved using the Luna C18 (2) 
LC-column and a mixture of 2.5 mM ammonium acetate in water and methanol as mobile 
phase. The detection of the target compounds was obtained via full scan data, from which 
the calculated theoretical masses of the target PFCs were extracted using very narrow 
mass tolerance windows. The theoretical masses, the mean measured masses, and the 
mass errors obtained are presented in Table IV.3. Except for PFDoA (ppm of 5.5), the 
obtained mean mass errors were below 5 ppm, resulting in a highly selective MS-
technique for the detection of PFCs in complex biotic matrices (Fig. IV.5). 
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Table IV.3. Characteristics of the PFC-analysis using ToF-MS: theoretical masses, mean measured 
masses, mean mass errors, internal standards, recoveries, and limits of quantification (LOQs). 
Compound Theoretical m/z Mean measured Mean mass Internal Recovery (%) LOQ
 [M-H]- ion m/z error (ppm) standard (x + RSD) ng g-1
PFHpA 362.9696 362.9705 3.2 13C4 PFOA 103 ± 10 2
PFOA 412.9664 412.9680 4.1 13C4 PFOA 100 ± 9 1
PFNA 462.9632 462.9648 4.3 13C5PFNA 101 ± 15 2
PFDA 512.9600 512.9625 4.9 13C2PFDA 105 ± 15 2
PFUnA 562.9563 562.9581 4.9 13C2PFDA 98 ± 15 2
PFDoA 612.9531 612.9565 5.5 13C2PFDoA 90 ± 17 5
PFBS 298.9430 298.9436 2.9 13C4PFOS 94 ± 18 5
PFHxS 398.9366 398.9387 4.9 13C4PFOS 106 ± 23 0.1
PFOS 498.9302 498.9317 3.9 13C4PFOS 100 ± 16 0.1
PFDS 598.9233 598.9250 3.7 13C4PFOS 96 ± 16 0.1
 
 
CHAPTER IV 
139 
 
Figure IV.5. Chromatograms of a Mytilus edulis sample fortified with the target PFCs at 100 ng g-1.  
 
3.3 Method performance 
The method performance of each of the three newly optimized analytical procedures was 
determined by constructing seven-point calibration curves in tissue matrix. To this end, 
freeze-dried M. edulis samples were used. The method proved to be applicable to pacific 
oysters (Crassostrea gigas) and brown shrimps (Crangon crangon) as well, and 
comparable limits of quantification (LOQs) were obtained upon analysis of these biotic 
organisms. The samples were spiked with a standard mixture at seven final concentrations 
between 0.1 and 250 ng g−1 and with the appropriate concentrations of the respective 
internal standard mixtures. This was performed in triplicate for each application (n=21). 
In addition, unspiked M. edulis samples (n=3) were also analyzed, to check the 
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occurrence of the target compounds in blank samples. Based on the obtained calibration 
curves, the LOQ, recovery (trueness), and linearity were assessed.  
Linear regression analysis was carried out by plotting the peak area ratios of the analyte 
against the I.S. versus the analyte concentrations. Good linearities were obtained for all 
analytes (regression coefficients ≥0.99), except for chlorpyriphos for which R2 equalled 
0.98. Due to the ubiquitous character of some of the compounds, analysis of unspiked M. 
edulis samples frequently resulted in their detection in the low nanogram per gram range. 
The calibration curves were corrected for these concentrations. Since no certified 
reference material was available, the accuracy in terms of recovery of the methods was 
assessed using M. edulis samples spiked at seven concentration levels between 0.1 and 
250 ng g−1 (three replicates). According to the guidelines SANCO/10684/2009 [43] on 
pesticide residues analysis in food and feed, and Commission Decision 2002/657/EC [44] 
concerning the determination of analytes in products of animal origin, typically a 
recovery is required within the range of 70–120% and 80–110%, respectively. As can be 
deduced from Tables IV.2 and IV.3, all obtained recoveries were between 90% and 
106%, indicating good accuracy for all compounds. LOQs were determined using spiked 
matrix samples and were defined as the lowest detectable concentrations of the 
calibration curve with a signal-to-noise of at least 10:1. The LOQs obtained varied 
between 0.1 and 10 ng g−1. For detection of pharmaceuticals in mussel tissue, the LOQs 
obtained in this study are an order of magnitude lower than a previous study [20]. For 
detection in fish muscle tissue, Ramirez et al. [19] determined comparable values for 
paracetamol, atenolol, and trimethoprim, and lower LOQs for propranolol and 
carbamazepine. With respect to pesticide analysis, the only analogous study reported 
limits of detection for simazine, atrazine, and terbutylazine of 0.21, 0.042, and 0.012 ng 
g−1, respectively [21]. The obtained LOQs for detection of PFCs in mussel tissue are 
comparable to previous reported values, yet based on wet weight sample volumes [15,45]. 
In general, the sensitivity of the reported methodologies is considered acceptable to good. 
A well-known interference, which is associated with analysis by LC-MS, is the potential 
for interaction with matrix co-elutants. Due to the complexity of biotic samples, the 
number of co-eluting interferences and their interactions with target analytes increase 
[13]. To anticipate these matrix effects, quantification using matrix-matched calibration 
curves is suggested in literature. Besides, the use of isotopically labelled internal 
standards or compounds, which are structurally related with the target analytes, has also 
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been recommended [13,46]. In this study, both strategies to compensate for matrix effects 
were applied. The results obtained were thus corrected for possible matrix-induced 
suppression or enhancement effects, resulting in reliable analytical methods for the 
detection of the three groups of analytes in biotic matrices.  
3.4 Application to M. edulis samples from the Belgian coastal zone  
The developed methods were applied to M. edulis samples, derived from two cage 
experiments (see “Study area and sampling” section). Since freeze-dried samples were 
analyzed, the obtained results are expressed on dry weight basis in nanograms per gram. 
As shown in Tables IV.4 and IV.5, five different pharmaceuticals were detected in the M. 
edulis samples. The widely used non-steroidal anti-inflammatory drug (NSAID) salicylic 
acid was found in almost every sample in levels up to 490 ng g−1. A second NSAID, 
namely paracetamol was detected less frequently at concentrations up to 115 ng g−1. Also 
the β-blocker propranolol and the antibiotic ofloxacin were measured in some samples: 
up to 63 and 65 ng g−1, respectively. Finally, carbamazepine was detected in 
concentrations ≤11 ng g−1. Salicylic acid has been identified by Wille et al. [6] as the 
most prevalent pharmaceutical in water samples collected in the Belgian coastal waters, 
which explains the presence of this compound in the M. edulis samples observed in this 
study. No obvious temporal trends could, however, be observed during the cage 
experiments. Moreover, the measured concentrations of salicylic acid showed large 
variations over time and location.  
Seven target pesticides were found in the M. edulis samples originating from the cage 
experiments. The concentrations of five pesticides (diuron, linuron, isoproturon, 
metolachlor, terbutylazine) were close to the limit of quantification, while the detected 
concentrations of chloridazon and dichlorvos were significantly higher. Chloridazon was 
observed at up to 16 ng g−1 and dichlorvos was found in most samples with a maximum 
concentration of 60 ng g−1. This implies that the European default maximum pesticide 
residue level (MRL) in foodstuffs of 10 ng g−1 [47], was exceeded for chloridazon and 
dichlorvos at several stations. Carafa et al. [21] also reported the exceeding of this MRL 
in clams, in which up to 73 ng g−1 of terbutylazine was retrieved.  
Only two PFCs were detected in the M. edulis samples; PFHxS was detected only once at 
a concentrations of 3 ng g−1, while PFOS was found in most samples at levels ≤5 ng g−1. 
These concentrations were in the same order as those reported by So et al. [48] who found 
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PFHxS and PFOS in mussel samples at levels ≤4 ng g−1 in coastal waters of China and 
Japan. In the study by Van de Vijver et al. [18], much higher concentrations of PFOS 
were measured in aquatic invertebrates of the southern North Sea, which is the same 
study area as the present study. PFOS was measured in shrimp (C. crangon), crab 
(Carcinus maenas), and starfish (Asterias rubens) up to 520, 877, and 176 ng g−1, 
respectively.  
 
  
Table IV.4. Detected concentrations (ng g-1 on dry weight basis) of the target micropollutants in Mytilus edulis deployed in a 6-month cage experiment 
performed at five stations in the Belgian coastal zone (n.d. = not detected; n.a. = not analyzed). 
 Sampling location
 ES ZB1 ZB2 Sea NP OO 
 Feb Mar Apr May Jun Jul Mar Apr May Jun Jul Apr May Jun Jul Mar Apr Mar Apr 
Pharmaceuticals                    
Ofloxacin n.d. n.d. n.d. n.d. n.d. 5 n.d. 5 n.d. n.d. n.d. n.d. 8 n.d. 7 n.d. n.d. n.d. 65 
Propranolol n.d. 40 n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. 19 n.d. n.d. 52 
Salicylic acid 145 444 208 223 n.d. 172 162 241 339 184 315 264 93 203 119 490 125 41 206 
Carbamazepine 1 11 3 1 1 3 n.d. 4 n.d. 3 n.d. n.d. n.d. 2 n.d. n.d. n.d. 3 n.d. 
Paracetamol n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. 96 n.d. n.d. n.d. n.d. n.d. 115 65 
PFCs                    
PFHxS n.d. n.d. n.d. n.d. n.d. 3 n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. 
PFOS 1 4 4 4 3 4 2 4 3 1 1 1 n.d. n.d. n.d. n.d. n.d. 2 3 
Pesticides                    
Dichlorvos 21 18 19 5 25 23 20 15 10 19 5 4 n.d. 20 28 5 11 n.a. 14 
Diuron 1 1 1 n.d. 1 1 1 1 1 1 1 n.d. n.d. n.d. n.d. n.d. n.d. n.a. 1 
Linuron n.d. 2 n.d. n.d. 1 n.d. n.d. n.d. n.d. 1 n.d. n.d. n.d. n.d. n.d. 1 n.d. n.a. n.d. 
Chloridazon n.d. n.d. n.d. n.d. 16 n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. 11 n.d. n.d. n.a. n.d. 
Isoproturon n.d. 1 n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d n.d. n.a. n.d. 
Metolachlor n.d. n.d. n.d. n.d. n.d. 1 n.d. 1 n.d. 1 1 n.d. n.d. n.d. n.d. 1 1 n.a. 1 
Terbutylazine n.d. n.d. n.d. n.d. 1 n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. 1 n.d. n.a. n.d. 
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Table IV.5. Detected concentrations (ng g-1 on dry weight basis) of the target micropollutants in 
Mytilus edulis deployed in a 6-week cage experiment performed at four stations in the Belgian coastal 
zone (n.d. = not detected). 
 Sampling location
 ES ZB1 ZB2 NP OO
Pharmaceuticals      
Ofloxacin n.d. n.d. n.d. n.d. n.d.
Propranolol n.d. 39 38 30 63
Salicylic acid 33 14 118 288 229
Carbamazepine n.d. 3 1 4 4
Paracetamol n.d. n.d. n.d. n.d. 115
PFCs      
PFHxS n.d. n.d. n.d. n.d. n.d.
PFOS n.d. 5 2 n.d. n.d.
Pesticides      
Dichlorvos 25 7 8 60 8
Diuron n.d. 1 1 n.d. n.d.
Linuron n.d. n.d. n.d. n.d. n.d.
Chloridazon 13 8 7 6 n.d.
Isoproturon n.d. n.d. n.d. 1 1
Metolachlor 1 n.d. n.d. n.d. 1
Terbutylazine n.d. n.d. n.d. 1 1
 
4. CONCLUSIONS 
In this study, three separate sensitive, selective, and reliable analytical methods have been 
developed for the quantification of 11 pharmaceuticals, 14 pesticides, and 10 
perfluorinated compounds in tissue from marine organisms. It was shown that these 
methods exhibited satisfactory linearities and recoveries. The LOQs varied between 0.1 
and 10 ng g−1 for all target compounds. Application of these analytical procedures to the 
blue mussel (M. edulis) deployed at different stations in the Belgian coastal zone revealed 
the presence of several of the target micropollutants. Five pharmaceuticals were found in 
M. edulis samples at up to 490 ng g−1, two PFCs were detected at up to 5 ng g−1, and 
seven pesticides were measured at concentrations up to 60 ng g−1. As a consequence, the 
present study demonstrates that presence of micropollutants in marine ecosystems clearly 
affect tissue concentrations in resident marine organisms [3–7]. These findings will 
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contribute to the assessment of the environmental and human health risk of these 
emerging micropollutants.  
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CHAPTER V 
RAPID QUANTIFICATION OF PHARMACEUTICALS AND PESTICIDES IN PASSIVE 
SAMPLERS USING ULTRA HIGH PERFORMANCE LIQUID CHROMATOGRAPHY 
COUPLED TO HIGH RESOLUTION MASS SPECTROMETRY  
Abstract 
The presence of both pharmaceuticals and pesticides in the aquatic environment has 
become a well-known environmental issue during the last decade. An increasing demand 
however still exists for sensitive and reliable monitoring tools for these rather polar 
contaminants in the marine environment. In recent years, the great potential of passive 
samplers or equilibrium based sampling techniques for evaluation of the fate of these 
contaminants has been shown in literature. Therefore, we developed a new analytical 
method for the quantification of a high number of pharmaceuticals and pesticides in 
passive sampling devices. The analytical procedure consisted of extraction using 1:1 
methanol/acetonitrile followed by detection with ultra-high performance liquid 
chromatography coupled to high resolution and high mass accuracy Orbitrap mass 
spectrometry. Validation of the analytical method resulted in limits of quantification and 
recoveries ranging between 0.2 and 20 ng per sampler sheet and between 87.9 and 
105.2%, respectively. Evaluation of the repeatability and within-laboratory 
reproducibility resulted in RSD values between 7 and 26%. Determination of the sampler-
water partition coefficients of all compounds demonstrated that several pharmaceuticals 
and most pesticides exert a high affinity for the polydimethylsiloxane passive samplers. 
Finally, the developed analytical methods were used to measure the time-weighted 
average (TWA) concentrations of the targeted pollutants in passive samplers, deployed at 
eight stations in the Belgian coastal zone. Propranolol, carbamazepine and seven 
pesticides were found to be very abundant in the passive samplers. These obtained long-
term and large-scale TWA concentrations will contribute in assessing the environmental 
and human health risk of these emerging pollutants. 
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1. INTRODUCTION 
Large amounts of various polar anthropogenic pollutants, including pesticides and 
pharmaceuticals, are continuously introduced into the aquatic environment [1]. As a 
result, the presence of pharmaceuticals and pesticides in marine waters, typically in the 
lower ng L-1 concentration range, has been reported occasionally [2-4]. However, 
monitoring these pollutants in the marine environment remains an ongoing challenge 
within the domain of environmental chemistry [5]. Besides the determination of the 
concentration of these pollutants, modern monitoring techniques should also enable the 
evaluation of their ecotoxicological effects and the assessment of their environmental and 
human health risks [6]. Therefore, the determination of time-weighted average (TWA) 
concentrations over extended sampling periods of these pollutants in the aquatic 
environment has been put forward.  
The most conventional screening technique involves active sampling, which is based on 
the collection of discrete grab or spot samples of water, and is used in most aquatic 
monitoring programmes [7]. To obtain long-term and large-scale TWA concentrations, a 
large number of samples have to be taken, which makes it an expensive and impractical 
technique [6,7]. Since pharmaceuticals and pesticides are mostly present at trace levels in 
the marine environment [2-4], large volumes of water need to be collected as well. 
Although these conventional sampling techniques are very useful, generally, they will not 
provide appropriate information for assessing the prevalence of pollutants in the marine 
environment on a long-term basis [8]. As a result, passive sampling techniques, which 
rely on the free flow of pollutants from the sampled medium to a receiving phase namely 
the sampling device [9], have gained in popularity, since most of the disadvantages of 
active sampling are avoided by this approach [6]. Additionally, passive samplers enable 
the discrimination between the relevant bioavailable fractions of pollutants from the total 
amounts present in environmental compartments [10]. In this way, passive sampling or 
equilibrium-based techniques mimic biological uptake in a more straightforward manner 
by determining the pollution level of contaminants with respect to their freely dissolved 
concentration [11,12]. Furthermore, passive samplers are designed to obtain TWA 
concentrations, providing a more complete picture of organism exposure than those 
concentrations measured in grab samples, certainly in cases where chemicals 
bioconcentrate and their environmental concentrations vary temporally [10]. 
CHAPTER V 
153 
With respect to pharmaceuticals and pesticides, the use of passive sampling devices such 
as polar organic chemical integrative samplers (POCISs) and Chemcatcher® passive 
samplers have been recently reported in literature [5,8,13-15]. However, the applicability 
of these passive sampling devices to characterize the tendency of pharmaceuticals and 
pesticides to bioaccumulate is limited. In addition, the quantitative aspect is still a major 
issue of concern, due to both the lack of calibration data to enable quantification of target 
analytes, as well as the missing insights in the effects of environmental conditions on the 
analyte uptake [14,16]. In this context, polydimethylsiloxane (PDMS) was preferred as 
passive sampling material for pharmaceuticals and pesticides in the marine environment 
in this study. So far, PDMS samplers have mainly been used for quantification of a 
variety of mostly hydrophobic pollutants [17]. However, Magner et al. [12] demonstrated 
that PDMS is suitable for mimicking biological uptake of more hydrophilic organic 
pollutants as well. 
Detection of pharmaceuticals and pesticides in complex environmental matrices has 
generally been performed using liquid chromatography coupled to mass spectrometry 
(LC-MS/MS) [18,19]. Nevertheless, their analysis at trace concentration levels in aqueous 
environmental samples remains an important challenge [20]. Nowadays, advances in 
instrumentation have resulted in a significant progress in the detection of these pollutants 
in environmental matrices. At first, the use of ultra-high performance liquid 
chromatography (U-HPLC) enabled fast separation of compounds in comparison to 
conventional LC, due to the use of columns with very small particles [21]. Secondly, with 
respect to the mass spectrometric detection, accurate mass full scan analysis, using time-
of-flight (ToF) and Orbitrap-based mass spectrometers (MS), proved to be a very suitable 
alternative to triple quadrupole instruments. Full scan data originating from ToF and 
Orbitrap instruments enable the accurate mass screening of a virtually unlimited number 
of analytes, targeted as well as untargeted compounds. Typically, the working resolution 
of an Orbitrap-MS amounts up to 100,000 at m/z 200, which is significantly higher than 
the resolution of a ToF-MS [22]. This high resolving power of Orbitrap-MS technology 
provides higher mass accuracy (<2 ppm) as compared to ToF-MS instruments (<5 ppm) 
[23]. Especially this high mass resolution and accuracy makes the Orbitrap MS very 
appropriate for the successful identification of pollutants in environmental samples 
containing high amounts of matrix co-extracts. 
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In general, the use of passive sampling devices for quantification of polar micropollutants 
in marine environments seems promising, however, the applicability for a wide range of 
compounds remains to be tested [8]. Therefore, we developed a new extraction procedure 
and analytical method for the quantification of the most frequently used pharmaceuticals 
in Belgium [4] and the most intensively applied pesticides in Belgium in PDMS passive 
sampling devices [24]. The method consisted of a liquid extraction using 1:1 
methanol/acetonitrile followed by U-HPLC coupled to Orbitrap mass spectrometry (MS). 
An extensive validation study was carried out to demonstrate the applicability of this 
analytical approach. In addition, the sampler-water partition coefficients (Ksa/wa) of the 
target analytes was determined, to enable quantification of the compounds in the passive 
samplers. Finally, the optimized method were applied to passive samplers, deployed at 
several locations in the Belgian coastal zone, to study the presence of pharmaceuticals 
and pesticides in the Belgian marine environment. 
 
2. MATERIAL AND METHODS 
2.1 Study area and sampling 
The sampler holders were deployed at eight sampling locations in the Belgian coastal 
zone: the marinas of Nieuwpoort (NP2), Oostende (OO2), and Zeebrugge (ZB2), the 
inner side of the harbour of Nieuwpoort (NP1), the outport of Zeebrugge (ZB1), and the 
location halfway the harbour of Oostende (OO3) were sampled. An additional location 
was selected at the Sluice Dock in Oostende (OO1) since at this location aquacultural 
activities take place. Finally, one location was situated in open sea at the Nieuwpoortbank 
(SEA) (Figure V.1). The samplers were deployed at 1.5 to 2 meters below surface for 
circa two months from May till July 2008, from March till May 2009 and from mid-July 
to mid-September 2010. The sampler holders were lost at the SEA-station in 2008 and 
2010, at OO1 in 2009, and at OO2 in 2010.   
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Figure V.1. Study area of the passive sampler experiments in the Belgian coastal zone.  
2.2 Reagents and chemicals 
The analytical method for pharmaceutical analysis included 16 substances. Paracetamol 
(99%), ketoprofen (99%), carbamazepine (> 99%), diclofenac (> 99%), salicylic acid (> 
99%), clofibric acid (97%), atenolol (≥ 98%), trimethoprim (≥ 98%), bezafibrate (≥ 98%), 
sulfamethoxazole (99%), pravastatin (≥ 98%), salbutamol (99%), carprofen (> 99%) and 
chloramphenicol (≥ 99%) were purchased from Sigma-Aldrich (St-Louis, MO, USA). 
Ofloxacin (> 99%) was obtained from ICN Biomedicals Inc. (Ohio, USA), while 
propranolol (> 99%) was purchased from Eurogenerics (Brussel, Belgium). The 13C-
labelled sulfamethoxazole-phenyl-13C6 (> 99%) from Sigma-Aldrich (St-Louis, MO, 
USA), two deuterated pharmaceuticals, bezafibrate-d6 (> 99%) from Dr. Ehrenstorfer 
GmbH (Augsburg, Germany) and salicylic acid-d4 (≥ 98%) from Toronto Research 
Chemicals Inc. (North York, ON, Canada), were used as internal standards.  
Thirteen pesticides were included in the study. Dichlorvos (> 98%), dimethoate (> 99%), 
pirimicarb (≥ 99%), linuron (> 99%), metolachlor (≥ 98%), chloridazon (≥ 99%), 
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simazine (> 99%), isoproturon (> 99%), terbutylazine (> 98%), 2,4-D (or 2,4-
dichlorophenoxy acetic acid) (> 99%) and diuron (> 99%) were obtained from Sigma-
Aldrich (St-Louis, MO, USA), while atrazine (> 99%) and kepone (≥ 98%) were 
purchased from Chem Service (West Hester, PA, USA). Isoproturon-d6 (> 99%) and 
atrazine-d5 (> 99%) from Sigma-Aldrich (St-Louis, MO, USA) were used as internal 
standards. 
Analytical grade solvents were used for extraction and purification purposes, and 
Optima® LC-MS grade for U-HPLC-MS analysis. They were obtained from VWR 
International (Merck, Darmstadt, Germany) and Fisher Scientific UK (Loughborough, 
UK), respectively. Aqueous formic acid (Merck, Darmstadt, Germany) and acetonitrile 
with formic acid (both 0.08%) were prepared by appropriate dilution of formic acid in 
ultra-pure water (Arium 611 UV system, Sartorius Stedim Biotech, Aubagne, France) and 
acetonitrile, respectively. 
Primary stock solutions of the pharmaceuticals and pesticides were prepared in ethanol at 
a concentration of 1 µg µL-1. Working standard mixture solutions were prepared by 
appropriate dilution of the stock solutions in ethanol. When necessary, sonication was 
applied to ensure the complete dissolution of the substances. All solutions were stored at -
20°C in the dark. 
2.3 Sampler preparation 
The polydimethylsiloxane (PDMS) samplers (AlteSil Laboratory Sheet, Altec Products 
Ltd, Bude, United Kingdom) with a thickness of 0.5 mm, were cut into sheets of 55mm x 
90mm, to obtain a total sampling surface of approximately 100 cm² and a mean mass of 
3.15g. These sampler sheets were pre-cleaned for 2 h in methanol prior to use. Sampler 
holders made of stainless steel for mounting the passive samplers were built. The sampler 
sheets were fixed in such a way that they could move freely, as proposed by Smedes [25]. 
By this approach, the design does not limit the uptake of the target compounds. After the 
sampling period, the loaded sampler holders were carefully dismantled and the sheets 
were transferred on ice to the laboratory where they were stored in a freezer at -20 °C 
before analysis.  
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2.4 Extraction and clean-up 
As proposed by Rusina [11], the surface of the sampler was cleaned with ultrapure water 
and wiped dry with a paper tissue before extraction. The internal standards were spiked 
on the surface of the samplers prior to extraction to a final concentration of 25 ng per 
sheet. Extraction of a sampler sheet was carried out by adding 20 mL of 1:1 
acetonitrile/methanol to a 50 mL tube containing the sheet, followed by shaking this for 
60 min and sonication for 60 min. The eluate was evaporated to dryness under a gentle 
stream of nitrogen and reconstituted in 50 µL methanol and 150 µL of 0.08% aqueous 
formic acid.  
2.5 Chromatography 
For both the pesticides and pharmaceuticals, chromatographic separation was carried out 
using ultra-high performance liquid chromatography (U-HPLC). This U-HPLC-system 
consisted of an AccelaTM high speed LC and an AccelaTM autosampler and degasser 
(Thermo Scientific, San Jose, CA, USA). Chromatographic separation was achieved 
using a Nucleodur C18 Pyramid U-HPLC column (1.8 µm, 100 x 2 mm, Macherey-
Nagel, Düren, Germany). For the pharmaceuticals, the mobile phase consisted of 0.08% 
aqueous formic acid (A) and 0.08% formic acid in acetonitrile (B). A linear gradient was 
used, starting from 98% A and 2% B, which was held for 0.8 min. In 30 sec the 
percentage of acetonitrile was increased to 65% B, which was held for 0.7 min. The 
percentage of acetonitrile was increased further to 100% B in 1 min and held for 2 min. 
Equilibration at initial conditions was done for 2.5 min. Pesticide separation was achieved 
using 0.08% aqueous formic acid (A) and methanol (C). The linear gradient started with a 
mixture of 98% A and 2% C for 1 min. The methanol percentage increased to 90% in 30 
sec, and further to 100% in 3 min, which was held for 1 min. Between samples, the 
column was allowed to equilibrate at initial conditions for 1 min. The injection volume 
was 10 µl. The column oven and tray temperature were 25 °C and 15 °C, respectively.    
2.6 Mass spectrometric detection 
Detection of pharmaceuticals and pesticides was carried out using an ExactiveTM 
Benchtop Mass Spectrometer (Thermo Fisher Scientific, San Jose, CA, USA) equipped 
with a heated electrospray ionization probe (HESI-II). The ExactiveTM is an Orbitrap-
based MS, which was operated alternating from positive to negative ion mode, with both 
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scan types at a resolution of 50,000 at 2 Hz (2 scans per second). For the compounds of 
interest, a scan range of m/z 80-800 was chosen. The automatic gain control (AGC) target 
was set at ultimate mass accuracy (5 x 105 ions) and the maximum injection time was 500 
ms. The instrumental settings were optimized to maximize the signal. The parameters as 
presented in Table V.1 were found to be the optimal ionization source working 
parameters for the respective analytes. Initial instrument calibration was done by infusing 
calibration mixtures for positive and negative ion mode (Thermo Fisher Scientific, San 
Jose, CA, USA). The positive calibration mixture included caffeine, MRFA and 
Ultramark® 1621, while the negative calibration solution comprised sodium dodecyl 
sulfate, sodium taurocholate and Ultramark® 1621. These compounds were dissolved in a 
mixture of acetonitrile, water and methanol, and both mixtures were infused using a 
Chemyx Fusion 100 syringe pump (Thermo Fisher Scientific, San Jose, CA, USA). The 
option of “all-ion fragmentation” using the High Energy Collision Dissociation (HCD) 
cell was turned off. The forevacuum, high vacuum and ultra high vacuum were 
maintained around 2 mbar, from 1E-05 to to 3E-05, and below 8E-10 mbar, respectively. 
Instrument control and data processing were carried out by means of Xcalibur 2.1 and 
ToxID software (Thermo Electron, San Jose, CA, USA). 
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Table V.1. HESI-II working parameters for ionization of the selected pharmaceuticals and pesticides. 
 Pharmaceuticals Pesticides
Spray voltage (kV) 4.0 4.0 
Sheath gas flow rate (arbitrary units, au) 30 30 
Auxiliary gas flow rate (au) 0 0 
Capillary temperature (°C) 275 250 
Heater temperature (°C) 250 350 
Capillary voltage  82.5 (-30.0) 82.5 (-30.0)
Tube lens voltage 170.0 (-95.0) 120.0 (-95.0)
Skimmer voltage 20.0 (-26.0) 20.0 (-26.0)
 
2.7 Determination of Ksa/wa 
This experimental setup was based on the study of Magner et al. [12]. Thirty-three sheets 
were placed in a beaker filled with 5 L of ultra-pure water under gentle stirring at 100 
rpm. The water was spiked with all pharmaceuticals at a concentration of 20 µg L-1, 
except propranolol and carbamazepine, which were spiked at 5 µg L-1. The pesticides 
were spiked at 5 µg L-1, apart from dichlorvos, 2.4-D, linuron and kepon, which were 
spiked at 20 µg L-1. Three 1 mL water samples and three sheets were sampled after 0, 
0.08, 0.75, 1, 2, 3, 5, 6, 7, 8, 9 d, respectively. After sampling, the sheets were left to dry 
on a paper towel and analyzed as described above. The water samples were analyzed by 
direct injection of 10 µl into the U-HPLC Orbitrap MS instrument, using the optimized 
analytical parameters. The Ksa/wa (L kg-1) is defined as: Ksa/wa = Csa / Cwa with Csa (g kg-1) 
and Cwa (g L-1) as the concentrations of the analyte in the sampler and the water phase, 
respectively. Knowledge of the Ksa/wa of the analytes is required to enable quantification 
of the compounds in the equilibrium based passive samplers. Each time water and sheets 
were sampled, the mean (n=3) water and sampler concentrations of the analytes were 
calculated. Equilibrium between the sampler and the water phase was achieved when the 
concentration of the analyte in the water phase remained constant throughout the 
experiment. 
2.8 Identification and quantification 
The target analytes were identified based on both their retention time relative to that of 
the internal standards, and their accurate mass. According to previous studies using 
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Orbitrap MS, a maximum mass deviation of 5 ppm was allowed within this study 
[20,22,26]. 
So far, appropriate identification criteria using these modern instruments based on high-
resolution accurate mass spectrometry are incomplete in the commonly used procedure 
prescribed by Commission Decision 2002/657/EC [20,27]. Both the criteria concerning 
mass resolution and mass accuracy, as well as the system of identification points have not 
been fully specified for these MS systems yet. Therefore, as was suggested by several 
authors [21,23,28], additional criteria for the use of these accurate mass LC-MS 
technologies should be implemented in the standardized validation procedures. 
Nevertheless, using maximum mass deviations of 5 ppm, a high reliability in 
identification can be expected.   
Upon identification, area ratios were determined by integration of the area of an analyte 
within the obtained chromatograms in reference to the integrated area of the internal 
standard. The analyte concentrations were calculated by fitting their area ratios to a ten-
point calibration curve in the sample matrix. To this end, sheets were spiked with a 
standard mixture obtaining ten final concentrations in the range of 0.01 to 100 ng per 
sheet and with a final concentration of 25 ng per sheet of the internal standards. 
2.9 Quality assurance 
Before and after analysis of a series of samples, a standard mixture (0.1 ng on column) of 
the targeted analytes and the internal standards was injected to check the performance of 
the U-HPLC Orbitrap MS system. Quality control of the method was performed by 
analysis of a blank sample, together with linear calibration curves constructed using 
matrix samples spiked with standard solutions at ten concentration levels ranging from 
0.01 to 100 ng per sheet. This was performed for every series of samples at least in 
duplicate.  
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3. RESULTS AND DISCUSSION 
3.1 Extraction of the samplers: recovery optimization  
3.1.1 Spiking of the samplers 
Spiking of passive samplers is generally performed according to Booij et al. [29]. This 
method is based on equilibration of the samplers in aqueous/methanolic solutions of the 
compounds. However, this method failed for most pharmaceuticals and pesticides within 
this study, with low uptake percentages for most compounds. This can be attributed to the 
low sampler to water and methanol partition coefficients of polar compounds. Therefore, 
an alternative method was employed by directly spiking the target compounds and 
internal standards onto the PDMS sampler surface, and allowing the solvent carrier to 
volatilize [30]. This spiking method resulted in high uptake percentages of all compounds 
and was further applied within this study. 
3.1.2 Optimization of the extraction procedure 
Generally, methanol has been reported to be the appropriate extraction solvent for 
compounds with log Kow < 8, with acetonitrile as a very good alternative [11]. Recently, a 
3:1 mixture of acetonitrile/water with 1% formic acid and a 1:1 mixture of 
methanol/acetonitrile provided the best results in extracting the same pharmaceuticals and 
pesticides from biotic tissue, respectively [31]. Therefore, both mixtures as well as the 
separate solvents methanol and acetonitrile were tested as extraction solvents for the 
targeted compounds. In addition, different extraction volumes (20 vs. 40 mL) and 
extraction conditions (sampler sonication, sampler shaking or both) were tested. 
Therefore, sheets were spiked with the targeted compounds at three concentration levels 
(10, 50 and 100 ng per sheet) and mean extraction efficiencies of each analyte were 
calculated upon U-HPLC-MS analysis. The optimal extraction parameters were 
determined based on both the extraction efficiencies and the clarity of the extract. The 
best results were obtained by adding 20 mL of the 1:1 mixture of methanol and 
acetonitrile to a PDMS sheet, and allowing this to shake and sonicate, both for 60 min. 
The extraction efficiencies of the pharmaceuticals and pesticides ranged, respectively, 
between 49 and 99% and between 42 and 92%.   
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3.2 Chromatography and mass spectrometry detection 
3.2.1 Chromatography 
Recently, the development and optimization of new U-HPLC methods for rapid 
chromatographic separation of pharmaceuticals and pesticides for analysis of marine 
organisms was reported by Wille et al. [31]. The same methods were set up in front of the 
Orbitrap MS, allowing good separation of the targeted compounds for our application. 
The chromatograms obtained upon analysis of a PDMS sheet spiked at ten times the LOQ 
level are shown in Figures V.2 and V.3, respectively. 
 
 
Figure V.2. Chromatograms of a passive sampler sheet fortified with the target pharmaceuticals at 
ten times the LOQ level.  
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Figure V.3. Chromatograms of a passive sampler sheet fortified with the target pesticides at ten times 
the LOQ level. 
 
3.2.2 Orbitrap MS 
The excellent applicability of Orbitrap MS for metabolomic and proteomic applications 
has been demonstrated in literature [22,32,33]. The suitability of Orbitrap MS for the 
identification of a large number of pharmaceuticals in aqueous matrices, has been 
demonstrated as well [20]. To the best of our knowledge, the use of Orbitrap MS for the 
quantification of pesticides and pharmaceuticals in environmental matrices, including 
passive samplers, has not been reported earlier.  
First, the observed masses were compared with the theoretical masses by direct infusion 
of individual analytes (10 ng μl-1) into the heated electrospray ionization source (HESI 
II). Next, the ionization source working parameters for the targeted analytes were one 
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after the other optimized by analyzing a standard mixture (0.1 ng µL-1). The optimal 
values of these parameters were determined based on the peak intensities, areas, S/N 
ratios and peak shape of the individual analytes. Since the tube lens voltage depends on 
the molecular structure, different values were obtained for the pharmaceuticals and 
pesticides in positive ion mode: 170 V and 120 V, respectively. Different temperatures 
for both groups were found as well (Table V.1).   
Before the ions are injected into the Orbitrap, they are trapped in a curved RF-only 
quadrupole, the C-trap. To avoid space charging [22,34], the number of ions present in 
the C-trap is controlled by the use of the Automatic Gain Control (AGC). The AGC target 
determines the number of charges collected for every scan. Three AGC values are 
possible: 3 x 106 ions for a high dynamic range scan, 1 x 106 ions for a balanced scan and 
5 x 105 ions for ultimate mass accuracy. Standard mixtures of the analytes (0.1 ng µL-1) 
were analyzed using these three possible AGC values. Based on peak shape and width, 
area, signal to noise ratio and mass deviation, the optimal AGC target value was found to 
be 5 x 105 ions. The ion density in the C-trap was kept as low as possible to ensure the 
best resolution and mass accuracy, without a significant loss of sensitivity. Besides the 
AGC target, another crucial parameter using the Orbitrap MS is the mass resolution. In 
recent years, several studies have reported the effect of the resolving power on analytical 
results [22,26]. Standard mixtures of the analytes (0.1 ng µL-1) were analyzed using mass 
resolution values varying between 10,000 and 100,000. A resolution of 50,000 at 2 Hz (2 
scans per second) proved to be the best compromise between peak shape and width, mass 
deviation and datapoints over the chromatographic peak for this application. Therefore, a 
resolution of 50,000 was further applied within this study. 
Identification of compounds was, together with the retention time, based on their accurate 
mass, i.e. by matching the theoretical mass with the observed mass. Therefore, the 
expected or theoretical masses of the target compounds were calculated to four decimal 
places, using the Xcalibur software (Tables V.2 and V.3). The mass accuracy or mass 
deviation was expressed in parts per million (ppm) and was defined as: 106 * [(measured 
mass – theoretical mass) / theoretical mass]. Extracted ion chromatograms (EIC) were 
obtained using a 5 ppm window. The mean mass deviations of all the compounds were 
calculated at LOQ level (n=10) and were presented in Tables V.2 and V.3, as well as the 
ion mode and retention times. The mass deviations obtained were below 2 ppm for most 
analytes, indicating a high mass accuracy. Propranolol, isoproturon and atrazine showed 
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slightly higher mass deviations, while for salicylic acid a mass deviation of 4.8 was 
obtained. The relatively higher mass deviation of salicylic acid, the only compound with 
m/z ratio below 150, can be attributed to the presence of many background ions in the 
lower mass area [35]. The same experiences were reported in literature: mass deviations 
between 1 and 3 ppm for compounds with m/z ratio higher than 150, while a 5 ppm error 
was observed for compounds with m/z <150 [20]. 
 
Table V.2. Ion mode, internal standard used, retention time, accurate mass and mean mass deviation 
of the targeted pharmaceuticals. 
Compound Ion mode Internal standard tR Accurate Mean mass
  used  mass error
   (min) (m/z) (ppm)
Salbutamol + Salicylic acid-d4 2.41 240.1594 1.10
Atenolol + Sulfamethoxazole-13C6 2.57 267.1703 1.37
Ofloxacin + Sulfamethoxazole-13C6 2.66 362.1511 1.58
Trimethoprim + Sulfamethoxazole-13C6 2.66 291.1452 0.95
Paracetamol + Salicylic acid-d4 2.70 152.0706 0.50
Propranolol + Sulfamethoxazole-13C6 2.72 260.1645 2.27
Pravastatin + Salicylic acid-d4 3.02 447.2357 1.27
Sulfamethoxazole + Sulfamethoxazole-13C6 3.03 254.0594 0.77
Chloramphenicol - Sulfamethoxazole-13C6 3.03 321.0051 0.93
Carbamazepine + Salicylic acid-d4 3.25 237.1022 0.72
Salicylic acid - Salicylic acid-d4 3.44 137.0244 4.80
Bezafibrate + Bezafibrate-d6 3.62 362.1154 0.99
Ketoprofen + Salicylic acid-d4 3.62 255.1016 1.47
Clofibric acid - Bezafibrate-d6 3.69 213.0324 0.95
Carprofen - Salicylic acid-d4 3.89 272.0484 1.69
Diclofenac + Salicylic acid-d4 4.07 296.0240 1.75
Sulfamethoxazole-13C6 +  3.04 260.0795 0.31
Salicylic acid-d4 -  3.38 141.0495 4.51
Bezafibrate-d6 +  3.62 368.1530 1.06
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Table V.3. Ion mode, internal standard used, retention time, accurate mass and mean mass deviation 
of the targeted pesticides. 
Compound Ion mode Internal standard tR Accurate Mean mass 
  used  mass error 
   (min) (m/z) (ppm) 
Pirimicarb + Isoproturon-d6 3.14 239.1503 0.55 
Dimethoate + Isoproturon-d6 3.18 230.0069 1.50 
Chloridazon + Atrazine-d5 3.20 222.0429 1.50 
Dichlorvos + Atrazine-d5 3.38 220.9532 1.83 
Simazine + Isoproturon-d6 3.42 202.0854 1.77 
Isoproturon + Isoproturon-d6 3.56 207.1492 2.14 
Atrazine + Atrazine-d5 3.56 216.1010 2.30 
Diuron + Isoproturon-d6 3.60 233.0243 1.42 
Terbutylazine + Atrazine-d5 3.72 230.1167 1.93 
Linuron + Isoproturon-d6 3.72 249.0192 1.78 
Metolachlor + Atrazine-d5 3.85 284.1412 1.82 
2.4-D - Atrazine-d5 4.16 218.9621 1.53 
Kepone - Isoproturon-d6 4.30 506.68260 0.76 
Isoproturon-d6 +  3.54 213.1869 1.37 
Atrazine-d5 +  3.56 221.1324 1.79 
3.3 Method validation 
The newly developed analytical method was validated according to the criteria specified 
in CD 2002/657/EC [27] for quantitative confirmation as well as to the guidelines of 
SANCO/10684/2009 [36] on pesticide residues analysis in food and feed. In practice, 
validation of the method was executed by adopting the protocol proposed by Antignac et 
al. [37]. This protocol was tailored for validating analytical methods based on MS 
detection and offers a compromise between CD 2002/657/EC [27] and practical aspects 
and limitations related to laboratory work. 
The use of isotopically labeled internal standards in MS-based chemical analysis has been 
highly recommended [27,38]. For the pharmaceuticals, one 13C-labelled 
sulfamethoxazole-phenyl-13C6 and two deuterated pharmaceuticals, bezafibrate-d6 and 
salicylic acid-d4, were used as internal standards. Isoproturon-d6 and atrazine-d5 were 
selected as the internal standards for the pesticides. The corresponding internal standards 
were used for sulfamethoxazole, bezafibrate, salicylic acid, isoproturon and atrazine, 
while the most appropriate internal standard available was used for the other compounds 
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(Tables V.2 and V.3). These internal standards were supplemented to every sampler prior 
to extraction to a final concentration of 25 ng per sheet. The results obtained were thus 
corrected for possible matrix-induced suppression or enhancement effects.  
3.3.1 Specificity 
The specificity of the methods was demonstrated by analysis of blank sampler sheets 
(n=6) and sheets fortified with each analyte separate at their LOQ level. Sheets spiked 
with a mixture of all analytes at LOQ level were analyzed as well. None of the 
compounds were detected in the blanks. The obtained chromatograms showed a 
significant increase in peak area and intensity at the specific retention time of the 
compounds. The specificity of these analytical approaches were confirmed since no other 
significant peaks with a signal-to-noise ratio of 3 or more were observed at the specific 
retention times of the targeted pharmaceuticals and pesticides (Figures V.2 and V.3). 
Using Orbitrap MS, the specificity is guaranteed by the high resolving power of the 
instrument [22].    
3.3.2 Selectivity 
Analytes were identified on the basis of their relative retention time, which is the ratio of 
the retention time of the analyte to that of the internal standard. In addition, the accurate 
mass of the ions ([M−H]− or [M-H]+) in the spectrum was taken into account when the 
chromatographic peak of interest had a signal-to-noise ratio of at least 3:1. A maximum 
mass deviation of 5 ppm was allowed within this study.  
3.3.3 Linearity 
The linearity of the developed methods was evaluated for each target compound by 
preparing ten-point calibration curves (3 replicates). Blank sheets were spiked with a 
standard mixture obtaining concentrations of 0.01, 0.05, 0.1, 0.5, 1, 5, 10, 25, 50 and 100 
ng per sampler sheet of the targeted pharmaceuticals and pesticides. Linear regression 
analysis was executed by plotting the peak area ratios of the analyte against the internal 
standard versus the analyte concentration. The mean correlation coefficients of the 
calibration curves were >0.99, indicating good linearity in this concentration range 
(Tables V.4 and V.5). Only dichlorvos, for which R² equaled 0.97, showed slightly 
inferior linearity. 
  
Table V.4. Validation parameters, Log Kow and Ksa/wa values of the targeted pharmaceuticals. 
Compound Extraction LOD LOQ LOQ R² Recovery Repeatability Within-lab Log Ksa/wa Log Log  
 efficiency       reproducibility Kow  Ksa/wa BAF 
 % ng sheet-1 ng sheet-1 ng g-1  Mean ± SD% RSD% RSD%  L kg-1 L kg-1 L kg-1 
Salbutamol 97 5.0 10 3.2 >0.99 102 ± 8 18 18 0.64 0.04 -1.42 - 
Atenolol 80 0.5 1.0 0.3 >0.99 99 ± 11 18 18 0.16 0.04 -1.38 - 
Ofloxacin 65 0.5 1.0 0.3 >0.99 89 ± 9 15 15 -0.39 0.21 -0.69 - 
Trimethoprim 58 0.5 1.0 0.3 >0.99 93 ± 11 17 18 0.91 0.68 -0.17 - 
Paracetamol 92 0.5 1.0 0.3 >0.99 90 ± 7 15 16 0.46 0.05 -1.29 1.5 ± 0.6 (n=8) 
Propranolol 49 0.5 1.0 0.3 >0.99 94 ± 9 17 17 3.48 23.52 1.37 - 
Pravastatin 82 5.0 10 3.2 >0.99 88 ± 10 18 19 3.10 0.06 -1.23 - 
Sulfamethoxazole 82 0.5 1.0 0.3 >0.99 102 ± 9 15 15 0.89 0.09 -1.04 - 
Chloramphenicol 72 0.5 1.0 0.3 >0.99 102 ± 11 15 16 1.14 0.09 -1.04 1.1 ± 0.4 
Carbamazepine 93 0.5 1.0 0.3 >0.99 101 ± 7 10 11 2.45 30.97 1.48 - 
Salicylic acid 98 0.5 1.0 0.3 >0.99 102 ± 15 18 19 2.26 0.16 -0.79 - 
Bezafibrate 75 0.5 1.0 0.3 >0.99 93 ± 6 11 11 4.25 0.04 -1.41 - 
Ketoprofen 72 5.0 10 3.2 >0.99 88 ± 12 15 16 3.12 0.29 -0.54 - 
Clofibric acid 60 1.0 2.0 0.6 >0.99 99 ± 8 11 11 2.57 0.08 -1.11 - 
Carprofen 75 0.5 1.0 0.3 >0.99 93 ± 10 20 20 3.79 1.81 0.26 - 
Diclofenac 99 1.0 2.0 0.6 >0.99 100 ± 9 17 20 4.51 2.40 0.38 - 
  
Table V.5. Validation parameters, Log Kow and Ksa/wa values of the targeted pesticides. 
Compound Extraction LOD LOQ LOQ R² Recovery Repeatability Within-lab Log Ksa/wa Log Log 
 efficiency       reproducibility Kow  Ksa/wa BAF 
 % ng sheet-1 ng sheet-1 ng g-1  Mean ± SD% RSD% RSD%  L kg-1 L kg-1 L kg-1 
Pirimicarb 42 0.5 1.0 0.3 >0.99 98 ± 11 10 11 1.70 356.4 2.52 - 
Dimethoate 49 0.5 1.0 0.3 >0.99 103 ± 14 13 13 0.78 0.5 -0.35 - 
Chloridazon 55 1.0 2.0 0.6 >0.99 104 ± 9 17 18 1.14 0.8 -0.10 - 
Dichlorvos 57 10 20 6.3 0.97 95 ± 9 18 26 1.43 180.5 2.24 - 
Simazine 65 0.5 1.0 0.3 >0.99 104 ± 10 15 14 2.18 112.7 2.05 - 
Isoproturon 55 0.1 0.2 0.1 >0.99 101 ± 7 9 10 2.87 118.2 2.07 1.1 ± 0.3 (n=8) 
Atrazine 67 0.1 0.2 0.1 >0.99 103 ± 10 11 12 2.61 162.0 2.20 - 
Diuron 50 0.5 1.0 0.3 >0.99 101 ± 12 13 15 2.68 138.3 2.13 1.1 ± 0.3 (n=35) 
Terbutylazine 62 0.1 0.2 0.1 >0.99 100 ± 9 15 15 3.21 332.5 2.40 0.6 ± 0.3 (n=8) 
Linuron 69 5.0 10 3.2 >0.99 97 ± 10 11 11 3.20 - - - 
Metolachlor 49 0.5 1.0 0.3 >0.99 94 ± 9 10 10 3.13 2534.8 3.40 1.7 ± 0.5 (n=22) 
2.4-D 92 1.0 2.0 0.6 >0.99 103 ± 4 7 7 2.81 0.1 -1.29 - 
Kepone 88 10 20 6.3 >0.99 105 ± 9 19 20 5.41 - - - 
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3.3.4 Limit of detection and quantification 
Limits of detection (LODs) and quantification (LOQs) were determined based on the 
outcome of the ten-point calibration curves of the previous section. The concentrations of 
the analytes were calculated using the overall equation of the calibration curves. The 
LOD was defined as the lowest detectable concentration of the calibration curve with a 
signal-to-noise ratio of at least 3:1. The LOQs were then determined as the final LOD 
multiplied by 2 [39]. The LOQs of the targeted pharmaceuticals and pesticides ranged, 
respectively, between 1 and 10 ng per sheet and between 0.2 and 20 ng per sheet. These 
LOQs are considered highly satisfactory, despite the absence of comparable data in 
literature. The LOQs obtained were also presented in ng per g sheet, providing values 
independent of the size of the sheets (Table V.4 and V.5). By calculating this, an average 
weight of 3.15 g (n=30) per sheet was considered.   
3.3.5 Trueness 
Since no certified reference material was available, trueness of the measurements was 
assessed by analysis of blank sheets spiked with each analyte at LOQ level, two times the 
LOQ level and ten times the LOQ level (recovery). This was performed in six replicates 
for all three concentration levels. Mean recoveries of the targeted pharmaceuticals and 
pesticides (n=18) varied, respectively, between 87.9 and 102.4% and between 94.2 and 
105.2% (Tables V.4 and V.5). These calculated recoveries fulfill the criteria set by CD 
2002/657/EC [27] and SANCO/10684/2009 [36], for which typically a recovery is 
required within the range of 80-110% and 70-120%, respectively.  
3.3.6 Precision 
Evaluation of the precision included the determination of the repeatability and the within-
laboratory reproducibility of these new methods. Both validation parameters were 
evaluated by calculating the relative standard deviation (%RSD). To study the 
repeatability of the method, three series of six replicates of sheets were analyzed, and this 
at three concentration levels: LOQ level, two times the LOQ level and ten times the LOQ 
level. These analyses were carried out by the same analyst under repeatable conditions. 
As presented in Tables V.4 and V.5, the calculated RSD values for most compounds were 
below 20%, indicating good repeatability according to SANCO/2007/3131 [36]. Only 
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carprofen showed a slightly inferior repeatability (%RSD of 20.2). The criterion of CD 
2002/657/EC [27], demanding RSD values below 15%, was achieved for half of the 
pharmaceuticals and most pesticides.   
For evaluation of the reproducibility only the within-laboratory reproducibility was 
evaluated. Therefore, four series of six replicates of fortified sheets were analyzed, and 
this at three concentration levels: LOQ level, two times the LOQ level and ten times the 
LOQ level. Different analysts carried out these analyses on different days, using different 
spiking solutions and sampling sheets. According to CD 2002/657/EC [27] and 
SANCO/2007/3131 [36], typically a reproducibility RSD ≤20% is required. As can be 
deduced from Tables V.4 and V.5, except for carprofen and dichlorvos, all RSD values 
were satisfactory. The higher RSD value of dichlorvos and carprofen could be attributed 
to the absence of an appropriate internal standard. The use of an internal standard with a 
higher structural similarity could result in lower RSD values [40]. However, the 
commercial availability of labeled internal standards is limited and the criteria for good 
reproducibility were only slightly exceeded using the most appropriate internal standards. 
3.4 Determination of Ksa/wa 
A 9-d experiment was conducted, to determine the sampler-water partition coefficient 
(Ksa/wa). The pharmaceuticals propranolol and carbamazepine showed a high affinity for 
the PDMS samplers, resulting in Ksa/wa values of 23.5 and 31.0 L kg-1, respectively. The 
Ksa/wa value obtained for carbamazepine was to a large extent in accordance with the 
value reported by Magner et al. [12]. For propranolol and carbamazepine, the enrichment 
profile is depicted in Figure V.4, using the logarithm of Ksa/wa as y-axis. Carprofen and 
diclofenac showed a moderate affinity for the PDMS samplers, while for the other 
pharmaceuticals, the Ksa/wa values obtained were <1 L kg-1, indicating a lower affinity for 
the sampler compared to the water phase. On the other hand, the affinity for the PDMS 
sampler was demonstrated for most pesticides, reaching equilibrium within 3d 
(Figure V.4). Except for chloridazon, dimethoate and 2.4-D, all Ksa/wa values were above 
1 L kg-1, ranging from 112.7 L kg-1 for simazine to 2534.8 L kg-1 for metolachlor. The 
Ksa/wa value of atrazine was 162.0 L kg-1, which is in the same order of magnitude as the 
partition coefficient of 153 L kg-1 reported in literature [10]. Using this experimental 
setup, no Ksa/wa values could be established for linuron and kepone. Probably, the Ksa/wa 
values of both pesticides were too high. Quickly after the introduction of the pesticides, 
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the initial concentration of these compounds in the water phase dropped below their 
LOQ. This depletion phenomenon prevented the determination of Ksa/wa for these 
compounds.  
 
 
Figure V.4. Enrichment profile of the two pharmaceuticals and eight pesticides with high affinity for 
the PDMS passive samplers.   
 
The logarithmic function of the octanol-water partition coefficient of each compound (log 
Kow), generally used as a criterion for hydrophobicity [41], is presented in Tables V.4 and 
V.5 as well [42]. Typically, the log Ksa/wa of an analyte is lower than its log Kow, except 
for pirimicarb, dichlorvos and metolachlor. However, no correlation between both 
partition coefficients was observed (R² of 0.097 and p-value of 0.114). Obviously, the 
sampler-water partitioning is not exclusively driven by the hydrophobicity of the 
substances, but compound-specific interactions in the sampler phase are important as well 
[43]. 
The Ksa/wa coefficients were determined on a standardized manner, as described by 
Magner et al. [12], without making a distinction between different values of pH, salinity 
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and temperature. According to current literature [5,14,16], these environmental 
parameters may definitely impact the uptake of pollutants into the samplers. Therefore, an 
intensive separate study dealing with the effects of environmental conditions on the 
analyte uptake is desired, however, this was outside the scope of the present study. 
Consequently, further research should concentrate on improved approaches for 
calibration and quantification of PDMS passive samplers, thereby taking the different 
environmental parameters into consideration. 
3.5 Application to passive sampler samples deployed in the Belgian coastal zone 
3.5.1 Targeted compounds 
Passive samplers were deployed for circa two months at eight sampling locations in the 
Belgian coastal zone in 2008, 2009 and 2010. Compounds with Ksa/wa <1 showed greater 
affinity for the water phase than for the PDMS passive sampler. As a consequence, the 
reliable calculation of TWA concentrations of these compounds using the samplers was 
inhibited [44]. Therefore, only the pharmaceuticals and pesticides with Ksa/wa >1 were 
considered for quantification. First, the analytes were measured in the samplers using the 
optimized extraction and U-HPLC Orbitrap-MS methods as described above. Next, the 
concentrations of the compounds in the water phase were calculated using the following 
equation: Cwa = Csa / Ksa/wa , expressed in nanograms per liter. These obtained 
concentrations may be considered as approximate calculated TWA concentrations, since 
the possible impact of the environmental conditions was not taken into consideration (see 
section 3.4). As can be seen from Table V.6, two pharmaceuticals were detected in all 
samplers: the β-blocker propranolol and the psychiatric drug carbamazepine in 
concentrations up to 7294 ng L-1 and 732 ng L-1, respectively. Propranolol and 
carbamazepine have been found in grab water samples collected in the same study area, 
in concentrations up to 24 ng L-1 and 321 ng L-1 [4]. Obviously, propranolol was 
quantified in significantly higher concentration levels using the equilibrium based passive 
samplers in comparison with grab water samples. A possible explanation is the decreasing 
hydrophilicity and thus higher affinity for the PDMS sampler of propranolol, due to the 
increasing salinity in the marine environment [5]. The rather high Setschenow salting-out 
constant of propranolol of 3.29 could significantly affect the Ksa/wa value [45]. Assuming 
a salinity of 30 g L-1, the Ksa/wa value will increase with a factor of about fifty [46]. Much 
more realistic TWA concentrations, in the low ng L-1 range, were found if this salting out 
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effect was taken into consideration. Carbamazepine was detected in every passive 
sampler as well. The calculated water concentrations were within the same order of 
magnitude with levels detected in grab samples. As a result, the salting-out effect was 
expected to be low [4,47]. Due to its high persistence, carbamazepine has been reported 
as an excellent tracer substance for pharmaceutical contamination [14,48]. From these 
results it may be concluded that the use of PDMS samplers to obtain long-term and large-
scale TWA concentrations of carbamazepine, as a representative of the pharmaceuticals, 
could be very useful in revealing pharmaceutical contamination of the marine 
environment. By this approach, using the PDMS samplers, both the pollution level of 
hydrophobic compounds for which they were initially designed (PAHs, PCBs, …) as well 
as the more hydrophilic pollutants (pharmaceuticals represented by carbamazepine, 
pesticides, …) could be estimated simultaneously. 
 
  
Table V.6. Calculated water concentrations (ng L-1) of the detected pharmaceuticals and pesticides at eight stations in the Belgian coastal zone in 2008, 2009 and 2010  
(n.d. = not detected). 
 Sea OO1 OO2 OO3  ZB1   ZB2   NP1  NP2 
 2009 2008 2010 2008 2009 2008 2009 2010 2008 2009 2010 2008 2009 2010 2008 2009 2010 2008 2009 2010 
Pharmaceuticals                     
Propranolol 93 285 169 682 1,169 443 348 1,417 405 824 498 443 221 1,855 6,329 658 2,095 7,294 812 2,663 
Carbamazepine 21 136 149 322 587 170 302 650 147 280 225 161 83 367 200 222 455 269 166 732 
Pesticides                     
Pirimicarb n.d. n.d. n.d. 41 10 10 3 25 4 3 20 5 n.d. n.d. 27 3 48 53 13 118 
Simazine n.d. 81 77 148 75 71 64 132 49 45 69 40 34 28 148 63 110 159 106 206 
Isoproturon 12 28 n.d. 67 33 51 29 31 73 41 37 70 37 24 83 51 45 148 260 106 
Diuron 6 143 32 263 92 103 80 70 120 56 36 262 68 73 75 73 47 197 93 104 
Atrazine n.d. 31 13 56 42 34 33 19 25 23 20 16 17 14 41 35 20 56 41 41 
Terbutylazine 3 94 95 355 63 283 62 220 115 78 179 57 51 122 385 251 383 407 215 469 
Metolachlor 1 19 4 104 7 49 5 21 22 8 19 30 5 8 113 8 38 164 22 82 
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As shown in Table V.6, seven pesticides were very frequently detected in the passive 
sampler extracts. Calculation of the TWA concentrations resulted in concentration levels 
of the pesticides up to 118 ng L-1 for pirimicarb, 164 ng L-1 for metolachlor, 56 ng L-1 for 
atrazine, 263 ng L-1 for diuron, 260 ng L-1 for isoproturon, 159 ng L-1 for simazine and 
469 ng L-1 for terbutylazine. These values are in line with reported levels of pesticides 
found in traditional grab samples from the same study area: maximum detected 
concentrations were 77 ng L-1 for atrazine, 454 ng L-1 for diuron, 292 ng L-1 for 
isoproturon, 60 ng L-1 for simazine and 347 ng L-1 for terbutylazine [49]. According to 
the Water Framework Directive (2000/60/EC) [50] and its daughter directive 
(2008/105/EC) [51], environmental quality standards (EQSs), expressed as annual 
average values, were established for atrazine, diuron, isoproturon and simazine being 0.6, 
0.2, 0.3 and 1 µg L-1, respectively. The calculated diuron concentrations exceeded these 
EQSs twice: at sampling locations OO2 and ZB2, both in 2008. The EQSs for the other 
compounds were however never exceeded. The comparison with EQSs present only a 
preliminary approach to characterize the environmental risks to aquatic ecosystems and 
organisms. To aid in assessing these risks, quantitative-structure-activity relationships 
(QSARs) [52-54] have recently been developed to generate screening and toxicity data. 
However, confirmation by direct measurements of concentrations in water is definitely 
required [10]. Therefore, these obtained concentration via passive samplers measurements 
are very useful, in particular because TWA concentrations of the relevant bioavailable 
fraction of the target pharmaceuticals and pesticides are provided. 
Typically, the highest concentrations of the pharmaceuticals and pesticides were found at 
the sampling points in the harbours; more specific those of Nieuwpoort and to a lesser 
extent Oostende. Both locations receive major inputs of contaminated surface water, 
resulting in the increased presence of the targeted pharmaceuticals and pesticides. Due to 
both dilution and degradation effects, only few target compounds were found at the SEA-
station, and this at rather low concentrations in comparison with the harbour stations. 
The present study was conducted side-by-side with the recent publication results reported 
by Wille et al. [31] on the accumulation of the same pharmaceuticals and pesticides in 
marine organisms. In this way, the commonality in contaminants and concentrations 
accumulated by these two matrices may be determined. Bioconcentration of several 
pharmaceuticals in Mytilus edulis has been observed, including propranolol and 
carbamazepine, which were found to be present in the passive samplers as well. Also four 
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pesticides have been found both in tissue and samplers: diuron, isoproturon, terbutyazine 
and metolachlor. Apparently, a correlation between analyte concentrations in side-by-side 
exposures of biota and samplers exists for several pharmaceuticals and pesticides. The 
tendency of an organism to bioaccumulate is assessed by the bioaccumulation factor 
(BAF) which can be calculated using the following equation [55]:  
BAF = Cbiota / Cwater 
BAF values are expressed in L kg-1, since the biota concentration (Cbiota) is expressed in 
µg kg-1 (dry weight) and the water concentration (Cwater) in µg L-1. The mean Log BAFs 
were calculated for every detected compound and are summarized in Tables 4 and 5. The 
obtained Log BAF values varied between 0.6 L kg-1 for terbutylazine to 1.7 L kg-1 for 
metolachlor. Comparable experimental data are not available for the target analytes, 
indicating the relevance of this study.  
 
3.5.2 Untargeted compounds 
A major advantage of the use of Orbitrap MS, is its suitability for untargeted analysis 
[22]. In theory, an infinite number of analytes could be screened using the high-resolution 
full scan data. Thus, the presence in the sampler extracts of non-a priori selected 
pharmaceuticals and pesticides could be examined as well. The retrospective screening of 
the passive sampler extracts, using a 5 ppm window, revealed the presence of two 
pharmaceuticals, simvastatin and fluoxetine, and one pesticide, diazinon. Since no Ksa/wa 
values were obtained for these compounds, estimation of TWA water concentrations was 
impossible. High affinity of simvastatin, fluoxetine and diazinon for the PDMS samplers 
could be expected, since their log Kow values amounted to 5.19, 4.05 and 3.81, 
respectively [42]. Only a small selection of pharmaceuticals and pesticides were screened 
afterwards, so it can be assumed that still other pharmaceuticals and pesticides were 
present in the passive sampler extracts. In conclusion, the excellent applicability of a new 
analytical approach to quantify a limited number of rather polar micropollutants in PDMS 
samplers was presented. In this context, the present study is only the initial stage of a 
more comprehensive study. Indeed, future research must enable the quantification of a 
very wide group of pharmaceuticals and pesticides in PDMS samplers by the 
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development of an extensive database including retention times, accurate masses and 
Ksa/wa values. 
 
4. CONCLUSIONS 
PDMS passive sampling devices were evaluated as a monitoring tool for measuring the 
concentrations of a wide group of frequently used pharmaceuticals and intensively 
applied pesticides in marine waters. Therefore, a new extraction procedure using 1:1 
methanol/acetonitrile was optimized and analysis was performed using ultra-high 
performance liquid chromatography coupled to high resolution Orbitrap-MS. Detection 
with the ExactiveTM Orbitrap MS enabled the use of a very narrow mass tolerance 
window of 5 ppm, providing high mass accuracy. These analytical procedures were 
validated successfully according to CD 2002/657/EC [27] and SANCO/10684/2009 [36], 
showing their excellent performance in quantifying pharmaceuticals and pesticides in 
PDMS passive sampler devices. In addition, an equilibrium-experiment was performed to 
determine the sampler-water partition coefficient (Ksa/wa) of the target analytes. Only a 
limited number of pharmaceuticals showed affinity for the PDMS samplers, while for 
most pesticides high Ksa/wa values were obtained. Deployment of the passive samplers at 
five stations in the Belgian coastal zone revealed the presence of propranolol, 
carbamazepine and seven pesticides. Calculation of the water concentration resulted in 
very high levels of propranolol up to 7 µg L-1, which is probably an overestimation due to 
the salting out effect. The concentrations of the other compounds were below 750 ng L-1. 
These long-term and large-scale TWA concentrations provide appropriate information for 
assessing the pollution level of these pollutants in the marine environment, in particular 
with respect to their biological uptake. 
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1. RESEARCH POSITION AND RELEVANCE 
This doctoral thesis is embedded in the INRAM project, which stands for Integrated Risk 
Assessment and Monitoring of micropollutants in the Belgian coastal zone. The INRAM 
project aims to assess through an integrated approach the risks of micropollutants to Belgian 
coastal zone ecosystems and man, as schematically depicted in Figure VI.1 [1]. The 
objectives of this doctoral work were mainly related to the green section of the scheme, 
including the development of new analytical approaches for the detection/quantification of 
micropollutants in different environmental matrices including seawater, marine biota and 
passive samplers, and a preliminary exposure assessment.  
 
 
Figure VI.1. Schematic overview of the objectives of the INRAM project [1].  
 
As the term micropollutants includes many different groups of contaminants, the scope of this 
study was limited to the more polar chemicals of emerging concern (CECs) such as 
pharmaceuticals, polar pesticides and perfluorinated compounds (PFCs). These emerging 
anthropogenic contaminants have recently gained more attention due their possible toxic, 
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genotoxic and/or endocrine disrupting properties, their potential to cause adverse effects in 
marine organisms and their human exposure via ingestion of contaminated seafood [2-5]. To 
study and evaluate the fate, effects, and environmental and human risks posed by these polar 
micropollutants in aquatic ecosystems, information regarding their presence in the marine 
environment is urgently needed. Therefore, the main goal of the present thesis was to 
investigate the prevalence of targeted CECs in the Belgian marine environment, which 
implicates the need for new reliable analytical methods for the determination of the CECs in 
aqueous samples, biotic tissue (species that are important in terms of human consumption) 
and passive samplers. The main achievements of this thesis are depicted in Figure VI.2.  
 
 
Figure VI.2. Schematic overview of the main achievements within this thesis. 
 
2. THE USE OF MODERN SAMPLE EXTRACTION AND MASS SPECTROMETRY IN 
CEC ANALYSIS 
Current literature on the determination of CECs in the aquatic environment was thoroughly 
reviewed in Chapter I, thereby considering aqueous as well as solid matrices. Obviously, 
considerable attention was spent on the analysis of CECs in environmental matrices in the last 
decade. Within this field of environmental chemistry, some prominent trends could be 
observed. At first, the common use of GC to allow separation of the analytes has to a large 
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extent been replaced by the application of LC, due to the rather hydrophilic character of the 
CECs. However, GC has not been completely ruled out, since it is still the method of choice 
for separation of some typical more hydrophobic CECs such as steroids, alkylphenols, 
fragrances and phthalates, displaying ionisation issues in LC-MS analysis. Nevertheless, 
alternative LC applications have recently been reported for most of these groups as well. 
Secondly, a clear tendency towards multiclass methods could be noticed [6]. Recent advances 
in instrumentation have enabled the simultaneous detection of a large number of compounds 
within one analytical run. Also, the recent emergence of higher resolution LC equipment 
enabling the use of sub-2 µm particle sizes and high flow rates (U-HPLC) allows CECs to be 
resolved more easily, which results in shorter analytical run times. [7]. In addition, the use of 
on-line SPE is currently promoted to shorten the analysis time as well [6,8]. Finally, an 
additional remarkable trend is situated within the field of mass spectrometry. Obviously, a 
gain in popularity of high-resolution full scan analysis could be perceived. ToF and Orbitrap 
instruments proved to be very suitable alternatives to triple quadrupole instruments, thereby 
allowing the accurate mass screening of a virtually unlimited number of analytes, targeted as 
well as untargeted [9,10]. 
Despite the above-mentioned remarkable evolutions and achievements in analytical 
approaches, some typical problems within this domain may be listed. At first, pitfalls in the 
identification and quantification are still generated due to the lack of standardized criteria for 
the identification and confirmation of CECs in environmental matrices. Nowadays, criteria 
comparable to the European criteria 2002/657/EC [11] concerning the determination of 
analytes in products of animal origin, or to SANCO/10684/2009 [12] on pesticide residue 
analysis in food and feed, are missing for environmental matrices such as (sea)water and 
biota. For example, the evaluation of matrix effects is not always taken into consideration 
within validation procedures of newly developed analytical methods, while the occurrence of 
matrix interferences is a well-known source of false positives or negatives and erroneous 
quantification using LC-MS methods [13,14]. Therefore, to our opinion, there is a huge need 
for a standardized validation procedure for analytical methods for environmental applications. 
A second issue is related to the use of modern instruments based on high-resolution accurate 
mass spectrometry, which in recent years have proven to be powerful screening and 
confirmation tools and which have been applied throughout Chapters III, IV and V. Still, 
appropriate identification criteria using these systems are currently incomplete in the 
commonly used procedure prescribed by Commission Decision 2002/657/EC [9,11]. Both the 
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criteria concerning mass resolution and mass accuracy, as well as the system of identification 
points have not been fully specified for these MS systems yet. Therefore, as was suggested by 
Nielen et al. [15], additional criteria for the use of these accurate mass LC-MS technologies 
should be implemented in the standardized validation procedures.  
Besides, several critical comments and useful recommendations concerning quantitative data 
obtained with new analytical methods could be enumerated. Recently, this has been 
demonstrated once again by Van Leeuwen et al. [16], who reported the results of an 
interlaboratory study on the analysis of PFCs in environmental matrices. Some typical sources 
that could contribute to the variance of analytical data include the occurrence of matrix 
effects, the limited use of mass labeled internal standards, the need for blank and recovery 
correction and the perceived failure in separation of isomers (especially for PFCs). However, 
the most important aspect is related to the fact that CECs are usually present at concentration 
levels close to the LODs of analytical methods, which results in less precise quantification 
and a higher variance. Therefore, for newly developed methods, it is definitely recommended 
to utilize sufficient mass labeled internal standards and to perform an extensive validation at 
environmentally relevant concentrations, thereby including the evaluation of matrix effects, 
accuracy and the natural background levels in so-called control samples. In addition, it is also 
suggested to participate in international interlaboratory studies or other data quality tests, 
which may be a good verification tool for the reliability of analytical methods. 
Another important shortcoming within the domain of environmental chemistry, is the current 
lack of comparability of analytical methods and results. In literature, widely differing 
analytical methodologies have been used for obtaining concentrations of CECs in 
environmental matrices. Therefore, to our opinion, there is a huge need for standardized 
‘state-of-the-art’ methods for the different groups of CECs. In Chapter I of this doctoral 
work, the EPA Method 1694 [17] and the ISO 25101/2009 [18] method were mentioned as 
standardized methodologies for analysis of pharmaceuticals and PFCs in water samples, 
respectively. Besides, EPA methods for analysis of different groups of pesticides are also 
available [19]. However, these standardized methods are only rarely applied in recent 
monitoring studies. We believe that the development of advanced up-to-date standardized 
methods and the widespread application thereof, would result in reliable and particularly 
comparable monitoring data.   
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3. DISTRIBUTION OF CECS IN THE MARINE ENVIRONMENT 
3.1 Pharmaceuticals 
In general, research towards the fate and the presence of CECs in the marine environment is 
sparse, certainly in contrast to the great efforts that have been made to study occurrence of 
CECs in freshwater systems. This has been pointed out in Table VI.1 in which a compilation 
of all marine monitoring data available in literature for the pharmaceuticals and pesticides 
included within this thesis have been summarized. Acetylsalicylic acid was included in this 
list as well, since fast hydrolysis to salicylic acid is expected. With an exception for the 
pharmaceutical levels obtained by Togola and Budzinski [20], typical concentrations in 
marine waters are below 200 ng L-1 (Table VI.1). Comparable pharmaceutical concentrations 
were found in this thesis (Chapter II), with somewhat higher levels for the NSAID salicylic 
acid (up to 855 ng L-1), the β-blocker atenolol (up to 293 ng L-1) and the psychiatric drug 
carbamazepine (up to 321 ng L-1). Also propranolol, bezafibrate and sulfamethoxazole have 
been detected in water samples from the Belgian coastal zone. To the best of our knowledge, 
the presence of atenolol, propranolol, and bezafibrate in the marine environment have not 
been reported earlier. Concomitantly, the abundance of salicylic acid in water samples was 
reflected to the mussel tissue concentrations as well, which amounted up to 490 ng g-1 
(Chapter IV). Bioconcentration has also been observed for propranolol and carbamazepine, 
however, lower concentrations were found in the marine biota for these two compounds. 
Comparison of the obtained pharmaceutical concentrations in biotic tissue with literature data 
is not straightforward, since analogues monitoring data are very sparse. Only for 
carbamazepine a concentration level of 0.83 to 1.44 ng g-1 (wet weight) in fish tissue has been 
reported [37]. Two other pharmaceuticals, ofloxacin and paracetamol, could be quantified in 
mussel tissue as well, in spite of their absence in water samples. This discrepancy could be 
attributed to the fact that traditional grab water sampling has been carried out. Grab water 
samples are taken at only a specific time and location, and may not necessarily be 
representative of pollutant levels at other times [38]. Therefore, the use of passive samplers 
for pharmaceutical monitoring in marine waters was investigated in Chapter V. By means of 
passive sampling, a direct estimation of the freely dissolved concentration of CECs is 
obtained, which enables the prediction of biological uptake in a more straightforward manner 
as compared to conventional grab sampling. 
  
Table VI.1. Occurrence of pharmaceuticals and pesticides in the marine and estuarine environment 
Compound Concentration (ng L-1) Location References 
Pharmaceuticals    
Aspirin < 8000 / < 1.6 – 85.8  Mediterranean Sea / Seine estuary  20/21 
Carbamazepine < 42 / 1.8 – 82.7 / 2  Mediterranean Sea / Seine estuary/ North Sea  20/21/22 
 35 – 41x / 26 Seine estuary / Baltic Sea 23/24 
Clofibric acid 0.5 – 7.8 / 18 / < LOQ – 1.35 North Sea / Elbe estuary / North Sea 25/26/26 
Diclofenac < 1100 / 7.1 – 172.5 / 6.2  Mediterranean Sea / Seine estuary / Elbe estuary  20/21/26 
Ketoprofen < 2.4 – 33.2 Seine estuary 21 
Paracetamol 200000 Mediterranean Sea 20 
Sulfamethoxazole 7 Baltic Sea 24 
Trimethoprim 0.03* Mediterranean Sea 27 
Pesticides    
Atrazine 0.2 – 1.5* / 2.35 – 8.18 / 1.27 – 5.93 / < LOQ – 30 Mediterranean Sea / Po delta / Adriatic Sea / Bay of Veys 27/28/28/29 
 < 50 / 19 – 432 / < LOQ – 736 / < 420 Vilaine estuary / Chesapeake Bay / Scheldt estuary / Scheldt estuary 30/31/32/33 
Chloridazon < LOD – 101.48 / < LOD – 40.59 Po delta / Adriatic Sea 28/28 
Chlorpyrifos < LOD – 3.1 Chesapeake Bay 31 
Diazinon < LOD – 56 / < 50 Chesapeake Bay / Scheldt estuary 31/33 
Dichlorvos < 25 Scheldt estuary 33 
Diuron 0.4 – 2.5* / < LOD – 40.78 / 1.65 – 25.32  Mediterranean Sea / Po delta / Adriatic Sea  27/28/28 
 0.015 – 132 / < 100 / < LOD – 21,800 / < LOD – 772  Bay of Veys / Vilaine estuary / Huelva estuary / Almeria  29/30/34/35 
Isoproturon < LOD – 32.08 / < LOD – 0.53 / < LOQ – 42 / < 50 Po delta / Adriatic Sea / Bay of Veys / Vilaine estuary  28/28/29/30 
Linuron < LOD – 30.79 / < LOD – 1.08 Po delta / Adriatic Sea 28/28 
Metolachlor 0.3 / < LOD – 171.53 / < LOD – 59.29 / < 100 North Sea / Po delta / Adriatic Sea / Vilaine estuary 22/28/28/30 
 < LOD – 58 / < 1000 / < LOQ – 0.61  Chesapeake Bay / Scheldt estuary / North Sea  31/33/36 
Pirimicarb 0.7 North Sea 36 
Simazine 0.1 – 0.9* / 1.45 – 24.13 / 1.83 – 25.96 /  Mediterranean Sea / Po delta / Adriatic Sea  27/28/28 
 < 50 / < LOD – 333 / < LOQ – 313  Vilaine estuary / Chesapeake Bay / Scheldt estuary /  30/31/32 
 < 500 / < LOD – 780  Scheldt estuary / Huelva estuary  33/34 
Terbuthylazine 0.7 / 0.35 – 694.32 / 0.57 – 234.50  North Sea / Po delta / Adriatic Sea  22/28/28 
 < LOQ – 261 / < LOD – 52,000 / < LOQ – 0.83  Scheldt estuary / Huelva estuary / North sea  32/34/36 
 
* values obtained by passive samplers; x values obtained by both grab and passive sampling 
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However, only a minority of the targeted pharmaceuticals showed affinity for the PDMS 
passive sampling material, probably due to their low hydrophobicity. Only four 
pharmaceuticals including carbamazepine, propranolol, carprofen and diclofenac were 
considered for quantification in the samplers, since their predicted Ksa/wa coefficients were 
>1. For the other pharmaceuticals, which have been found in mussel tissue, such as 
salicylic acid, paracetamol and ofloxacin, the use of more polar passive samplers is 
desired. Regarding carbamazepine, its ubiquitous character was confirmed using the 
PDMS passive samplers as described in Chapter V, obtaining slightly higher 
concentrations as compared with the levels in the grab samples. For propranolol, 
excessively high concentrations (up to 7,3 µg L-1) were quantified using the passive 
sampling devices. This was ascribed to a possible salting out effect on propranolol due to 
the salinity of the seawater, while Ksa/wa was determined in pure water. In addition, it may 
be assumed that other differences in environmental conditions (water flow rate, 
temperature, pH, and biofouling) between calibration of Ksa/wa in the laboratory and 
deployment of the samplers in marine waters, may affect the final time-weighted average 
concentrations of pharmaceuticals or CECs in general [38]. In conclusion, it seems that 
pharmaceuticals are omnipresent in the Belgian coastal zone, despite the efforts made in 
wastewater treatment plants to remove these micropollutants. 
3.2 Pesticides 
Besides pharmaceuticals, this thesis described the monitoring of a selection of rather 
polar pesticides in the marine environment as well, thereby using biotic tissue (Chapter 
IV) and passive sampling devices (Chapter V). Analysis of mussel tissue revealed the 
presence of 7 pesticides, from which only two pesticides were present above 2 ng g-1: 
dichlorvos and chloridazon. Apparently, dichlorvos has the tendency to bioconcentrate in 
mussel tissue (up to 60 ng g-1), while a decrease in acetylcholinesterase (AChE) activity 
in bivalves using laboratory assays caused by dichlorvos has been reported in literature 
[39,40]. Therefore, further research is definitely recommended to examine possible toxic 
effects caused by exposure to the measured dichlorvos levels. Despite their presence in 
biota, dichlorvos and chloridazon were not detected in passive samplers. In contrast to 
chloridazon (Ksa/wa = 0.79 L kg-1), dichlorvos exhibited a high affinity for the sampler 
compared to the water phase, obtaining a Ksa/wa value of 181 L kg-1. However, the 
absence of dichlorvos could probably be attributed to its minor sensitivity obtained upon 
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optimization of the analytical procedure, achieving an LOQ of 20 ng per sheet while most 
pesticides could be quantified ≤ 2 ng per sheet.  
Seven pesticides were very frequently detected in the passive sampler extracts: 
pirimicarb, simazine, isoproturon, diruon, atrazine, terbutylazine and metolachlor. 
Generally, the time-weighted average passive sampler concentrations for the targeted 
pesticides were below 500 ng L-1, with noticeably higher levels for diuron and certainly 
terbutylazine as compared to the other pesticides. As can be seen from Table VI.1, 
atrazine, diuron, metolachlor, simazine and terbutylazine have been frequently detected in 
marine waters before. Comparison with literature concentration data is complicated, since 
a wide range of concentrations could be observed in the various marine waters. Leaving a 
few outliers out of consideration, typical pesticide concentrations in marine waters are 
below 1 µg L-1. 
3.3 Perfluorinated compounds 
With respect to PFCs, relatively more data on their presence in marine environments have 
been reported. Concentrations of PFOA and PFOS, which are considered as the two 
major contaminants within the group of the PFCs, are usually around tens of pg to a few 
ng L-1 in ocean and coastal seawaters [41]. The concentrations of the detected PFCs 
(PFOS, PFOA, PFHxS and PFOSA) within our PFC-monitoring study (Chapter III) 
were in the same concentration order, except for the S22 and OO2 sample, in which 
higher levels were measured. Since S22 is located in the industrial zone of Antwerp, large 
inputs of PFCs could be expected. With respect to the marine tissue, PFOA could not be 
detected while PFOS was found in most mussel samples. In general, PFOS was found to 
be very abundant in the Belgian marine environment, however, in considerably low 
concentrations. 
3.4 Distribution in the Belgian coastal zone 
In general, a decreasing contamination of the micropollutants with increasing distance 
from the coast could be observed. The highest micropollutant concentrations were found 
at the harbour locations and in the Scheldt estuary (sample location S22). The industrial 
zone of Antwerp and the major inputs of contaminated industrial and domestic 
wastewater rendered the Scheldt estuary into a highly polluted marine environment. 
Rather high levels of the micropollutants were quantified in the coastal harbours as well, 
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probably due to the discharge of high volumes of polluted surface water into the harbours. 
From the data obtained for pharmaceuticals, pesticides as well as PFCs, generally lower 
concentrations in the North Sea could be noticed. To our opinion, both dilution and 
degradation processes resulted in little transport of micropollutants from the Scheldt 
estuary and the harbours towards the open sea. 
 
4. BIOACCUMULATION FACTOR 
Chapter IV has demonstrated that aquatic organisms can accumulate micropollutants 
which are present in the surrounding aquatic environment. Apparently, some chemicals 
such as carbamazepine and diuron were found only at low levels in biotic tissues, whereas 
others such as salicylic acid and dichlorvos were found up to substantially higher 
concentrations. Bioconcentration or bioaccumulation is the increase in concentration of a 
substance in or on an organism, relative to the concentration of the substance in the 
surrounding medium [42]. The tendency of the organism to bioaccumulate is assessed by 
the bioaccumulation factor (BAF) which can be calculated using the following equation 
[43,44]:  
BAF = Cbiota / Cwater 
BAF values are expressed in L kg-1, since the biota concentration (Cbiota) is expressed in 
µg kg-1 (dry weight) and the water concentration (Cwater) in µg L-1. The mean Log BAFs 
were calculated for every detected compound and are summarized in Table VI.2. The 
obtained Log BAF values varied between 0.6 L kg-1 for terbutylazine to 3.7 L kg-1 for 
propranolol, while for PFOS the Log BAF amounted to 2.8 L kg-1. Comparable 
experimental data are available for PFOS: Log BAF values of 3.3 and 4.5 were obtained 
for eel and lake trout respectively, however, expressed on a wet weight basis [43,44]. 
Obviously, the BAF values differed considerably by using grab sample data or passive 
sampler data for carbamazepine and propranolol. This can be attributed to the fact that 
higher water concentrations were obtained by using the passive sampling devices, 
especially for propranolol. Both the Log Kow and the Log Ksa/wa values are presented in 
Table VI.2 as well. The Log Kow is commonly used as an indication of a chemical's 
potential for bioconcentration by aquatic organisms [42]. Hydrophilic or polar 
micropollutants (Log Kow < 2.5) will stay particularly in the water phase, while 
hydrophobic or non-polar substances (Log Kow > 4) will partition to solids such as 
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sediments, suspended matter or biota. Depending on the compound, medium hydrophilic 
micropollutants with Log Kow between 2 and 4 will adsorb to solids or stay in the aqueous 
phase [45]. No correlations between the Log BAF values and the Log Kow coefficients (R² 
of 0.063 and p-value of 0.548) nor between the Log BAF values and the Log Ksa/wa 
coefficients (R² of 0.391 and p-value of 0.133) could be observed. Apparently, 
bioaccumulation is not exclusively driven by the hydrophobicity of substances, which 
turns prediction of partitioning of CECs into different parts of the aquatic environment 
into a difficult task. For this reason, information regarding their presence in both the 
aquatic phase and biotic tissue is required, which is provided within this thesis. 
 
Table VI.2. Bioaccumulation factors (BAFs), Log Kow [46] and Log Ksa/wa values of the detected CECs 
in water and biota 
Compound Log BAF Log Ksa/wa Log Kow 
 L kg-1 L kg-1  
Carbamazepine 2.1 ± 0.4 (n=48) 1.48 2.45 
 1.1 ± 0.4 (n=32) *   
Propranolol 3.7 ± 0.4 (n=9) 1.37 3.48 
 1.5 ± 0.6 (n=8) *   
Salicylic acid 3.1 ± 0.5 (n=65) -0.79 2.26 
Diuron 1.1 ± 0.3 (n=35) * 2.13 2.68 
Isoproturon 1.1 ± 0.3 (n=8) * 2.07 2.87 
Metolachlor 1.7 ± 0.5 (n=22) * 3.40 3.13 
Terbutylazine 0.6 ± 0.3 (n=8) * 2.40 3.21 
PFOS 2.8 ± 0.3 (n=14)  - 6.28 
* obtained with passive sampler data 
 
Besides the ecological relevance of BAFs, their determination is also important for 
regulatory purposes. Nowadays, the European regulation on chemical substances REACH 
requires bioconcentration factors (BCFs), which can be considered as BAFs obtained on a 
standardized manner [42], for all compounds. However, the experimental determination 
of BCFs is time-consuming, complicated, expensive and moreover, calculating these for 
the many thousands of chemical substances of interest is simply not possible [47]. 
Therefore, in recent years, models based on quantitative structure–activity relationships 
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(QSARs) have been developed to predict the partitioning of pollutants in biotic tissue [48-
50]. With respect to CECs, modeling QSARs may certainly form the subject for further 
research, to enable accurate estimations of the accumulation and toxicity caused by CECs 
in organisms, thereby reducing the experimental variability as much as possible. 
 
5. RISK ASSESSMENT 
The risks for the aquatic environment, associated with the measured water concentrations 
of the targeted CECs within this thesis, have been assessed by using the regulatory 
guidance of the Water Framework Directive (2000/60/EC) [51] and its daughter directive 
(2008/105/EC) [52]. In this way, it was observed that the Environmental Quality Standard 
(EQS) of diuron was exceeded at two sampling locations (OO2 and ZB2) (Chapter V). 
However, this preliminary risk assessment is limited to the priority substances listed in 
the WFD guidance, such as the pesticides atrazine, diuron, isoproturon and simazine. 
Although PFOS is included in the WFD list of possible priority substances or priority 
hazardous substances, no EQS for PFOS has been established. Consequently, the 
preliminary risk assessment for PFOS was restricted to a comparison with the Predicted 
No Effect Concentration (PNEC) value of 25 µg L-1 [53]. Obviously, no adverse risks to 
aquatic organisms may be anticipated. Also the drinking water equivalent levels 
(DWELs) reported in literature of 0.04 – 2.4 µg L-1 for PFOA and the provisional health 
advisory developed by the US EPA for PFOA (400 ng L-1) and PFOS (200 ng L-1) were 
not exceeded [54-57]. In addition, no guidance is currently established for widely used 
and widespread occurring pharmaceuticals such as carbamazepine and salicylic acid. The 
risk assessment of pharmaceuticals is usually carried out by comparison of the Predicted 
Environmental Concentration (PEC) with a PNEC value and/or by calculation of the risk 
characterization ratio (RCR = PEC / PNEC). The obtained pharmaceutical monitoring 
data within this thesis did not pose an immediate substantial risk to marine life in the 
Belgian coastal zone, since all RCRs were far below 1 [58].  
The above mentioned assessments, based on acute ecotoxicity data, present only a 
preliminary approach to characterize the environmental risks to aquatic ecosystems and 
organisms for the CECs detected within this thesis. In order to perform a more 
comprehensive risk assessment, more information on the chronic, mixture and 
mechanism specific toxic effects of CECs is needed. Furthermore, the measurements of 
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the body burdens of CECs in species that are important in terms of human consumption 
such as mussels (Chapter IV), are very useful in estimating the human exposure and 
dietary intake of these CECs. It was observed that the European default maximum residue 
level (MRL) for pesticides in foodstuffs of 10 ng g−1 [59] was exceeded for chloridazon 
and dichlorvos at several stations. Consequently, these findings will contribute to the 
evaluation of the human risks posed by these emerging micropollutants.     
 
6. FURTHER RESEARCH RECOMMENDATIONS 
In addition to the previous remarks, some final research recommendations can be stated. 
Several pharmaceuticals, including widely used active substances such as carbamazepine 
and diclofenac, usually undergo only limited degradation in conventional WWTPs [60]. 
Both their polar nature and the low concentrations at which they occur in WWTPs render 
their efficient removal a challenge [61]. Rather low elimination rates were reported for 
other CECs as well, including surfactant degradation products, PPCPs and polar 
pesticides [62]. Consequently, these substances pass through WWTPs unaltered before 
they find their way into receiving waters or land by the application of sewage sludge [63]. 
It is clear that a general removal strategy, which can tackle a broad spectrum of these 
recalcitrant micropollutants at both extremely low and very high concentrations, is 
required. Innovative strategies such as ozonation, advanced oxidation processes and bio-
Pd technology have been suggested to obtain successful removal of micropollutants, and 
should be further explored [64,65]. Additionally, if degradation of parent compounds by 
microbial activity occurs, metabolic intermediates are formed, which could also be toxic 
to aquatic organisms. For this reason, modern monitoring and toxicity studies certainly 
should also include metabolites of CECs as well. 
In 2006, the EU legislation established the PFOS directive 2006/122/EC [66], which aims 
at ending the use of PFOS. In addition, it was recommended to voluntarily reduce the use 
of PFOA as well [67]. Consequently, alternatives and substitute materials were 
introduced, which still offer the needed functionality, but lack the toxicity and 
bioaccumulation potential of PFOS, PFOA and the longer chain PFCs in general. Typical 
substitutes include new and short-chain PFCs (< eight carbons) and their mixtures. 
However, these “new” PFC substances could contribute significantly to the total PFC 
level in waters, since their removal from drinking water by common treatment techniques 
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has been proven to be difficult [67]. In addition, it has been reported that concentrations 
of short-chain PFCs with mildly phytotoxic properties, such as trifluoroacetic acid (TFA), 
could amount to harmful levels in ecosystems [68]. Therefore, more toxicological 
information on these short chain PFCs is needed, to assess their environmental impact. 
Besides, future environmental monitoring studies should certainly include these short-
chain PFCs. 
In the light of REACH, routine measurements of CECs are required in order to ensure 
that the quality of the aquatic environment is maintained [69]. Therefore, cost-effective 
and user-friendly monitoring strategies such as passive sampling devices are needed. 
Although passive samplers constitute an emerging alternative or complement to 
conventional grab sampling, their usage for the polar CECs is still rather limited. Passive 
sampling devices such as polar organic chemical integrative samplers (POCISs) and 
Chemcatcher® samplers have been recently applied for pharmaceutical and pesticide 
monitoring [70,71]. However, the quantitative aspect is still a major issue of concern, due 
to both the lack of calibration data to enable quantification of the target analytes, as well 
as the missing insights in the effects of environmental conditions on the analyte uptake. 
Therefore, further research should concentrate on the use of passive samplers as an 
efficient alternative to active water sampling of CECs, and more specific on the 
approaches for calibration and quantification thereof. 
This thesis is a comprehensive evaluation study of the presence of a wide variety of 
emerging micropollutants in the Belgian marine environment. New data of CECs in 
water, biotic tissue and passive samplers are provided, thereby using newly developed 
analytical methods employing modern and sophisticated analytical equipment. The 
obtained findings will surely contribute to an integrated assessment of the environmental 
and human health risk of these emerging micropollutants, however, much additional 
research is still needed.   
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SUMMARY 
  
In the last decade, there has been a growing public and scientific concern regarding the 
occurrence and potential harmful effects of chemicals of emerging concern (CECs) in the 
aquatic environment. However, little attention has been paid so far to their prevalence and 
quantification in marine ecosystems. To study and evaluate the fate, effects, and 
environmental and human risks posed by these emerging contaminants, information 
regarding their presence in marine waters and organisms is urgently needed. Therefore, 
the research within this doctoral thesis aimed at the determination of different groups of 
CECs, including pharmaceuticals, perfluorinated compounds (PFCs) and pesticides, in 
environmental matrices. To this end, new analytical methods employing modern and 
sophisticated equipment were developed, validated and applied to samples originating 
from the Belgian coastal zone. 
 
In Chapter I, a comprehensive overview is given of the analytical chemistry of the most 
environmentally important groups of CECs, including the pharmaceuticals and personal 
care products (PPCPs), pesticides, steroid hormones, PFCs, alkyphenolethoxylates, 
bisphenol A and phthalates. Due to both the typically very low concentrations at which 
CECs occur and the fact that environmental samples are complex matrices demanding 
extensive extraction and clean-up procedures, very specific and sensitive analytical 
procedures are needed. In this context, state-of-the-art instrumentation for sample 
preconcentration, analyte separation and detection was discussed. Several prominent 
trends could be observed: the common use of LC to allow separation of the CECs instead 
of GC, the development and application of multiclass methods, and a gain in popularity 
of high-resolution full scan analysis, combined with the trend towards the use of sub-2 
µm particle sizes and high flow rates (U-HPLC). Overall, due to the recent advances in 
instrumentation, a significant progress in the analytical chemistry of CECs in 
environmental matrices could be noticed. 
 
The objective of Chapter II was to develop, optimize and validate a new analytical 
method for the quantitative analysis of 13 multiclass pharmaceuticals in seawater. Using a 
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combination of solid-phase extraction (SPE) and liquid chromatography coupled to 
multiple mass spectrometry (LC-MS/MS), limits of quantification between 1 and 50 ng L-
1 could be obtained. Validation according to Commission Decision 2002/657/EC resulted 
for most pharmaceuticals in linearities > 0.99 and recoveries between 95–108%. 
Application of this method to water samples from the Belgian coastal zone, revealed the 
presence of seven pharmaceuticals. Salicylic acid and carbamazepine were the most 
abundant pollutants, in concentrations up to 855 ng L-1. 
 
The development, validation and application of a new analytical method for the 
determination of 14 PFCs in surface-, sewage- and seawater was described in Chapter 
III. The occurrence of branched isomers, matrix interferences and cross contamination 
rendered quantitative analysis of PFCs in aqueous matrices a challenging task. However, 
the use of SPE followed by LC coupled to time-of-flight mass spectrometry (LC–ToF-
MS) using very narrow mass tolerance windows (<10 ppm) resulted in a highly selective 
analytical approach for the detection of PFCs in complex aqueous matrices. Validation of 
this new method in surface-, sewage- and seawater resulted in LOQs ranging from 2 to 
200 ng L−1, satisfying recoveries (92–134%) and good linearities (R2=0.99 for most 
analytes). Analysis of North Sea and Scheldt estuary samples confirmed the presence of 
several PFCs, with the main contaminant perfluorooctane sulfonate (PFOS) detected in 
concentrations up to 39 ng L−1. 
 
In Chapter IV, the occurrence of 14 pesticides, 10 PFCs, and 11 pharmaceuticals in 
freeze-dried tissue of blue mussels (Mytilus edulis) is described. Therefore, new methods 
were presented consisting of pressurized liquid extraction and SPE followed by ultra 
high-performance liquid chromatography coupled to triple quadrupole mass spectrometry 
(U-HPLC-QqQ-MS/MS) for pharmaceuticals and pesticides. For PFCs, a liquid 
extraction using acetonitrile and SPE followed by LC-ToF-MS was applied. Evaluation 
of the method performance resulted in LOQs in M. edulis tissue between 0.1 and 10 ng 
g−1, and satisfactory linearities (≥0.98) and recoveries (90–106%) were obtained. Five 
pharmaceuticals, two PFCs, and seven pesticides at levels up to 490, 5, and 60 ng g−1, 
respectively, were detected in the M. edulis samples originating from cage experiments at 
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different locations in the Belgian coastal zone. The most prevalent micropollutants were 
salicylic acid, paracetamol, PFOS, chloridazon and dichlorvos.  
 
The use of passive samplers as an efficient alternative to active water and biological 
sampling of CECs is presented in Chapter V. A new analytical method was optimized 
for the quantification of a high number of pharmaceuticals and pesticides in passive 
sampling devices. The analytical procedure consisted of extraction using 1:1 
methanol/acetonitrile followed by detection with U-HPLC coupled to high resolution and 
high mass accuracy Orbitrap MS. The LOQs obtained were between 0.2 and 20 ng per 
sampler sheet and the recoveries ranged from 88 to 105%. In addition, the sampler-water 
partition coefficients of all compounds were determined. It was found that few 
pharmaceuticals and most pesticides exerted a high affinity for the polydimethylsiloxane 
passive samplers. This was confirmed by measuring the time-weighted average 
concentrations of the targeted pollutants in passive samplers, deployed at eight stations in 
the Belgian coastal zone. Propranolol, carbamazepine and seven pesticides were found to 
be very abundant in the passive samplers.  
 
Finally, in Chapter VI, general conclusions of this doctoral work and further research 
perspectives were formulated. The major goal of this doctoral thesis was the development 
of new analytical approaches for quantification of emerging micropollutants in the 
Belgian coastal zone. The obtained concentrations of the targeted micropollutants in 
marine waters, biota and passive samplers were discussed in terms of their distribution in 
the marine environment. In addition, the bioaccumulation potential of the measured 
micropollutants was determined and a preliminary risk assessment based on acute 
ecotoxicity data and regulatory standards was provided. Still, more information on both 
the accumulation potential of CECs and their chronic, mixture and mechanism specific 
toxic effects is needed, to enable the integrated assessment of the environmental and 
human health risk. Within this view, modeling QSARs may certainly form the subject for 
further research. 
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SAMENVATTING 
 
De laatste 10 jaar is er zowel vanuit maatschappelijke als wetenschappelijke hoek een 
toenemende bezorgdheid merkbaar omtrent de aanwezigheid en de potentiële effecten van 
bepaalde opkomende contaminanten in het aquatisch milieu. Evenwel werd de 
aanwezigheid en de kwantificering van deze vervuilende stoffen in het mariene milieu tot 
nu toe slechts in beperkte mate bestudeerd. Om een juiste inschatting te kunnen maken 
van de verspreiding, effecten en risico’s voor mens en milieu veroorzaakt door deze 
polluenten, is er duidelijk meer informatie nodig omtrent hun aanwezigheid in mariene 
wateren en organismen. Het huidige doctoraatsonderzoek kadert binnen deze 
problematiek en heeft als algemeen doel het bepalen van verschillende groepen van 
opkomende contaminanten waaronder farmaceuticals, pesticiden en perfluorverbindingen 
in diverse milieumatrices. Daartoe werden nieuwe analysemethoden ontwikkeld, 
gevalideerd en toegepast op stalen afkomstig van verschillende plaatsen aan de Belgische 
kust, daarbij gebruik makend van moderne en gesofisticeerde analytische apparatuur. 
 
In Hoofdstuk I wordt een uitgebreid literatuuroverzicht gegeven van de recente 
analytische methodiek voor de detectie van de belangrijkste groepen van opkomende 
contaminanten. Daartoe behoren de farmaceuticals en persoonlijke verzorgingsproducten, 
de pesticiden, de steroïden, de perfluorverbindingen, de alkylphenolethoxylaten, bisfenol 
A en de ftalaten. Deze stoffen komen typisch in heel lage concentraties voor in het 
aquatisch milieu en bovendien gaat het om heel complexe matrices waaruit de doelstoffen 
moeten geïsoleerd worden. Om deze redenen is een grondige staalvoorbereiding, een 
geschikte extractiemethode en heel specifieke en gevoelige analytische apparatuur 
essentieel. In dit opzicht werd de huidige stand van zaken besproken van de mogelijke 
methoden en apparatuur om de doelstoffen te extraheren, opconcentreren, scheiden en 
detecteren in diverse aquatische milieumatrices. Enkele trends die naar voorkomen zijn 
de volgende: het toenemend gebruik van vloeistofchromatografie (LC) in plaats van 
gaschromatografie (GC), de ontwikkeling van methoden die toepasbaar zijn voor 
verschillende groepen van contaminanten tegelijk, en het toenemend gebruik van hoge 
resolutie massaspectrometrie (MS), en dit alles in combinatie met het toenemend gebruik 
van ultrahoge druk vloeistofchromatografie. Over het algemeen kan men stellen dat door 
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de recente ontwikkelingen op vlak van instrumentatie er een enorme vooruitgang is 
geboekt in dit onderzoeksdomein.  
 
Het doel van Hoofdstuk II bestond erin om een nieuwe analysemethode te ontwikkelen, 
optimaliseren en valideren voor de kwantitatieve bepaling in zeewater van 13 
farmaceuticals uit verschillende therapeutische klassen. De combinatie van vaste-fase 
extractie en LC gekoppeld aan ion trap MS resulteerde in kwantificeringsgrenzen tussen 1 
en 50 ng L-1. Validatie volgens de Europese criteria (2002/657/EC) toonde aan dat een 
lineaire (R² > 0.99) en accurate (95–108%) methode werd bekomen. Toepassing van deze 
nieuwe methode op waterstalen afkomstig uit het studiegebied van de Belgische kustzone 
toonde de aanwezigheid aan van 7 farmaceuticals. Salicylzuur en carbamazepine werden 
hierbij het vaakst en in de hoogste concentraties teruggevonden, meer bepaald tot een 
concentratie van 855 ng L-1.         
 
De ontwikkeling, validatie en toepassing van een nieuwe analysemethode voor de 
bepaling van 14 perfluorverbindingen in oppervlakte-, afval- en zeewater is beschreven in 
Hoofdstuk III. De aanwezigheid van vertakte isomeren en het mogelijk optreden van 
matrixinterferenties en contaminatie maakt van de kwantificering van 
perfluorverbindingen in waterige matrices een complexe taak. Door gebruik te maken van 
vaste-fase extractie gevolgd door LC gekoppeld aan een ‘time-of-flight’ MS met een lage 
massa-afwijkingsgrens (< 10 ppm), werd een heel selectieve methode bekomen voor deze 
toepassing. Validatie van deze methode resulteerde in kwantificeringslimieten tussen 2 en 
200 ng L−1, een geschikte accuraatheid (92-134%) en lineariteit (R2 = 0.99 voor de meeste 
van de doelstoffen). Analyse van stalen afkomstig van de Belgische kustzone bevestigde 
de aanwezigheid van verschillende perfluorverbindingen, waarbij PFOS teruggevonden 
werd in de hoogste concentraties tot 39 ng L−1. 
 
In Hoofdstuk IV werd de aanwezigheid van 14 pesticiden, 10 perfluorverbindingen en 11 
farmaceuticals in weefsel van de blauwe mossel (Mytilus edulis) bestudeerd. Daartoe 
werden nieuwe methoden opgesteld die voor de bepaling van farmaceuticals en pesticiden 
bestaan uit vloeistofextractie onder verhoogde druk en temperatuur, gevolgd door vaste-
fase extractie en detectie met behulp van ultra-hoge druk vloeistofchromatografie en 
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triple quadrupole massaspectrometrie (U-HPLC-QqQ-MS/MS). Voor de 
perfluorverbindingen werd gebruik gemaakt van vloeistofextractie met acetonitrile 
gevolgd door vaste-fase extractie en LC-ToF-MS detectie. Evaluatie van de 
prestatiecriteria van deze methode resulteerde in kwantificeringsgrenzen tussen 0.1 en 10 
ng g-1, adequate lineariteiten (R² > 0.98) en terugvindingen tussen 90 en 106%. Vijf 
farmaceuticals, 2 perfluorverbindingen en 7 pesticiden in respectievelijke concentraties 
tot 490, 5 en 60 ng g-1, werden gedetecteerd in de M. Edulis stalen afkomstig van 
kooiexperimenten uitgevoerd op verschillende plaatsen in de Belgische kustzone. De 
meest voorkomende polluenten waren salicylzuur, paracetamol, PFOS, chloridazon en 
dichloorvos.    
 
Het gebruik van passieve bemonsteringstechnieken als alternatief voor actieve 
bemonstering van de opkomende contaminanten in water en biota werd besproken in 
Hoofdstuk V. Daartoe werd een nieuwe analysemethode ontwikkeld voor de 
kwantificering van een groot aantal farmaceuticals en pesticiden in passieve 
bemonsteringssytemen. Deze analysemethode bestond uit extractie met een mengsel van 
methanol en acetonitrile (50/50) gevolgd door detectie met behulp van U-HPLC 
gekoppeld aan hoge resolutie en accurate massa analyse met behulp van Orbitrap MS. Dit 
resulteerde in kwantificeringsgrenzen tussen 0.2 and 20 ng per sampler sheet en 
terugvindingen tussen 88 en 105%. Daarnaast werden de partitiecoëfficiënten tussen 
water en het passief bemonsteringssysteem bepaald voor alle componenten. Enkele 
farmaceuticals en de meeste pesticiden vertoonden een hoge affiniteit voor de passieve 
bemonsteringssystemen bestaande uit polydimethylsiloxaan. Dit werd bevestigd bij het 
bepalen van de tijdsgewogen gemiddelde concentraties van de polluenten in de passieve 
bemonsteringssystemen die werden geplaatst op 8 verschillende locaties in de Belgische 
kustzone. Hierbij werden zowel de farmaceuticals propranolol en carbamazepine als 
zeven pesticiden vaak gedetecteerd in de passieve bemonsteringssystemen.  
 
Tenslotte werden in Hoofdstuk VI de algemene besluiten van deze thesis geformuleerd, 
alsook enkele toekomstige onderzoeksmogelijkheden. Het hoofddoel van deze 
doctoraatsstudie bestond in de ontwikkeling van nieuwe analysemethoden om 
kwantificering van de opkomende micropolluenten in de Belgische kustzone mogelijk te 
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maken. De gemeten concentraties van de micropolluenten werden in dit deel besproken 
op vlak van hun verspreiding in het mariene milieu. Ook werd hun vermogen tot bio-
accumulatie bepaald en werd een beperkte risico-inschatting uitgevoerd op basis van 
korte-termijn ecotoxiciteitsdata en standaardwaarden afkomstig uit de wetgeving. Om tot 
een geïntegreerde risico-inschatting voor mens en milieu te komen, is er duidelijk nog 
nood aan meer informatie omtrent hun bio-accumulatie potentieel alsook aan chronische-, 
mengsel- en mechanismespecifieke toxiciteitsdata. In dit opzicht vormt de verdere 
ontwikkeling van de QSAR-technologie een zeer interessant onderzoeksperspectief. 
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DANKWOORD 
Het dankwoord… het laatste stukje tekst om te schrijven, maar misschien wel het deel dat 
het meest wordt gelezen. Geheel in de sfeer van mijn onderzoek, zou ik de voorbije 4 jaar 
willen vergelijken met een staalnamecampagne met de wetenschapsboot de Belgica, 
waarmee ik toch een 4-tal keer op staalname ben geweest in de Noordzee en Schelde. De 
4 jaar durende tocht met het schip kreeg de naam INRAM, en het doel ervan was om de 
vervuiling van de ons zo geliefde Noordzee wat beter in kaart te brengen. Ikzelf had het 
geluk om te mogen deel uitmaken van de bemanning van het schip. En het moet gezegd, 
het was een heel boeiende ontdekkingstocht op zee! Meestal was het een gladde zee met 
kleine golven, maar soms waren er ook hoge, moeilijk te nemen golven, bij windkracht 
10. Maar mede dankzij de hulp van heel wat mensen is het schip gelukkig nooit ten onder 
gegaan! 
Mijn eerste woord van dank gaat naar de beheerder van het schip, de admiraal in militaire 
termen, professor Hubert De Brabander. Bedankt professor om mij deze kans te geven, 
om gedurende de voorbije 4 jaar interesse te tonen in mijn onderzoek en voor de 
uitstekende sfeer die in het labo hangt. Mijn laatste dag op het labo viel samen met uw 
laatste werkdag. Ik wens je dan ook een lang en gelukkig pensioen! Onder de admiraal 
vinden we de kapitein-ter-zee, en in dit geval zijn het er twee: Herlinde en Lynn. Eerst en 
vooral wil ik Herlinde bedanken, voor het vertrouwen in mij bij de selectie van een 
geschikte doctoraatsstudent en de begeleiding gedurende het eerste jaar. Ook heel erg 
bedankt dat je, nadat je besloten had om een andere koers te varen, mijn onderzoek toch 
verder wou opvolgen! De tweede kapitein-ter-zee is Lynn, of ondertussen professor 
Vanhaecke. Professor Vanhaecke, een welgemeende dankuwel voor je begeleiding 
gedurende de laatste 2,5 à 3 jaar. Zoals het een echte kapitein betaamt heb je mijn 
onderzoek de juiste koers en snelheid gegeven. Bovendien was het aantal knopen 
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waarmee je verbeterwerk afleverde ongezien! Ook de andere bemanningsleden van het 
labo wil ik bij deze uitvoerig bedanken. Karolien, Julie, Karen: bedankt voor de leuke tijd 
in onze kajuit (lees: bureau). Het was heel fijn om dagelijks met jullie samen te werken, 
overleggen, discussiëren en lachen. We horen elkaar nog wel! Ook een dankuwel aan 
Lieven en Julie! Lieven, probeer de eer van het mannelijk geslacht hoog te houden in het 
labo, het zal niet gemakkelijk zijn tussen al dat vrouwelijk geweld. En Julie, mijn enige 
thesisstudent, bedankt voor je hulp met misschien wel het moeilijkste deel van mijn 
doctoraat: de methodeontwikkeling voor analyse van de biota. Honderden extracties van 
mosselen, garnalen en oesters: evident was het allemaal niet. Ook een dikke merci aan 
Soetkin voor alle administratieve zaken die je hebt geregeld, je hulp voor de lay-out en 
cover van mijn boekje en je (meestal geslaagde) humor. We zullen elkaar in Houtem nog 
wel eens tegenkomen zeker… Mieke, eerst en vooral bedankt voor je hulp bij de 
analyses, maar zeker en vast ook voor de leuke babbels over dingen die niks met het werk 
te maken hadden; over de familie, marathons lopen, Kenia, … Lucie, bedankt voor de 
vele hulp en de fijne tijd in het labo. Ik probeer er te zijn op je pensioenviering 
binnenkort! Ook Martine, Marleen, Wendy, Els, Fanny, Joke, Vera en Thijs bedankt! Een 
speciale dank gaat ook uit naar Dirk, de meest stipte carpoolpartner ter wereld! Ik 
daarentegen…mijn welgemeende excuses dat je dikwijls enkele minuten moest wachten 
op mij. Toen ik op het labo begon, was je er de enige man. Wat later bleek dat je ook 
voetbalde en dat je ook in Lede kwam wonen: wat een gelukkig toeval! Een dikke merci 
en ik hoop dat we elkaar nog regelmatig horen! Ik wil zeker ook de andere mensen van de 
vakgroep bedanken (voor onder andere de leuke middagpauzes): prof. De Zutter, prof. 
Houf, Sarah, Julie, Adelheid, Inge, Annelies, Sandra, Carine, Martine, Laid, Johan, Lieve, 
Sigrid, … 
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Ik heb het geluk gehad om gedurende twee jaar twee dagen per week een ander schip te 
mogen bemannen, namelijk dat van de Vlaamse Milieumaatschappij. Hierbij wens ik 
Peter Van Caeter te bedanken, ook een speciale dank gaat uit naar Eric De Wulf voor het 
dagdagelijks begeleiden gedurende deze periode! Deze samenwerking heeft mijn 
onderzoek zeker in grote mate geholpen. Maar wat ik het meest zal onthouden zijn de 
hele leuke mensen met wie ik er heb kunnen samenwerken: Leona voor de hulp met de 
moeilijke perfluors, Jaime, Geert, Annick, Chris, Sofie, Inge, Peter, Ingrid, Liesbet,… 
Wie weet tot later nog eens! 
Samen met de andere project-medewerkers Karen, Michiel en Els hebben we ons uiterste 
best gedaan om de tocht van het INRAM-schip tot een goed einde te brengen. 
Uiteindelijk denk ik dat we er, ondanks alles, vrij goed in geslaagd zijn. Karen, bedankt 
om al het mooie leven in de zee een naam te geven; Michiel voor het vlotte verloop van 
het project en Els voor het verstaanbaar uitleggen van het principe van de passive 
samplers. Het is mede dankzij jullie dat ik vandaag dit werk kan afleveren: een 
welgemeende dankuwel en veel succes met jullie doctoraten! Bij deze wens ik ook de 
projectbegeleider en co-promotor professor Colin Janssen te bedanken, alsook Patrick, 
An, Annelies, Ghijs en alle andere medewerkers van INRAM.   
Regelmatig legde het INRAM-schip aan in de haven en was er tijd voor de broodnodige 
ontspanning! Daarvoor zorgde onder andere het fenomeen Lazio Lede, beter bekend als 
(in alle bescheidenheid) de beste zaalvoetbalploeg van Oost-Vlaanderen. Ook al hadden 
de veelvuldige overwinningen in beker en competitie niet altijd een positieve invloed op 
de productiviteit van ondergetekende: toch bedankt! Ook bedankt aan vrienden, 
vriendinnen,  familie, en de mannen van de veldvoetbal voor de nodige verstrooiing. 
Maar bovenal heeft een bemanningslid van een schip nood aan een goeie thuis, en wat 
voor één! Een hele hele hele grote dankuwel aan moe en va, die altijd op de eerste rij 
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staan en stonden om mij te steunen en op te monteren tijdens mijn studies, werk en al de 
rest. Zonder jullie stond ik niet waar ik nu sta, merci! Hetzelfde geldt natuurlijk ook voor 
mijn 2 oudste broers en fantastische schoonzussen, een heel hartelijke dankuwel Wouter 
& Nathalie en Stijn & Anneleen! En ik kan natuurlijk ook de 2 jongste broers niet 
vergeten. Sander, mijn laatste week op de unief betekende voor jou de eerste! Je hebt niet 
de makkelijkste maar wel een heel mooie keuze gemaakt. Als ik je kan helpen, laat maar 
weten want ik begin de professoren ondertussen een beetje te kennen... Maar ook zonder 
hulp en met een beetje geluk zal het wel lukken! Sep, tegenover wat jij hebt meegemaakt 
2 jaar geleden is een doctoraat schrijven peanuts. Evenveel hoofdstukken in dit boekje als 
jouw aantal operaties, het was echt niet min. Gelukkig is het besluit bij u veel positiever 
dan het mijne! Doe zo voort en wie weet sta je hier binnen enkele jaren ook… Ook 
bedankt aan de grootouders en schoonouders voor hun interesse in mijn onderzoek. 
En dan tot slot, een wel heel speciaal woordje van dank aan mijn beste maatje op zee, 
Katrien. Ondanks dat mijn boekje nu echt naar de drukker moet, zou ik nu wel nog een 
volledig nieuw hoofdstuk kunnen schrijven... We zijn scheepsmaatjes sinds 2002, enkele 
maanden voor ik begon te studeren. Je hebt dus elk examen en herexamen (ja, zo waren 
er ook een paar) meegemaakt. Ik kan je dus niet genoeg bedanken voor alle steun die je 
gedurende de voorbije 9,5 jaar aan mij hebt gegeven. Je was er om mee te vieren bij elk 
leuk moment en om me op te beuren bij elke tegenslag. Enkele maanden geleden zijn we 
in het huwelijksbootje gestapt. Hopelijk kan ons bootje nog heel lang blijven drijven 
zoals dat het nu doet en wie weet komen er dan nog wel enkele kleine matroosjes bij… 
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